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Abstract 
Despite the advent of powerful modern antibiotics, pneumonia continues to be of 
great importance. Although most cases of community acquired pneumonia (CAP) will 
recover fully, some (including those previously fit and well) may die. Many hospital patients 
will suffer nosocomial pneumonia (NP), with a high mortality rate. This is particularly true 
on the intensive care unit. 
The neutrophil granulocyte is of particular importance in the defence of the lung. It 
contains many substances that are bactericidal. During pneumonia, it is recruited from the 
intravascular space into the lung interstitium and the air -spaces. There, its bactericidal 
products are capable not only of damaging and killing bacteria, but also of causing'by- 
stander' damage to the host lung. During the course of pneumonia it is important that 
neutrophils are not only recruited rapidly to defend against bacteria, but that their 
recruitment should cease as soon as adequate numbers are attained or their function is no 
longer required. Not only that, but the neutrophils that have already been recruited must then 
be safely and speedily removed from the site of pneumonia. 
To investigate these dynamic processes, a rabbit model of pneumonia was used. 
Bacteria were instilled to a localised area via a fibre -optic bronchoscope. This allowed strict 
definition of the time of onset of pneumonia, and study of subsequent evolving processes. 
Two organisms were used; 1) Streptococcus pneumoniae, an organism characteristic of CAP 
and; 2) Escherichia coli, an organism characteristic of NP. It was hypothesised that in 
pneumonia due to the former (PneuS), the usual remarkably complete recovery witnessed 
clinically is due to the tissue load of neutrophils being carefully controlled. By contrast, 
pneumonia due to the latter (pneuE) is clinically much more severe and lung- damaging, due 
to a larger lung neutrophil burden. This could be because of earlier cessation of neutrophil 
influx and /or more rapid neutrophil clearance in pneuS than pneuE. 
3 
Radiolabelled neutrophils from donor animals were injected at intervals after 
induction of pneumonia to assess the magnitude of ongoing neutrophil recruitment. In 
pneuS, neutrophil influx was significantly elevated above control levels at 6 hour but not 30 
hour or subsequent time points. In pneuE, neutrophil influx was at least as high at 30 hours 
as at 6 hours. This confirms the hypothesis that neutrophil influx is more prolonged in 
pneuE than in pneuS. 
The requirement for the CD18 adhesion molecule, (known to be important in 
recruitment of neutrophils) has been shown to change with time in the peritoneum. This 
could be an important facet of control of the development of inflammation. In pneuS, 
neutrophil recruitment is known to be CD18 independent. The previous finding of others 
that such antibodies inhibit neutrophil recruitment early (6 hours) in pneuE was confirmed. 
It was found there was no change in this CD18 dependency later on (at 30 hours). 
The chemokine IL -8 is thought to be particularly important in the recruitment of 
neutrophils. An anti -IL -8 blocking antibody was used to assess the importance of IL -8 in 
neutrophil recruitment at 6 and 30 hours. Although this inhibited IL -8 induced neutrophil 
shape change in vitro and intradermal IL -8 induced neutrophil influx in vivo, iand reversed 
the prolonged retention of tracer neutrophils in pneumonic lungs minutes after injection, the 
antibody failed to block neutrophil influx in either type of pneumonia at 6 or 30 hours. 
hndeed, there was a trend towards increased influx after treatment. High dose antibody 
produced the same effect. These surprising results are partly explained by higher broncho- 
alveolar lavage (BAL) and plasma levels of IL -8 after antibody treatment. This may be due 
to IL -8 /anti -IL -8 antibody complexes amplifying the inflammatory response, although no 
endothelially bound anti -IL -8 was detected. Alternatively, it may represent the release of 
negative feedback on IL -8 production. 
In both pneus and pneuE, the early peak in BAL neutrophil numbers was followed by 
an increase in the number of apoptotic neutrophils. This in turn was followed by an 
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increased number of alveolar macrophages containing apoptotic bodies. Trypan blue 
positive, necrotic neutrophils were rare. This is consistent with neutrophil apoptosis and 
associated macrophage phagocytosis, (a process that limits the release of toxic neutrophil 
products), playing an important role in neutrophil clearance in pneumonia. 
BAL from animals with pneumonia promoted rabbit neutrophil apoptosis in vitro. In 
pneuS (but not pneuE) this correlated weakly though significantly with the amount of 
apoptotic neutrophils recovered from BAL and with BAL levels of IL -8, gro and MCP -1. It 
is suggested that a factor is elaborated within the lung during inflammation that promotes 
neutrophil apoptosis, thus giving negative feedback control on the lung neutrophil burden. 
The different relationships found between in vitro and in vivo in pneuS and pneuE may 
again contribute to the different clinical outcomes in the two diseases. 
In summary, an animal model demonstrated that neutrophil influx was more 
prolonged in pneuE than in pneuS. It is suggested this contributes to the more severe 
manifestations of the former clinically. CD18 was important to the influx of neutrophils in 
pneuE late as well as early in the disease. Anti -IL -8 antibody failed to inhibit neutrophil 
influx in either type of pneumonia, which may be due to immune -complex formation or 
release of negative feedback controls. Evidence that neutrophil apoptosis is involved in their 
clearance during pneumonia was obtained, together with evidence that a factor is released to 
promote neutrophil apoptosis and thus provide negative feedback control of inflammation 
during pneumonia. The control may differ in PneuS and PneuE, affecting outcome. 
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I. INTI2ODUCTION 
"Sir William Osler called pneumonia 'the Captain of the men of death'. Although progress 
has been made to reduce the rank from Captain, greater efforts are needed to improve our 
understanding of the pathogenesis, prevention, diagnosis, and treatment of this infection" 
(Craven and Steger, 1989) 
1.1 Scope and aims of this thesis 
This thesis examines neutrophil granulocyte recruitment to and clearance from the 
lung in the context of pneumonia. Normally the neutrophil is produced in the bone marrow, 
before release into the circulation, where it has a limited lifespan. In pneumonia (as in other 
forms of acute inflammation) the neutrophil leaves the circulation and enters the tissues to 
perform a valuable defensive function. Paradoxically its presence may also be associated 
with detrimental injury. Hence, the neutrophil's safe and efficient clearance from the tissues 
is also of prime importance. 
The thesis begins by reviewing the continuing importance of pneumonia, and 
describes some of the important interactions between invading bacteria and the body's 
defences. It then describes the normal circulating pattern of the neutrophil, drawing attention 
to the unique relationship the neutrophil has with the pulmonary circulation. Following this, 
it describes how this alters in disease, and how the neutrophil is induced to pass from the 
circulation to the tissues, emphasising the rôles of adhesion molecules (particularly the 132 
integrins) and chemotactic factors (particularly interleukin -8) in this. It then goes on to 
describe evidence that neutrophil clearance is an actively controlled event in which 
apoptosis (programmed cell death) is of great importance. 
Much of the current knowledge of this whole process is derived from important in 
vitro experiments which have provided great molecular and cellular insights. However, there 
is a need to re- integrate this information to understand how the various factors contribute 
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and interact in vivo. This thesis attempts particularly to examine data that addresses this 
need to re- integrate knowledge, giving particular prominence to in vivo models. In 
particular, it emphasises that acute inflammation is a dynamic and evolving process that has 
a beginning, a middle and an end, and is the result of a dynamic interaction between host 
and inciting stimulus. Inflammation is often regarded as a light with a switch that may be 
either on or off; but it may be much more appropriate to describe it as a range of lights 
controlled by an array of dimmers! 
The thesis also highlights the fact that, because of its special relationship with the 
pulmonary microcirculation, the neutrophil may behave differently during pulmonary 
inflammation (as typified by pneumonia) compared to inflammation elsewhere. 
Original work is then described and discussed. Clinical observation has suggested that 
some types of pneumonia are characteristically associated with more tissue damage than 
others. It was hypothesised that there is a greater tissue neutrophil burden in the latter than 
the former, contributing to damage. Neutrophil accumulation is the balance of influx and 
clearance so these processes were examined separately, something that has been rarely 
performed in the past. 
In chapter one, the pattern of neutrophil influx in two representative types of 
pneumonia is examined, to establish whether there is a different pattern in each. In chapters 
two and three respectively, the functional contribution of two molecules, CD 18 and IL -8, to 
neutrophil influx during the course of pneumonia is then examined. These molecules were 
selected on the basis of many previous studies suggesting a rôle in neutrophil influx. 
However, in both cases, there have been no previous studies to examine whether their 
contribution specifically to neutrophil influx varies with time. This question is addressed for 
each molecule in turn. 
Increased tissue neutrophil burden and hence damage could result from less efficient 
clearance of neutrophils in some types of pneumonia. Chapter four looks specifically at 
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apoptosis, a process that could be important in clearing neutrophils from the inflamed lung. 
It is hypothesised that this is an actively controlled process, important to successful 
resolution of inflammation. Evidence for its existence and control during pneumonia is 
sought. 
L2 Pneumonia and its importance. 
Pneumonia is infection of the lung, giving rise to inflammation of the air spaces. This 
changes the lung from its normal soft, sponge like character to a much more solid 
consistency, a process known as consolidation. 
There is a perception among some that the importance of bacterial pneumonia has 
diminished with the development of modern antibiotics, which may be highly active against 
the causative organisms. There is no doubt that antibiotics have cut overall mortality 
significantly. A review of 34,883 patients with pneumococcal pneumonia between 1938 and 
1941 found an untreated mortality rate of 30.5 %. This was reduced to 14.9% with serum 
treatment, and 7.6% with the use of sulphonamides (Finland, 1979). 
Despite such advances, pneumonia remains of great significance. Overall, it is the 
sixth leading cause of death and the highest cause of death due to infectious disease in the 
USA (Garibaldi, 1985, and U.S. Department of Commerce, Statistical Abstract of the United 
States, 1984). The subject is made more serious by the progressive development of 
microbial resistance to antibiotics (Campbell, 1995, Doern, 1995). Studies showing that the 
mortality rate for bacteraemic pneumococcal pneumonia remains high (Hook et al, 1983, 
Gruer, et al 1984) led to the pessimistic suggestion (Bates, 1989) that even modern intensive 
care merely prolongs death rather than saving lives in severe primary pneumonia, although 
more recent data suggests that this extreme view is not justified (The British Thoracic 
Society Research Committee and the Public Health Laboratory Service, 1992). 
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L3 Classification of pneumonia 
Pneumonia may be classified in a number of ways. Traditionally, a distinction has 
been made between lobar pneumonia and bronchopneumonia. In the former, the pneumonia 
is confined within a lobe of the lung, its spread being limited by fibrinous exudate. In the 
latter, areas of consolidation are more widespread, being found among a number of lobules 
along the course of one or more bronchi, due to spread of infection along the airways 
(Coalson, 1995). There is a degree of associated bronchitis and bronchiolitis. 
Pneumonia due to the pneumococcus, Streptococcus pneumoniae tends to be 
associated with lobar pneumonia (Coalson, 1995). However, lobar pneumonia may be due to 
other organisms, and broncho -pneumonia may be due to the pneumococcus. Thus, this 
distinction has not been sufficient to be of value pathologically or clinically (Farr et al, 
1989, MacFarlane et al, 1984, Sue, 1994). 
A more useful distinction is that between pneumonia acquired outside the hospital, 
community acquired pneumonia (CAP), and that acquired inside the hospital, nosocomial 
pneumonia (NP). The spectrum of causative organisms and the prognosis differ significantly 
in the two groups (American Thoracic Society, 1993, American Thoracic Society, 1996, 
Research Committee of the British Thoracic Society and the Public Health Laboratory 
Service, 1987, The British Thoracic Society, Research Committee and the Public Health 
Laboratory Service, 1992, Campbell, 1994, Coalson, 1995, Faas, 1993, George, 1995, 
Griffin and Meduri, 1994, Meyer. and Finch, 1992, Niederman, 1994, Scheld, 1991). 
1.4 Community acquired pneumonia 
1.4.1 Incidence 
It is estimated that, in the United States, there are 4 million cases of community 
acquired pneumonia (CAP) annually (Garibaldi, 1985), or 0.68 to 2.6 per 1000 population 
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(McKinsey and Bisno, 1988). In a prospective study of 4 027 lower respiratory tract 
infections in the community in Nottingham, UK, 5.6% were found to be pneumonia 
(Woodhead et al, 1987). Of these, about 15 % required hospital admission. Of patients 
admitted to hospital, 5 to 11 % require admission to the intensive care unit (Lévy et al, 1988, 
and Research Committee of the British Thoracic Society and the Public Health Laboratory 
Service, 1987). 
1.4.2 Bacterial Aetiology 
A prospective multicentre study of British hospitals examined 453 cases of CAP and 
identified a bacteriological cause in 67 %. Thirty-three % had infection due to Strep. 
pneumoniae, 18 % due to Mycoplasma pneumoniae, and 7% due to influenza A. In addition, 
many of the cases in which a pathogen was not formally identified were likely to be due to 
Strep. pneumoniae. Many patients had received an antibiotic to which this organism was 
sensitive prior to hospital admission. In patients not receiving antibiotics on admission who 
were tested for the presence of pneumococcal antigen, > 50 % were positive. Fifty % of 
patients for whom the aetiology of pneumonia was not detected using more routine methods 
such as those employed in the British Thoracic Society study had evidence of pneumococcal 
infection on more sensitive, invasive testing (Jimenez et al, 1994). 
Studies in many parts of the world have confirmed Strep. pneumoniae as the most 
common pathogen in CAP, including Finland (Kauppinen et al 1995), the Netherlands 
(Bohte et al, 1995), Ethiopia (Aderaye, 1994), Cameroon (Koulla -Shiro et al, 1993) and 
Denmark (Ostegaard and Andersen, 1993). It has also been found to be the commonest 
cause of CAP in children (Bahl et al, 1995), the elderly (Woodhead, 1994), and populations 
with a high prevalence of HIV infection (Mundy et al, 1995). In addition it is the leading 
cause of severe community acquired pneumonia, being the leading cause of CAP 
necessitating admission to the intensive care unit (The British Thoracic Society Research 
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Committee and the Public Health Laboratory Service, 1992, Leroy et al, 1995). The 
occasional exceptions to the overwhelming importance of Strep. pneumoniae are likely to be 
due to unusual local conditions, e.g. the very high rates of tuberculosis in Singapore make 
this the commonest form of CAP requiring hospitalisation on the island (Hui et al, 1993). 
1.4.3 Outcome 
The total mortality rate for CAP is low. In a study examining all cases occurring in a 
defined community, the mortality rate was 3 %. Seventy-eight % were managed in the 
community, with only one death occurring in this group (Woodhead et al, 1987). 
Although the overall mortality rate is low, CAP may be severe, especially in some 
subgroups. Of those hospitalised during Woodhead et al's study the mortality rate was 11.5 
%, but patients aged 70 -79 had a ten fold greater mortality rate than patients aged 20 -29. 
Similar findings were made in a hospital survey of CAP (Research Committee of the British 
Thoracic Society and the Public Health Laboratory Service, 1987). Of the deaths that did 
occur in this study, 27 % occurred within 48 hours of admission to hospital, suggesting that 
this was due to rapid overwhelming disease. 
In survivors, the mean length of hospital stay was 11 days. 6 weeks after the onset of 
pneumonia, 79 % of these patients were considered fit for return to work, and 55 % had 
chest radiographs showing complete resolution. 
Of patients deemed ill enough to be admitted to the intensive care unit, the mortality 
rate is significant. Although the British Thoracic Society study of CAP managed on the 
Intensive Care Unit included a third of patients that were previously completely fit and a 
similar number under 44 years of age, the overall mortality rate was 48 %. The majority of 
the deaths were due not to respiratory failure but to multi- system organ failure, raising the 
possibility that deaths from CAP are due not so much to the bacterial cause of the 
pneumonia, but to an inappropriately aggressive host inflammatory response causing 
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'bystander' damage not only to the lungs themselves, but also to other organs, particularly 
the kidneys and the cardiovascular system. 
In support of this, in bacteraemic disease, penicillin is able to markedly reduce 
mortality after day 5 of disease compared to no treatment or treatment with immune serum, 
but it is unable to prevent earlier deaths (Austrian and Gold, 1964). Penicillin is extremely 
active against Strep pneumoniae, and it is likely that all organisms would be killed in a 
matter of hours rather than days. Although toxic products produced by the bacteria could 
continue to cause injury, it is possible that the failure of penicillin to prevent early death is 
due to an uncontrolled inflammatory cascade triggered in the patient (Johnston, 1991). 
Among the survivors of patients requiring intensive care treatment, over 50 % make a 
full recovery, with evidence of residual airways damage in 10 %, and pulmonary 
parenchymal damage (the microbiological aetiology for which was not reported) in just 6.5 
% (The British Thoracic Society Research Committee and the Public Health Laboratory 
Service, 1992). 
1.5 Nosocomial pneumonia 
1.5.1 Incidence 
The diagnosis of nosocomial pneumonia (NP) may not be easy, requiring invasive 
measures that are far from perfectly sensitive or specific for the diagnosis of pneumonia 
(Bamberger, 1988, Griffin and Meduri, 1994, Torres, 1991). 
Nevertheless, it is clear that NP is common. It occurs in 0.6 % to 1.1 % of hospital 
patients (Haley et al, 1981 and Hughes et al, 1983), or about 300 000 patients per year in 
the USA (Gross, 1987). In intensive care units it is even more common. Four prospective 
studies have shown rates of NP in patients mechanically ventilated for more than 48 hours 
of 23 %, 21.9 %, 21 % and 24 % respectively (Jimenez et al, 1989, and Rello et al, 1991, 
Craven et al, 1986, Torres et al, 1990). George found that the incidence of nosocomial 
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pneumonia in patients on a medical intensive care unit was 0.9 cases per 1000 patient -days 
in unventilated patients, but 20.6 cases per 1000 patient days in mechanically ventilated 
patients (George, 1995). 
Other groups may also be at particularly high risk, either because of their primary 
disease or because of the treatment they must receive. For instance, there is an incidence of 
NP of around 20 % after upper gastrointestinal surgery (Vickers, 1982), neurosurgery 
(Dauch et al, 1989) and bone marrow transplants (Pannuti et al, 1991), whilst 4 % of 
patients with solid organ transplants develop NP (Mermel and Mai, 1990). 
Patients at risk of aspiration will also show a higher incidence, even when the 
aspiration is not clinically obvious (Kingston et al, 1991). 
1.5.2 Bacterial Aetiology 
NP has a much more variable bacteriological cause than CAP, including the presence 
of polymicrobial infection. The patient group, the type of hospital and the country of the 
study will have significant effects on the exact pathogens encountered. Individual studies 
have shown that gram negative rods are the most frequent pathogens (e.g. Hughes et al, 
1983, Bartlett et al, 1986, Bryan and Reynolds, 1978), and this is confirmed by the overall 
figures for the USA showing the following frequencies of isolation (Horan et al, 1986): 
Pseudomonas spp. 16.9 % 
Staphylococcus aureus 12.9 % 
Klebsiella spp. 11.6% 
Enterobacter spp. 9.4 % 
Escherichia coli 6.4 % 
Serratia spp. 5.8 % 
Proteus spp. 4.2 % 
The remainder of this thesis emphasises E. coli as a typical member of the gram 
negative rods so frequently involved in NP. 
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L 5.3 Outcome 
In hospital -wide surveys of NP, crude mortality rates have been very high (25 %. 
30 % and 36.6 %, Louie et al, 1991, Leu et al, 1989, Celis et al, 1988, respectively). In the 
study of Leu et al, 1989 case -control matching suggested an attributable mortality of 33 %. 
though this failed to reach statistical significance. An increase of 7 days in hospital stay was 
clearly necessary in survivors. 
Still higher crude mortality rates have been encountered on intensive care units (55 %, 
33 %, 42 %, and 54.2 %, Craven et al, 1986, Torres et al, 1990, Rello et al, 1991, Fagon et al, 
1993, respectively). Rello et al, 1991, found that the mortality rate of intensive care patients 
with or without NP was very similar at 42 % and 37 % respectively, but Torres et al, 1990 
found mortality rates of 33 % versus 19 %. Fagon et al, 1993, compared the outcome in 
patients in Intensive Therapy Units with NP with that of a carefully matched control group, 
and showed an statistically significant attributable mortality of 27.1 %. This is of a very 
similar magnitude to the study of Leu et al, 1989, for NP throughout a general hospital 
population. 
In summary, NP is common, occurring in about 1 in 1000 hospital patients. Best 
estimates suggest that about I in 3 of these will die as a result of their pneumonia. 
1.6 The lung's defences 
Each human lung has a surface area of 70 m2 (Murray, 1986) which is in direct 
continuity via the bronchi, trachea, pharynx and mouth with the external environment. In 
excess of 10,000 litres of air will be respired per day and this may contain thousands of 
bacteria per cubic metre (Samet et al, 1987). A variety of defence mechanisms have evolved 
to cope with this. 
In addition to potential airborne pathogens, the lung also has to cope with aspirated 
material from the oropharynx. Even in normals, 40 % aspirate radiolabel from the 
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oropharynx during sleep (Huxley et al, 1978), and this figure rises to 85 % in the severely 
ill. It is generally felt that defences are usually adequate to challenge by respired pathogens 
except in particular cases (Legionella and viral infection), but that pneumonia usually results 
when the defence to aspirated material is overcome. This may be either because of a large 
infective load or because of poor host defences (Coalson, 1995, Levine and Niederman, 
1991, Nelson et al, 1995). Three orders of magnitude more bacteria are required to cause 
pneumonia when administered experimentally by aerosol than by bolus inoculation into the 
trachea (Ansfield et al, 1977). 
1.6.1 Nasopharynx and oropharynx 
The convoluted path of air flow through the nasopharynx ensures that all but the 
smallest particles will be trapped in this way before entering the lungs (Newhouse et al, 
1976). 
The normal oropharynx is colonised with 10' to 101° bacteria per ml. The ability of 
other bacteria to survive here is limited by salivary flow, desquamation of the epithelium 
and local secretion of IgA, IgG and complement (Mackowiak, 1982). Normally, gram 
negative bacteria are not present (Johanson et al, 1969). Even normal subjects gargling with 
suspensions of 108 per ml Klebsiella pneumoniae, Proteus mirabilis or E. coli clear these 
bacteria within 6 hours (LaForce et al, 1976). 
1.6.2 Trachea and bronchi 
The normal lower respiratory tract is sterile (Lees and McNaught, 1959). Bacteria are 
mechanically cleared from the respiratory tract by the mucociliary escalator ( see Levine and 
Niederman, 1991). Defects in the mucocilliary escalator leading to an increased risk of 
infection (Cammer, 1980). 
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1.6.3 Terminal airways and alveoli 
A variety of soluble products within the alveolar lining fluids have antibacteriological 
properties. These include IgA, IgG, lactoferrin, free fatty acids and lysozyme (Coonrod, 
1986). However, the greatest antimicrobial defence to low levels of bacteria in the normal 
lungs is provided by alveolar macrophages. (Fels and Cohn, 1986, Goldstein et al, 1974, 
Green and Kass, 1964, Hocking and Golde, 1979, Rylander, 1968). The alveolar 
macrophages are able not only to ingest bacteria and kill them intracellularly, but also to 
produce reactive oxygen species and other toxic metabolites that kill bacteria extracellularly 
(Brieland et al, 1982, Fantone, 1987, Jonhnston 1988, and Nathan, 1987). 
It has long been recognised that, although resident cells of the alveolus may 
successfully defend the lung against relatively minor challenge, larger challenges are met by 
the recruitment of further phagocytic cells in the form of neutrophils and monocytes from 
the bloodstream (Briscoe, 1907, and Onofrio et al, 1983). Aspects of this neutrophil 
recruitment and their subsequent removal are the subject of this thesis. 
1.7 Pathogenesis and pathology of community acquired pneumococcal 
pneumonia with special reference to pneumococcal pneumonia 
1.7.1 Epithelial attachment 
Strep. pneumoniae is spread from person to person by aerosol. 40 % of normal 
subjects harbour the bacterium in their nasopharynx without any deleterious effect 
(Austrian, 1986). In some, it is able to advance further into the respiratory tract to cause 
disease. This was appreciated long ago by Metchnikoff (Metchnikoff, 1905); 
"People who carry the Pneumococcus on their mucous membranes may remain for 
long without being attacked by fibrinous pneumonia or any other maladies due to this micro- 
organism. But often, in consequence of some special circumstance, a cold for example, the 
refractory state gives way to a more or less marked susceptibility" 
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Why this occurs in some cases but not in others remains unclear, but as previously 
noted this will depend on the balance between bacterial load and efficacy of host defence 
when small amounts are aspirated. It has also been noted that invasion tends to occur soon 
after the colonisation by a new serotype (Gray et al, 1980, Hodges and MacLeod, 1946). Of 
importance is the ability of Strep. pneumoniae to adhere to and enter cells of the respiratory 
tract. Some, but not all, Strep. pneumoniae are able to penetrate A549 cells, a human 
alveolar carcinoma line (Talbot et al, 1996). Another group could not show that the 
bacterium was able to invade resting A549 cells, but demonstrated increased adhesion with 
invasion into A549 cells after cytokine pre -treatment of the cell. In this case the Strep. 
pneumoniae adhere to the platelet activating factor (PAF) receptors. Avirulent strains were 
unable to adhere in this way (Cundell et al, 1995), suggesting that it is of critical importance 
to the establishment of disease. 
1.7.2 Virulence factors 
Strep. pneumoniae produces a number of factors that may be of importance in 
virulence. The capsular polysaccharide is clearly important, different serotypes having 
different propensity to cause disease. Pneumolysin has the capacity to injure endothelial 
cells in vitro (Rubins et al, 1992). It may activate complement (Paton et al, 1984), and at low 
doses causes neutrophil chemotaxis and granule release, whilst at high doses it lyses 
neutrophils and platelets (Johnson et al, 1981). Pneumolysin sufficient pneumococci survive 
better within mouse lung and are more rapidly invasive, producing bacteraemia more 
rapidly. Addition of pneumolysin to inoculates of pneumolysin deficient strains enhances 
survival and invasion. Both complement activating and cytotoxic activities seem to be 
important in this effect (Rubins et al, 1995). Pneumococci also produce hydrogen peroxide, 
which was shown to be damaging to alveolar epithelial cells in vitro and is well known to be 
highly toxic in vivo (Duane et al, 1993). As they are catalase negative, this also means that 
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Strep. pneumoniae are easily killed when phagocytosed, even in patients with chronic 
granulomatous disease whose granulocytes are unable to generate reactive oxygen species 
themselves (Johnston and Newman, 1977). Strep. pneumoniae strains with insertional 
inactivation of either pneumolysin or autolysin had greatly reduced virulence when assessed 
by survival of mice after intraperitoneal injection of the deficient organisms (Berry et al, 
1992), and it seems that both factors (which are released during lysis of bacteria) are 
important in establishing pneumonia. The manner in which these different elements interact 
to cause disease is not well defined. 
1.7.3 Pathology 
Typical non -fatal pneumococcal pneumonia is an archetypal resolving inflammation. 
Initially, there is congestion and hyperaemia of the lung, with exudation into the alveolar 
spaces, followed by microhaemorrhages of red blood cells, producing what is classically 
described as 'red hepatisation'. Next, there is an influx of phagocytic cells to produce grey 
hepatisation. Initially these are neutrophils, followed by mononuclear cells. Later, resolution 
follows (Loosli, 1940, Wood, 1952). Not all areas of the pneumonic lung will be at the same 
pathological state simultaneously as the disease spreads, but rather each area passes through 
these stages. 
Classical series of untreated pneumococcal pneumonia showed 'delayed resolution' 
(failure of resolution of clinical symptoms within the expected two weeks) in only about 4 
% (McCrae, 1910). Three post mortem studies showed evidence of fibrosis in 0.6 %, 7.6 % 
and 0.7 % respectively (Chatard, 1910, Lord, 1925, and Fränkel, personal communication to 
Lord, 1925). 
The normal lung tissue is seen to be composed of a very fine network of delicate 
tissue. During the height of pneumonia it is solidly packed with neutrophils, which have 
great potential to cause damage (Haslett et al, 1989a, Henson and Johnson, 1987, Stockley, 
32 
1995, Weiss, 1989). It is quite remarkable that following pneumococcal pneumonia, the 
apparently delicate lung is usually restored completely to normal (Johnston, 1991). 
1.8 Pathogenesis and pathology of nosocomial Gram negative pneumonia, with 
special reference to E. coli pneumonia 
1.8.1 Epithelial attachment 
The ability of bacteria to bind to respiratory epithelium increases in disease. This has 
been shown to directly correlate with colonisation of the upper respiratory tract with gram 
negative bacteria (Johanson et al, 1979). Furthermore, in a group followed before and after 
major surgery, those showing a less than twofold increase in in vitro adherence had no 
respiratory tract colonistion with gram negative bacteria. By contrast, in the group with a 
greater than twofold increase in adhesion in vitro , 69 % became colonised. (Johanson et al, 
1980). Colonised patients have an eightfold increased risk of pneumonia (Johanson et al 
1 972). 
Decreased stomach acidity associated with the use of antacids and H, blockers may 
allow the stomach to become an important reservoir in NP. In 60 mechanically ventilated 
patients, no case of pneumonia was seen in the 8 patients whose gastric and oropharyngeal 
growths were different, but more than 50 % of the remainder developed gram negative 
pneumonia. The number of bacteria cultured from the stomach correlated with gastric pH 
(Moulin et al, 1982). This has led to studies of the use of sucralfate, a gastric mucosal 
protective agent with no effect on pH. A meta -analysis showed the rate of NP to be lower in 
patients treated with sucralfate than H2 blockers (Cook et al, 1991, and Tryba, 1991) 
although whether this is due directly to an effect on pH, or to a direct antimicrobial action of 
sucralfate is disputed. 
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Attempts have been made to prevent NP by selective decontamination of the 
gastrointestinal tract, using various regimes. Meta -analysis of a number of studies showed 
clear efficacy in reducing the risk of NP (Vandenbroucke -Grauls and Vandenbroucke, 
1991), but disappointingly, no benefit was demonstrated on overall mortality. This is 
perhaps not surprising, given the difficulty in clearly demonstrating significant attributable 
mortality in NP, as discussed above. It seems likely that benefit will be confined to a 
subgroup with potentially remediable underlying disease (Van Saene et al, 1992), 
demanding a large scale trial to demonstrate. Nevertheless, these trials provide strong 
evidence for the important rôle of gram negative bacteria from the gastrointestinal tract in 
the pathogenesis of NP. 
Even if bacteria resident within the patient's gastrointestinal tract are of prime 
importance, aspiration may not be the only route of pulmonary infection. A prospective 
study of NP in intensive care unit patients identified stress ulceration, illness severity and 
stomach intramucosal pH as most predictive of NP. Although use of H2 blockers analysed 
independently were predictive of NP in a multiple regression analysis, inclusion of this risk 
added nothing to the predictive value of the previously enumerated risks. The three major 
risks are all associated with loss of gastrointestinal mucosal integrity. The authors 
speculated that this could indicate that bacterial translocation from the gut lumen and 
haematogenous spread is important (Fiddian -Green and Baker, 1991). This mechanism may 
contribute, but it seems more likely that demonstrated frequency and risk of aspiration make 
it the most important factor. 
Thus it seems that in ill hospitalised patients, particularly those mechanically 
ventilated, there is overgrowth of gastrointestinal gram negative rods within the stomach. 
Epithelial changes in the pharynx allow these to colonise upwards, following which they 
may be aspirated to cause NP. 
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L 8.2 Virulence factors 
E. coli virulence factors in extrapulmonary disease have been relatively well studied. 
In the urinary tract, pilus associated with pyelonephritis, haemolysin, aerobactin and 
cytotoxic necrotising factor are among those shown to be important (Yasamato et al, 1995). 
In diarrhoea) diseases, E. coli may produce a variety of exotoxins and specific adhesion 
factors are of importance (Blanco et al, 1991 and Cassels and Wolf, 1995). 
There have been far fewer studies examining virulence factors of E. coli within the 
respiratory tract. Respiratory infections were included in an examination of clinical isolates. 
E. coli isolated from the respiratory tract showed the presence of haemolysin and adhesins in 
84 % of cases, infecting a large number of patients with apparently intact host defences. 
Many hosts of infection with E. coli deficient in adhesins and haemolysin had impairment of 
their defences, illustrating the interplay between bacterial virulence and disease (Maslow et 
al, 1993). 
E. coli haemolysin causes increased pulmonary artery pressure and increased filtration 
by a mechanism that can be primed with endotoxin and involves the co- operation of 
neutrophils in generating thromboxane A2 and leukotrienes (Grimminger et al, 1990, Seeger 
et al, 1991, Walmarth et al, 1994). 
In addition, E. coli contain large amounts of endotoxin, which may have a damaging 
or activating effect on a wide range of cells. 
1.8.3 Pathology 
In general, the pathological appearances are the same in gram negative nosocomial 
pneumonia as in pneumococcal pneumonia. The exception to this is that Pseudomonas 
aeruginosa may produce a characteristic lesion called " Pseudomonas vasculitis" in which 
large numbers of bacteria cluster around and invade small vessels (Nash, 1989). In addition, 
gram negative pneumonia may cause necrosis of the alveolar walls to give multiple small 
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abscesses (Colason, 1995). This represents much more serious damage than is usually 
witnessed in pneumococcal pneumonia where the alveolar walls characteristically remain 
intact (Johnston, 1991). This initial damage is of great importance as it is likely to lead to 
increased residual damage and scarring. 
1.9 Bacterial clearance and the pulmonary cellular response 
1.9.1 Bacterial clearance 
Bacteria deposited in the lung by aerosol are usually cleared quite rapidly. Using a 
combination of radiolabelling of bacteria and bacteriostatic inhibition of multiplication, the 
viable bacteria remaining in the lungs of mice were found to be determined by the sum of 
bulk removal, in vivo replication and killing (Jay et al, 1976a). Physical removal accounted 
for 7 -12 % of bacteria over 4 hours in all bacterial species studied. Killing of Strep. 
pneumoniae amounted to 87% per hour, whilst that of E. coli was 18 % per hour. The 
doubling time of Strep. pneumoniae and E. coli were 310 and 212 minutes respectively. The 
net result was that after 4 hours, 7.3 % of deposited Strep. pneumoniae were viable whilst 
88.5 % of E. coli were viable. Clearly, the pattern and mechanisms of clearance depended 
on the species of bacteria. 
Bacterial clearance rates also depend on the magnitude of the initial inoculate. More 
Staphylococcus aureus were cleared from the lung after 4 hours following a low dose rather 
than a high dose exposure. The opposite was true for Klebsiella pneumoniae and, whilst low 
doses of Pseudomomas gave net clearance, high doses led to net proliferation (Toews et al, 
1979). 
Clearance of aerosol- deposited Strep. pneumoniae and Pseudomonas aeruginosa were 
greatly impaired in hypocomplementaemic mice, whereas clearance of Klebsiella 
pneumoniae and Staphylococcus aureus were unaffected (Gross et al, 1978). 
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In addition, clearance of viable pneumococci varies depending on host species 
(Coonrod et al, 1990). Clearance was faster in rabbits than guinea pigs or rats. In the latter 
two species, extracellular killing was important, whilst in the former intracellular killing was 
predominant in vivo. Both mechanism and kinetics of bacterial killing by alveolar 
macrophages have also been shown to depend on the species source of the macrophages in 
vitro (Nguyen et al, 1982). 
Clearly bacterial clearance is not a stereotyped process, but relies on a dynamic 
interaction between the specific bacteria and host. This is further illustrated by the cellular 
response of the lung to bacterial challenge. 
1.9.2 Cellular response to bacterial challenge to the lung 
After aerosol exposure to Staphylococcus aureus, mice failed to show an increase in 
intrapulmonary neutrophils. Klebsiella pneumoniaé and E. Coli produced a marked 
neutrophil influx as early as 2 hours after exposure (Pierce et al, 1977). Over a longer time 
course, exposure to aerosolised Staphylococcus aureus was found to produce a modest 
increase in alveolar macrophage number, without any change in the number of neutrophils. 
By contrast, Pseudomonas aeruginosa produce a mild initial rise in alveolar macrophages, 
followed by a marked increase in neutrophils. Finally, over several days there was an 
increase predominately in peroxidase positive mononuclear cells, representing recently 
recruited monocytes (Sordelli et al, 1985). 
The relative lack of importance of neutrophils in clearance of Staphylococcus aureus 
was demonstrated by the finding of unchanged clearance rates in mice rendered 
neutropaenic by anti- granulocyte globulin. By contrast, neutropaenia impaired the clearance 
of Klebsiella pneumoniae and Pseudomonas aeruginosa (Rehm et al, 1980). 
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The magnitude of innoculum was also shown to be important, with the number of 
neutrophils recruited being directly related to Streptococcus pneumoniae challenge (Toews 
et al, 1979). 
The pattern of host response is not necessarily directly related to bacterial persistence. 
Four different patterns of clearance were found among 13 different strains of Pseudomonas 
aeruginosa, and these produced a variety of patterns of lung histology. However, no 
correlation between the clearance rate and histological appearances could be discerned 
(Southern et al, 1970). 
Therefore it is clearly true that the host response is not stereotyped, but varies with 
the size and type of challenge. The above studies were performed using aerosolised bacteria 
to deposit relatively modest numbers of bacteria. When challenged with boluses delivered 
into the more distal airways, which may be more directly relevant to pneumonia as discussed 
above, responses may differ. Thus, just 104 Streptococcus pneumoniae placed 
intrabronchially in mice were able to proliferate to 10' viable organisms in 48 hours 
(Ansfield et al, 1977). This contrasts markedly with the rapid clearance seen in aerosol 
exposure studies. 
Clearance studies of Staphylococci also differ with the two techniques. As discussed 
above, aerosol exposure to Staphylococcus aureus results in a mild increase in alveolar 
macrophages only. With direct inoculation, 105 organism were promptly cleared with a 
selective increase in alveolar macrophages. 106 organisms cleared more slowly and there 
was a small neutrophil influx. 10' organisms were cleared very slowly and elicited a very 
marked neutrophil influx. 108 organisms provoked an intense neutrophil influx, despite 
which the organism proliferated and death often followed. 
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1.93 Summary 
These studies show that bacterial clearance varies greatly with number and species of 
bacteria, type of administration and the nature of the host. The cellular response varies with 
all these factors. Therefore, there is no stereotypical interaction between the lungs and 
bacteria, but a very specific one depending on exact circumstances. 
1.10 The neutrophil in host defence 
1.10.1 Importance of the neutrophil in host defence 
Although the response to bacterial challenge is variable at low doses, it is clear that at 
higher doses the recruitment of neutrophils is intimately associated with host defence. 
Indeed, their arrival is the hallmark of the early stages of pneumonia. 
The importance of neutrophils to host defence is indicated by the high risk of 
infection in neutropaenic patients (Dale et al, 1979), and neutropaenia has been confirmed to 
adversely affect defence to pneumonia experimentally (Wood and Irons, 1946, and Skinsnes, 
1948). In leukaemic patients, the risk of infection correlates with the degree and duration of 
neutropaenia (Bodley et al, 1966). In patients with chronic infection, infusion of G -CSF 
elevates the peripheral blood neutrophil count and this was associated with resolution of 
infection (Bonilla et al, 1989). 
Functional disorders of neutrophil also give rise to increased risk of bacterial 
infection e.g. chronic granulomatous disease (Churnutte et al, 1974) and leukocyte adhesion 
deficiency (Anderson et al, 1985). 
Normally, the mature neutrophil is an intravascular cell. If an infection occurs, 
neutrophils collect at the site of the infection and invade the tissues to provide defence, 
flooding in great numbers. This astonishingly rapid and specific process led Andrew to 
remark; 
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"In presence of local tissue attack.... we find that the polymorphonucelar phagocytes 
converge upon this spot from all over the body, and this with truly remarkable rapidity. So 
prompt is the action, so purposeful its aim, that it is at first difficult to believe it other than 
an intelligent response on the part of the active agents" 
(Andrew, 1910). 
Although he continues by noting that members of the local constabulary converge 
promptly at sites of disorder, and thus that directed behaviour is not necessarily a sign of 
intelligence, he identifies well the high degree of specificity of control of neutrophil kinetics 
that this implies! 
In order for these processes to occur, the normal circulating neutrophil must be 
detained at the site of infection, adhere to the vascular endothelium there, and migrate 
through. To accomplish this, substances activate the neutrophil to change its stiffness and its 
adhesion properties, whilst simultaneously endothelial adhesivity is specifically modulated. 
Chemicals are elaborated which direct neutrophil migration, either as soluble factors 
(chemotaxins) or as fixed factors (haptotaxins). 
1.10.2 Neutrophil damage to the host; the paradox of inflammation 
Although neutrophils are very clearly required for host defence, they contain a large 
armamentarium including oxidants and proteases (Root and Cohen, 1981). These have the 
potential not only to damage invading bacteria, but also (as they may be liberated 
extracellularly during inflammation, Schraufstätter et al, 1984) to cause 'bystander' damage 
to host tissues (Fujishima and Aikawa, 1995, Haslett et al, 1989a, and Henson and Johnston, 
1 987). 
An example of this was provided in a model of Pseudomonas aeruginosa infection 
produced by intratracheal instillation in guinea pigs. Low (104) or high (108) bacterial 
inoculates were used in normal animals, animals rendered neutropaenic by 
cyclophosphamide and in animals rendered neutrophilic by G -CSF (Terashima et al, 1995). 
With low bacterial inoculates, persistence of viable bacteria was greater in neutropaenic 
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animals in which pulmonary epithelial permeability was also greatest. At high bacterial 
inoculates, bacterial permeability was highest in neutrophilic animals. There was a high 
mortality only in this group. 
This suggests that, at low inoculates, the predominant lung damage was consequent to 
direct effects of the bacteria. A moderate neutrophil influx was required to clear the 
organisms and protect against this. However, at high dose in the presence of pre- existing 
neutrophilia such a profound influx of neutrophils (which may also have been partially 
activated by G -CSF) was produced that the predominant lung damage was produced by the 
neutrophils themselves. Once again, the dynamic relationship between the invading 
organism and the inflammatory response is well illustrated. 
The neutrophil has been suggested to play a rôle in tissue damage in a wide range of 
diseases in which its recruitment may be regarded as inappropriate or excessive, both within 
the lung (in diseases such as asthma, chronic bronchitis, pulmonary fibrosis and ARDS, 
Reynold, 1987, Stockley, 1995) and elsewhere (such as in rheumatoid arthritis, 
ischaemia/reperfusion injury, various skin diseases, and ulcerative colitis, Weiss, 1989). 
Neutrophils may even be important in host damage at a site distant from the original 
insult, such as in ARDS (Donnelly and Haslett, 1990, Repine and Beechler, 1991), in acid 
aspiration (Goldman et al, 1993) and in ischaemia -reperfusion (Simpson et al, 1993). 
Neutrophil tissue burden must be of sufficient magnitude to protect against invading 
bacteria whilst at the same time not being so excessive as to cause host injury. A dramatic 
example of this is provided by the 'vicious circle' hypothesis of bronchiectasis (Cole and 
Wilson, 1989). Initial bronchial infection gives rise to bronchial damage secondary to 
inflammation, causing disruption of the mucocilliary escalator. This predisposes to further 
infection, another cycle of inflammation and further damage. Repeated cycles lead to 
bronchial wall damage and scarring. 
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The requirement for fine control of neutrophil burden during pulmonary inflammation 
may be exercised at the level of neutrophil production, intravascular trapping in the lungs, 
adhesion to the vascular endothelium, directed migration through the vessel wall into the 
interstitium and airspaces, and clearance from extravascular areas. 
1.11 Normal neutrophil kinetics 
1.11.1 Development 
Neutrophil granulocytes are derived in the bone marrow from pluripotent stem cells. 
This process takes around 6 days in normal physiological conditions (Price et al, 1992). 
During development, they develop a large antibacterial armamentarium, contained in 
granules within the cytoplasm. Primary or azurophilic granules' contents include 
myeloperoxidase, lysozyme, and neutral serine proteases such as elastase, cathepsin G and 
proteinase 3, acid hydrolases, defensins and bacterial permeability increasing factors 
(Bainton and Farquhar, 1966, Baggiolini and DeWald, 1984 ). Secondary or specific 
granules contents include lysozyme, col lagenase, lactoferrin, and supplies of receptors for 
FMLP, iC3b, and laminin. Granulocytopoiesis is enhanced by granulocyte colony 
stimulating factor (G -CSF), granulocyte- monocyte stimulating factor (GM -CSF) and 
interleukin -3 (IL -3) (see Clark and Kamen, 1987, and Weisbart, 1989). G -CSF is a product 
of T lymphocytes, endothelial cells, fibroblasts and macrophages. GM -CSF is produced by 
monocytes and fibroblasts. IL -3 is a T cell product. These substances also have a 
modulatory effect on mature blood cells. Their receptors are also expressed on cells outside 
the haematological system (see Gasson, 1989), implying further actions. 
The pre -eminent rôle of G -CSF in normal granulopoiesis is indicated by the binding 
of marked neutropaenia in G -CSF gene knock -out mice (Lieschke et al, 1994).On the other 
hand, GM -CSF gene knock -out mice show no significant perturbation of haemopoiesis. 
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Surprisingly, they do show characteristically abnormal pulmonary pathology (Stanley et al, 
1994). 
Furthermore, it is known that new -born mice clear intrapulmonary E. coli very poorly. 
In adults challenged thus, there is a granulocytopaenia at 4 hours, but the neutrophil count 
returns to or past normal by 24 hours. By contrast, although new -borns exhibit the initial 
granulocytopaenia, there is no recovery over 24 hours. The inability to accelerate neutrophil 
production over this period is correlated with failure to increase total G -CSF mRNA in liver, 
spleen or lungs (Liechty et al, 1993). 
1.11.2 Circulating life 
Once they have matured in the bone marrow, neutrophils are released into the 
circulation where they have a half -life of 4 - 7 hours (Cohen et al, 1981 and Doershuk et al, 
1987). Damaged neutrophils are cleared more rapidly. At the end of their life span, 
neutrophils are cleared by cells of the mononuclear- phagocyte system. In physiological 
rather than pathological states, the number of extravascular neutrophils is very small. 
Morphometry shows that there are fewer than 106 intra- alveolar neutrophils in the rabbit 
(Cohen et al, 1979). There was no evidence of neutrophils leaving the lungs via the 
lymphatics, implying that neutrophils were disposed of locally. 
The circulating half -life of the neutrophil is of the same order as the life span of the 
neutrophil in vitro before the onset of apoptosis. Apoptotic neutrophils can be recognised 
and phagocytosed by macrophages in vitro, and this may well represent a normal 
physiological process. There is some support for this from the examination of the kinetics 
and distribution of BrdU labelled cells in the rabbit (Bicknell et al, 1994). 
1.11.3 Distribution of circulating neutrophils 
The lungs are an important site of this temporary sequestration. Measurement of cells 
entering and leaving the lungs shows that there is rapid release of neutrophils after infusion 
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of adrenaline, with induction of peripheral neutrophilia, whilst LPS produces the opposite 
change (Ambrus and Ambrus, 1959, Athens et al, 1961), confirmed in humans using 
external scintigraphy (Muir et al, 1984) 
Morphological studies have shown a tenfold concentration of leukocytes compared to 
erythrocytes in small pulmonary vessels, in in vivo and ex vivo dog preparations (Hogg et al, 
1988 and Perlo et al, 1975). The latter study found that the leukocyte excess was 
predominantly due to mononuclear cells, possibly due to extensive extracorporeal 
manipulation. Retention of cells was inversely related to the perfusing pressure, suggesting 
that the lungs were acting as a cellular sieve. 
Analogous findings have been found in vivo. Inflation of a balloon catheter in the 
inferior vena cava of dogs reduces the perfusion pressure to the lungs and increases 
intrapulmonary neutrophil retention (Thomassen et al, 1984), and a similar mechanism is 
also likely to explain the effect of adrenaline and exercise. 
More direct measurement of this effect was performed using 99'ntechnetium labelled 
erythrocytes and "1 indium labelled neutrophils (Martin et al, 1987, and Doerschuk et al, 
1987). Regional blood flow was directly related to pulmonary neutrophil retention, being 
greater at slower flows. The marginated neutrophil pool was at least twice that of the 
circulating pool and there was a turnover of cells within the marginated pool of around 1 % 
per second. 
In a dog with a pulmonary window, videomicroscopy of FITC labelled neutrophils 
demonstrated that they were delayed in pulmonary capillaries. Neutrophils had a transit time 
of < 2 seconds to > 20 minutes, with a median of 26.1 seconds. Cells were observed to be 
held up at discrete points rather than passing evenly and steadily through the capillaries 
(Lien et al, 1987) confirming that the sequestered or marginating pool of neutrophils exists 
because the lung acts as a sieve, trapping individual neutrophils. This situation differs 
markedly from that observed in the systemic circulation, where the neutrophils appear to 
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pass more freely through the capillaries. However, neutrophils are displaced from the centre 
of post -capillary venules by axial flow of erythrocytes, and those held for a moment against 
the vessel walls are seen to roll for some moments, adhering temporarily to the endothelium, 
before passing on (Schmid -Schönbein et al, 1980). 
The relative size of the neutrophil and pulmonary capillaries have been compared in 
humans, dogs and rabbits. 38 %, 67 % and 61 % of capillaries were found to be less than the 
mean spherical diameter of the neutrophil (Doerschuk et al, 1993). During its passage 
through the pulmonary capillaries, the neutrophil is likely to have to deform, and indeed, in 
this study, intra- capillary neutrophils were seen to adopt an ellipsoid shape. In addition, 
pulmonary blood pressure is lower than systemic blood pressure (Von Euler and Lijestrand, 
1946) and, in the lungs, flow is pulsatile (Lee and DuBois, 1955). These factors together 
mean that the ability of the neutrophil to deform in order to pass through small capillary 
segments is likely to be critical in the lung. Studies of passage of erythrocytes and 
neutroph ils through pores in vitro suggest that the erythrocyte's ability to deform is three 
orders of magnitude greater than that of the neutrophil (Chien, 1985), and thus neutrophils 
will be held up and concentrated in the lung relative to erythrocytes. 
This mechanism was demonstrated in a model system using 99inTechnetium labelled 
erythrocytes and "Indium labelled neutrophils. Their passage through filter pores with sizes 
equivalent to pulmonary capillaries was examined. Selective neutrophil retention was flow 
dependent (Downey and Worthen, 1988). 
Individual neutrophil stiffness was later measured with a "cell poker ". It was 
confirmed that, after treatment with FMLP, cells became stiffer, an effect that could be 
antagonised by inhibition of f -actin assembly. Neutrophil stiffness correlated with first pass 
retention by the lung (Worthen et al, 1989). An antibody to the adhesion glycoprotein CD18 
failed to have any effect on either passage through the filter or first pass retention in the 
lungs. 
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Using pulmonary vascular lavage to recover sequestered neutrophils, it has been 
demonstrated that sequestered cells are on average stiffer than those from the peripheral 
circulation, whilst also expressing more CD18 molecules on the cell surface (Brown et al, 
1995b). 
In summary, neutrophils are normally produced in the marrow under the influence of 
G -CSF. They are released into the circulation, where they have a short half -life. As a 
consequence of their stiffness and size, a proportion are temporarily sequestered in the 
pulmonary circulation. As they age, they are removed from the circulation by cells of the 
mononuclear- macrophage system, probably after undergoing apoptosis. 
1.12 Pulmonary sequestration of neutrophils during inflammation 
1.12.1 Induction of sequestration by inflammatory mediators 
During inflammation there is an increased sequestration of neutrophils within the 
pulmonary vasculature, caused by a variety of substances. 
Increased pulmonary sequestration of I' indium- labelled neutrophils has also been 
demonstrated after intravenous PAF (Hultkvist -Bengtsson et al, 1991), inhaled PAF (Tam et 
al, 1992), intravenous GM -CSF (Hovgaard et al, 1992) and zymosan activated plasma 
(Doerschuk, 1992). Morphological techniques show sequestered neutrophils after 
intravenous C5f are located in pulmonary capillaries (Downey et al, 1993). 
'chromium labelled neutrophils exposed to sufficient PAF in vitro to cause priming 
for superoxide release and enhanced expression of the CD 11 b adhesion molecule did not 
exhibit any increased pulmonary sequestration when reinjected into rats (Fontes et al, 
1995).The initial sequestration of neutrophils after infusion of zymosan activated plasma 
was unaffected by antibody- blockade of the CD18 adhesion molecule, although subsequent 
washout from the lungs was accelerated by anti -CD18 antibody (Doerschuk, 1992). Initial 
sequestration is thus independent of (3, integrins. 
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1.12.2 Increased sequestration in inflammation; neutrophil or endothelial 
changes? 
Theoretically, changes in the neutrophil or the pulmonary vascular endothelium could 
mediate increased neutrophil sequestration in the lung. 
The exposure of "'indium labelled neutrophils to endotoxin ex vivo increased their 
sequestration when reinjected into rabbits with normal lungs (Haslett et al, 1987), showing 
that endothelial changes are not necessary for increased sequestration. 
After infusion of LPS, sequestered neutrophils from pulmonary vascular lavage were 
more activated than peripheral blood neutrophils and showed an increased ability to bind to 
nylon columns, though it is not possible to say whether the increased adhesivity caused their 
sequestration (Williams et al, 1993). 
"'indium labelled neutrophils were retained in the lung in excess of 99mtechnetium 
labelled erythrocytes when simultaneously injected into normal rats (Brown et al, 1995a). 
This was more marked when cells taken from normal rats were injected into animals with 
lungs inflamed by instillation of Corynebacterium parvum. However, inflammatory 
neutrophils obtained by broncho- alveolar lavage were sequestered to an even greater degree 
when injected into normal rats. This suggests that neutrophil changes have more potential to 
affect sequestration than changes in the endothelium. 
During pneumococcal pneumonia in rabbits, 51chromium labelled cells were 
sequestered at 2, 4 and 8 hours after the onset of pneumonia. In control, non -pneumonic 
areas of the lung there was also sequestration of neutrophils at 1 and 4 hours. (Doerschuk et 
al, 1994). It is likely that the generalised sequestration reflects neutrophil activation, as 
endothelial changes are likely to be localised. In addition, there was increased localised 
sequestration, which could be due to rapid neutrophil changes at the inflammatory site, or 
local endothelial changes. 
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Overall, the balance of evidence indicates that, during inflammation, increased 
pulmonary sequestration is largely due to an effect on the neutrophil, with endothelial 
changes having a lesser rôle. 
1.12.3 Neutrophil rheology and pulmonary sequestration during inflammation 
As discussed above, neutrophil rheology seems to play an important rôle in 
sequestration of neutrophils in the lungs in physiological conditions. The stiffness of 
neutrophils can be modulated by a number of factors. In vitro, smoke exposed neutrophils 
become stiffer as a result of actin polymerisation induced by oxidants (Drost et al, 1992). 
This is reflected in vivo when smoking reduces the washout of 11lindium labelled neutrophils 
from the lungs (MacNee et al, 1989). 
Sequestered neutrophils after C5f infusion have rearranged f -actin compared to 
intracapillary neutrophils in animals receiving saline, and are more spherical (Motosugi et 
al, 1996). This is likely to result in neutrophils that are mechanically detained in pulmonary 
capillaries. FMLP produced actin rearrangement increased neutrophil stiffness in vitro, 
which paralleled their retention in filters and their retention in lungs when returned after ex 
vivo treatment (Worthen et al, 1989). 
Sequestered cells obtained by pulmonary vascular lavage after inflammation induced 
by Corynebacterium parvum show increased stiffness compared to cells obtained from the 
peripheral vascular pool (Brown et al, 1995b). 
Colchicine caused an initial pulmonary neutrophil sequestration, followed by 
recovery in rabbits (Mueller et al, 1994), indicating a rôle for microtubule reassembly during 
normal passage through the lung. Colchicine failed to inhibit the increased neutrophil 
sequestration after Strep. pneumoniae instillation intra- bronchially. However, it inhibited 
migration from the vascular to the alveolar space. It is not possible to say whether this was 
due to an effect on the neutrophil or on resident lung cells. 
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Clearly, modulation of neutrophil rheological properties is of critical importance in 
their increased sequestration in the lung during inflation. 
1.12.4 Adhesion molecules and neutrophil sequestration during inflammation 
Adhesive interactions between the neutrophil and the vascular endothelium are 
mediated by a number of molecules. The three selectins are important. These are molecules 
possessing lectin -like domains. L- selectin is found on the neutrophil, whilst E- and P- 
selectin are found on activated endothelial cells. They bind to carbohydrate moieties, 
particularly sialyl -Lewis x and sialyl -Lewis a. 
The ß, integrins are heterodimeric molecules with a common ß subunit (CD18) 
found on the neutrophil. They bind to the immunoglobulin -superfamily members ICAM -1 
and ICAM -2, and additional uncharacterised receptors, on the endothelial surface. These 
molecules are also distributed among a variety of other cell types. 
1.12.4.1 Selectins and pulmonary neutrophil sequestration during inflammation 
In combined E- and P- selectin gene knockout mice there was a peripheral neutrophilia 
in the absence of infection, together with a concomitant increase in pulmonary neutrophil 
sequestration (Mizgerd et al, 1996). 
P- selectin knockout mice show an increase in peripheral blood neutrophil count after 
infusion of adrenaline, suggesting that P- selectin is not necessary for physiological 
sequestration (Johnson et al, 1995). Mulligan et al, 1992, noted that fewer neutrophils were 
closely apposed to the pulmonary capillary wall after anti -P- selectin antibodies, but whether 
this pool is strictly the same as that defined functionally is unclear. 
Neutrophil sequestration in guinea pigs after TNFa infusion was moderately reduced 
by pre -treatment with antibodies against sialyl -Lewis X and Lewis X (ligands for the 
selectins), as assessed by lung myeloperoxidase content (Lo et al, 1994). 
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In rats, the generalised sequestration of "'indium labelled neutrophils in a number of 
tissues after burns (Hansbrough et al, 1996) was inhibited by anti E- and P- selectin 
monoclonal antibody. This global sequestration is probably not the same as the more 
specific pulmonary sequestration of neutrophils in other circumstances. 
The lack of a demonstrable rôle for selectins in pulmonary neutrophil sequestration in 
gene knockout mice argues strongly against their importance in this process. The apparently 
contradictory efficacy of anti -bodies against selectins or their ligands in reducing 
sequestration could be due to experimental differences, or unsuspected in vivo cross 
reactivities of the antibodies, although compensatory mechanisms could be induced in gene 
knock -out mice. Overall, the rôle of selectins in pulmonary neutrophil sequestration seems 
at most limited. 
1.12.4.2 Integrins and pulmonary neutrophil sequestration during inflammation 
Sequestered neutrophils recovered by pulmonary vascular lavage have increased 
CD18 expression (Brown et al, 1995b) and increased adhesivity (Williams et al, 1993), 
suggesting that CD18 may play a rôle in sequestration. This has been supported by the 
ability of anti -CD18 antibodies to inhibit sequestration in a variety of circumstances; 
zymosan injection, following LPS (Miotta et al, 1991), during cardiopulmoanry bypass 
(Dreyer et al, 1995), after intraperitoneal LPS (Moriasaki et al, 1991) and after gut 
ischaemia/reperfusion (Hill et al, 1991). 
Nevertheless, in vitro PAF induced up- regulation of CD18 did not increase 
neutrophil sequestration when the cells were returned to the circulation (Fontes et al, 1995). 
On the other hand, GM -CSF causes clear neutrophil sequestration that cannot be inhibited 
by anti-CD18 antibody (Yong et al, 1992). 
Others have found CD18 dependence to vary with site or time. Generalised 
pulmonary neutrophil sequestration was CD18 dependent except in the portion of lung 
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directly exposed to acid, where anti -CD18 antibodies fail to inhibit neutrophil sequestration 
(Goldman et al, 1995). Pulmonary sequestration of "'indium labelled cells after intravenous 
E. coli was CD18 independent after 4 hours, but became CD18 dependent after 24 hours 
(McCandless et al, 1994). 
Doerschuk (1992) found that initial neutrophil sequestration due to infusion of 
zymosan activated plasma was CD18 independent, but that subsequent washout of these 
cells was accelerated by anti -CD18 antibody. She proposed a two -stage mechanism, where 
initial sequestration was CD18 independent, but the position of the cells within the 
pulmonary vasculature was stabilised by CD18 dependent mechanisms. 
Studies showing CD18 dependent sequestration were generally performed over 
relatively long periods (several hours). Both mechanisms will be included, with overall 
CD18 dependence of sequestration, and it is reasonable to regard this as generally true. 
Nevertheless, other studies have clearly shown that expression of increased CD18 does not 
necessarily lead to sequestration, and that increased sequestration may in some 
circumstances be entirely CD18 independent. 
1.13 Adhesion molecules in migration of neutrophils from the intra -vascular 
space 
"A beneficial inflammatory reaction that leads to containment of infection may cause early 
tissue damage and later lead to fibrosis and disturbed lung function. Since nature has also 
recognised the importance of containment and limitation of inflammation, the exit of cells 
from the circulation into the tissues is subtly regulated at multiple levels" 
Furfaro and Berman, 1992 
1.13.1 Contrasts between systemic and pulmonary circulation 
In order to combat infective challenges, neutrophils must migrate from their usual 
intravascular position and pass out into the tissues. In tissues supplied by the systemic 
circulation, this migration occurs from the post -capillary venules (Grant, 1974). As the 
51 
vascular space widens, there is axial streaming of the erythrocytes, tending to displace 
neutrophils to the periphery. Here, they exhibit a characteristic rolling against the 
endothelium (Atherton and Born, 1971, and Atherton and Born, 1973). Rolling increases in 
the presence of inflammation. Intermittently, neutrophils are seen to stop, and it is following 
these halts that migration occurs. 
The two mechanisms were dissociated using intravital microscopy of rabbit 
mesentery. Anti -L- selectin antibody inhibited rolling. Anti -CD18 antibody had failed to 
inhibit the number of neutrophils that rolled (though mean velocity of rolling neutrophils 
increased), but inhibited subsequent firm adhesion (Von Andrian et al, 1989). 
Since the rôle of L- selectin on the neutrophil in mediating rolling was first elucidated, 
it has also been shown that rolling is supported by E- and P- selectin on the endothelium 
(Abassi et al, 1993, and Jones et al, 1992). 
It is hypothesised that the rapid adhesion mediated by selectins is important in 
conditions of significant sheer stress witnessed in blood flowing in venules. Once the 
neutrophils have been slowed and temporarily "captured" by selectin mediated adhesion, 
further firmer integrin mediated adhesion can occur, followed by emigration from the 
vascular space. The firm integrin mediated adhesions are only able to be established at low 
shear stresses (Lawrence and Springer, 1991, and see Butcher, 1991, Smith, 1992a ). 
A further elegant demonstration of the dissociation of these types of adhesion is 
provided by the infusion of neutrophils from humans with leukocyte adhesion deficiencies I 
and II into in vivo IL -113 activated rabbit mesentery. In leukocyte adhesion deficiency I there 
is a congenital absence of the CD18 132 integrin, but normal selectin expression. In the 
rabbit mesentery preparation, these cells are seen to roll normally. However, they do not 
show the normal firm attachments. By contrast, cells from patients with leukocyte adhesion 
deficiency II do not present sialyl Lewis X, a ligand for endothelial E- and P- selectins, due 
to defective fucosyl -transferase activity. These cells do not roll and fail to adhere in 
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conditions of flow. However, if flow is diminished by cross clamping the supplying artery, 
neutrophils are seen to successfully adhere in near static conditions. 
It has since been shown that L- selectin crosslinking actually increases CD18 
adhesivity (as revealed in latex bead binding), demonstrating that, although the two types of 
receptors mediate different functions, they are not independent (Simon et al, 1995). This 
interrelationship was also seen in an activated rabbit mesentery preparation (Von Andrian et 
al, 1992). Neutrophil rolling was inhibited by anti -L- selectin antibody. Activation of 
neutrophils before infusion gave decreased rolling that paralleled the loss of L- selectin seen 
on cell activation. However, after brief (1 -3 minutes) activation, the loss of L- selectin was 
incomplete. Though rolling diminished, cells that did roll had a strong propensity to 
progress to firm adhesion. 
The situation in the lungs differs importantly from this. Careful morphometric 
analysis of inflamed rabbit lung has shown the site of neutrophil emigration is the capillary 
rather than the post -capillary venule (Downey et al, 1993). In addition, studies of neutrophils 
in pulmonary vasculature demonstrate that they move with intermittent stop /starts rather 
than the rolling observed in systemic circulation (Lien et al, 1987). As discussed, their 
sequestration in the lungs, both in physiological and pathological conditions, is primarily 
dependent on neutrophil rheological characteristics, because of the narrow pulmonary 
capillary bed (Doerschuk et al, 1993), the unusually low pressure (Von Euler and Lijestrand, 
1946) and pulsatile flow characteristics of the pulmonary circulation (Lee and DuBois, 
1955). Adhesion molecules play a minor rôle in initial sequestration. The overall effect of 
these mechanical constraints means that, in the pulmonary circulation, neutrophils are 
brought into close contact with the epithelium at low shear stresses without prior 
intervention of specific adhesive interactions. This very different mechanical relationship 
between the neutrophil and the endothelium in the pulmonary circulation compared to the 
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systemic circulation raises the possibility that the use of adhesion molecules may be 
significantly different in the two cases. 
Once tethered to pulmonary vascular endothelium, the neutrophils are able to migrate 
out of the vascular space, probably passing between endothelial cells, then through pre- 
formed holes in the basement membrane. It has been suggested that these are normally 
covered by fibroblasts, and that the neutrophils 'lift' these away from the hole as they 
migrate through (Walker et al, 1995). 
1.13.2 Selectins and neutrophil migration from the systemic circulation 
L- selectin 
L- selectin is clearly important for successful neutrophil emigration from the systemic 
circulation. Anti -L- selectin antibody inhibits neutrophil influx in rabbit peritonitis 
(Fortenberry et al, 1994) and L- selectin gene knockout mice have reduced neutrophil influx 
into thioglycolate broth induced peritonitis (Tedder et al, 1995). 
P- and E- selectin 
Anti -P selectin antibody alone has been reported to inhibit neutrophil influx following 
ischaemia and reperfusion of the liver (Garcia -Craico et al, 1995), heart (Chen et al, 1994) 
and ear (Winn et al, 1993), but not after limb ischaemia (Seekamp et al, 1994). 
In other situations, P- selectin blockade has only inhibited neutrophil influx when E- 
selectin is not available as an alternative; there appears to be some functional redundancy. In 
peritonitis, anti -E or anti -P selectin antibodies only produced moderate inhibition of 
neutrophil influx, but influx was abolished by the two together (Bosse et al, 1994). Similar 
effects were observed in pleurisy (Henriques et al, 1996). 
Although P- selectin knock -out mice showed decreased neutrophil rolling in response 
to peritonitis, the eventual effect on neutrophil influx was not reported (Johnson et al, 1995). 
Anti -P- selectin antibody inhibited early but not late neutrophil influx in response to 
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peritonitis and delayed type skin hypersensitivity in wild type animals. Neutrophil influx 
was normal in these models in E- selectin knock -out mice, but in these animals, anti -P- 
selectin antibodies abolished late as well as early neutrophil influx (Labow et al, 1994). 
The time -dependence of P- selectin blockade in wild -type mice is likely to result from 
the fact that increased E- selectin expression depends on protein synthesis and thus takes 
several hours (Bevilaqua et al, 1989), whereas P- selectin is stored preformed in Wiebal- 
Palade bodies which can be translocated to the cell surface in minutes (McEver et al, 1989). 
If there is P- selectin blockade, E- selectin is only available as an alternative later on in 
inflammation. 
Selectin expression not only evolves with time during inflammation, but also varies 
anatomically too. Activated endothelial cells may express E- selectin, tissue factor and 
thrombomodulin, but in baboon sepsis, expression of these is discordant in different tissues 
(Seekamp et al, 1994). 
In summary, P- and E- selectin are important for neutrophil migration from the 
systemic circulation, but there is some functional redundancy. Their expression varies with 
place and time. 
1.13.3 Selectins and neutrophil migration from the pulmonary circulation 
L- selectin 
Anti -L- selectin treatment has been shown to inhibit pulmonary neutrophil influx in a 
wide variety of circumstances. Oligosaccharides produced to block selectin binding, anti -L- 
selectin antibodies, and L- selectin /antibody chimeras reduce neutrophil influx after IgG 
deposition (Mulligan et al, 1993c, Mulligan et al, 1994a and Mulligan et al, 1993b). Burns 
and hindlimb ischaemia and reperfusion both produce local and pulmonary neutrophil influx 
that can be inhibited by anti -L- selectin antibodies (Mulligan et al, 1994b and Seekamp et al, 
1994). 
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The only report of failure of L- selectin blockade to inhibit neutrophil influx is in 
Streptococcal pneumonia, when fucoidin failed to affect neutrophil influx (Mizgerd et al, 
1996). 
E- and P- selectin 
There is much more variable data relating to the rôles of E- and P- selectin in 
neutrophil emigration from the pulmonary vasculature. 
E- selectin is not expressed in normal lung, but is found in areas of neutrophil influx 
during pulmonary fibrosis (Nakao et al, 1995). An antibody against both E- and P- selectins 
inhibits pulmonary neutrophil influx when given before or soon after intravenous 
Pseudomomas aeruginosa (Ridings et al, 1995b and Ridings et al 1995a). 
After hindlimb ischaemia/reperfusion, pulmonary neutrophil influx is inhibited by 
anti -E- selectin antibody alone (unlike neutrophil influx to the post -ischaemic limb), whilst 
anti -P- selectin inhibits early neutrophil influx only (Seekamp et al, 1994). 
E- selectin chimeras inhibit pulmonary neutrophil influx after IgG immune complex 
deposition, but P- selectin chimeras have no effect, whilst after cobra venom factor, the 
opposite is true (Mulligan et al, 1993b). 
In the ICAM -1 /P- selectin double knockout mouse, although neutrophil influx to 
pneumococcal peritonitis is abolished, there is no abnormality of influx to pneumococcal 
pneumonia (Bullard et al 1995). In the E- and P- selectin double knock -out mouse, 
additionally treated with fucoidin to inhibit L- selectin, neutrophil influx to pneumococcal 
pneumonia is still normal (Mizgerd et al, 1996). 
In summary, E- and P- selectin usually (but not always) play important parts in 
neutrophil influx to the lung, but their exact rôles dependent on the stimulus. 
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1.13.4 Integrins and neutrophil migration from the systemic circulation 
There is no doubt that the 32 integrins have a substantial rôle in adhesion and 
migration of neutrophils. The integrins are heterodimers, and the 32 chain (CD18) can 
combine with aL (CDI la) to give LFA -1, aM (CD1 lb) to give Mac -1 or aX (CDI lc) to give 
p150,95, although the latter appears to play a minor rôle in adhesion. 
In vitro, migration of neutrophils across filters is greatly inhibited by anti -CD18 and 
anti -CD 11 b, but anti-CD1 1 a causes very little inhibition. Anti -CD 11 a and anti -CD 11 b each 
inhibit neutrophil migration across cultured endothelial monolayers by about 50 %, and their 
action together is additive (reviewed in Smith, 1992a). 
Activation of cells leads to upregulation of Mac -1 number and function, whereas 
LFA -1 numbers can only be slightly increased. LFA -1 binds to two members of the 
immunoglobulin supergene family, ICAM -1 and ICAM -2, on endothelial surfaces. Mac -1 
binds not only ICAM -1, but also other undescribed endothelial ligands (reviewed in 
Zimmerman et al, 1992). 
Clinically there is no doubting the importance of CD18. Patients with a deficiency of 
this molecule show a marked propensity to develop life- threatening infections. These 
characteristically fail to show neutrophil infiltration, although there is a peripheral 
leukocytosis (Anderson and Springer, 1987). 
The ability of anti -integrin antibodies to inhibit neutrophil migration to inflammatory 
sites in vivo has been studied in a multitude of models. In a review published in 1992, 10 
studies of anti -CD18, 2 of anti-CD' lb and 2 studies of anti -ICAM -1 effects on neutrophil 
recruitment from the systemic circulation to sites of inflammation were documented, all 
showing clear inhibition (Harlan et al, 1992). In addition, they tabulate 17 studies of anti - 
CD18, 2 studies of anti -CD1 lb and 3 studies of anti -ICAM -1 antibodies that have protected 
against inflammatory tissue injury (including ischaemia/reperfusion damage) in sites 
supplied by the systemic circulation, presumably because of inhibition of neutrophil 
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recruitment, and consequent decrease 'bystander' damage caused to the host by neutrophils. 
Since, there have been at least an additional 20 studies that have shown anti -integrin 
manipulations to have reduced neutrophil influx from the systemic circulation. 
There have been some exceptions to these general findings. Neutrophil influx is not 
always CD18 independent in glomerulonephritis (Tipping et al, 1994, and Wu et al, 1993). 
Anti-CD18 antibody was unable to prevent neutrophil influx after hepatic 
ischaemia/reperfusion (Langdale et al, 1993). 
Particularly interesting is a study comparing neutrophil influx in peritonitis caused by 
either Listeria monocytogenes or Salmonella typhimurium in mice. In the latter case, 
neutrophil influx was almost completely inhibited by either anti -CD18 or anti -CDl lb 
antibodies. These antibodies were without effect on neutrophil influx due to Listeria 
monocytogenes (Conlan and North, 1994). If listeriolysin- negative strains of Listeria were 
used, the neutrophil influx became CD18 dependent. It is not clear whether the listeriolysin 
was inducing a CD18- independent pathway of neutrophil migration, or whether it was 
inhibiting the more frequent CD18 dependent one, necessitating recruitment of reserve 
pathways. Yet again, the dynamic interplay between host and challenging organisms in the 
determination of the inflammatory response is indicated. 
The neutrophil response to peritonitis has also been studied with Escherichia coli and 
Streptococcus pneumonia (Mileski et al, 1990). Anti -CD18 antibody inhibited the 
recruitment of neutrophils to the peritoneal cavity in both cases. If the peritoneum was pre - 
primed by protease peptone injection 72 hours prior to bacterial challenge, neutrophil influx 
to Strep. pneumoniae became CD18 independent, whilst E. coli induced influx remained 
CD18 dependent. Lavage of the peritoneum after priming but before administration of Strep. 
pneumoniae restored CD18 dependency. Transplantation of the lavaged macrophages to a 
virgin mouse peritoneum and subsequent challenge with Strep. pneumoniae showed that 
CD18 independence could be transferred with the macrophages. Thus it seen-is that Strep. 
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pneumoniae interacts with macrophages to induce a CD18- independent pathway of 
neutrophil passage into the peritoneum. 
In E. coli and protease peptone induced peritonitis, neutrophil accumulation assessed 
by peritoneal lavage neutrophil counts was inhibited by anti -CD18 antibody (Winn and 
Harlan, 1993). By contrast, at 24 hours, there was very little, if any, inhibition of neutrophil 
numbers, implying that CD18 independence had developed during the course of the 
inflammation. Inhibition of macrophage accumulation by co- administration of anti -CD49d 
antibody blocked the increase in both mononuclear cells and neutrophils at 24 hours. 
Neutrophils do not possess CD49d, so this implies that the inhibition of 24 hour neutrophil 
numbers seen when both antibodies were administered is secondary to the inhibition of 
mononuclear infiltrate. As in the case of Strep. pneumoniae, induction of CD18- independent 
migration is postulated to rely on the presence and action of local macrophages. 
This experiment urges some caution in the interpretation of other studies of CD18- 
dependency of neutrophil migration. Almost without exception other studies that have 
overwhelming supported the role of CD18 in neutrophil migration have measured 
neutrophil accumulation after 3 -12 hours. It remains a possibility that normal neutrophil 
migration in other forms of inflammation becomes neutrophil independent as a result of 
normal evolution of the inflammatory process. 
In summary, in the overwhelming majority of studies, neutrophil emigration from the 
systemic circulation has been shown to depend on the 132 integrins. Some stimuli may cause 
CD18 independent neutrophil migration, and this may develop in the presence of high 
numbers of local macrophages. In some cases, neutrophil migration may become 
independent of CD18 during the course of the inflammatory response, but how widespread 
this phenomenon is remains uncertain. 
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1.13.5 Integrins and neutrophil migration from the pulmonary circulation 
Fewer studies have been undertaken of the importance of ß2 integrins from the 
pulmonary than the systemic circulation. The 1992 review referred to earlier (Harlan et al, 
1992) tabulates 3 studies of anti -CD 18 antibodies, one of anti -CD 11 b antibodies and 1 of 
anti -ICAM -1 antibodies on neutrophil recruitment. The results of these have been rather 
more variable than studies of neutrophil migration from the systemic circulation. 
Intra- tracheal LPS produces a neutrophil influx in rats that is approximately 30 % 
inhibited by anti -CD1la antibody and 60 % inhibited by anti -ICAM 1 antibody (Tang et al, 
1995). The effects of anti -CD118 and ant -CD11b antibodies were not reported, so it is 
unclear if complete inhibition of ß2 integrins would have been able to inhibit neutrophil 
influx more effectively. 
IgG immune complex deposition causes neutrophil influx (Mulligan et al, 1995). 
Intravenous antibodies to CDI la and ICAM -1 were able to block this, although anti -CD11 b 
antibodies given intravenously were without effect. When these antibodies were given 
intratracheally, anti -ICAM -1 still markedly inhibited neutrophil influx. However, anti - 
C D 1 1 a was now without effect whereas anti -CD 11 b markedly inhibited. This suggests that 
CD I 1 a is important intravascularly, but as the neutrophil migrates from the circulation 
CD' l b becomes important. 
In lung injury due to infusion of cobra venom factor, neutrophil influx was inhibited 
by anti-CD1 la, anti -CD1lb and anti -ICAM -1 by 30 %, 50 % and 60 % respectively 
(Mulligan et al, 1993a). 
Ozone induced neutrophil accumulation to the lung is also inhibited by anti -CD18 
molecules in dogs (Li et al, 1992). 
Anti -ICAM -1 and anti -CD18 inhibit neutrophil influx to the lung after PMA 
instillation, though anti -CD11a was without effect (Barton et al, 1989). 
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An early suggestion that CD18 mediated adhesion was not always comparable in the 
pulmonary and systemic circulations was provided by the finding that anti -CD18 antibody 
protects against neutrophil- dependent tissue damage after hypotensive shock in most tissues, 
but not in the lung (Vedder et al, 1988). In keeping with this, some cases of leukocyte 
adhesion deficiency type I show histological evidence of successful recruitment of 
neutrophils to the lung during pneumonia, despite the congenital lack of CD18 (Hawkins et 
al, 1992). 
In an acid aspiration model in the rabbit, instillation of hydrochloric acid produces a 
local influx of neutrophils into the lung that is CD18 independent (Goldman et al, 1993). 
Interestingly, there was a neutrophil sequestration in the rest of the lung that was inhibited 
by CD18 blockade. 
Direct pulmonary ischaemia/reperfusion using different experimental protocols has 
been found to be CD18 independent (Thomas et al, 1995) or CD18 dependent (Horgan et al, 
1990). Whether timing or degree of ischaemia is critical in the difference is uncertain, but it 
is interesting that the requirement for CD18 may vary in such apparently similar 
circumstances. 
Anti -CD 18 antibody inhibited neutrophil influx to LPS (though not completely) but 
was without effect in neutrophil recruitment to Strep. pneumoniae (Doerschuk, 1990). 
Animals were also simultaneously challenged with sponges containing Strep. pneumoniae or 
LPS placed in the anterior abdominal wall. Neutrophil influx to these sites was abolished by 
anti -CD18 antibody in both cases. PMA was similarly studied. Neutrophil influx to this 
stimulus was completely CD18 dependent in both the abdominal wall and the lungs. 
Lungs have a content of resident macrophages, and this may contribute to induction of 
CD18 independent pathways. Experiments performed in peritonitis (Mileski et al, 1990) , 
have supported the view that macrophages may contribute to induction of CDI 8 
independent neutrophil migration pathways. 
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Further studies were undertaken in the rabbit. Neutrophil accumulation after 4 hours 
was shown to be predominately CD18 dependent for PMA, LPS, and live E. coli. Strep. 
pneumoniae produced largely CD18 independent migration, as did the instillation of 
supernatant from Strep. pneumoniae exposed alveolar macrophages. Emigration in response 
to PMA could not be inhibited by cycloheximide administered intravenously prior to the 
stimuli. By contrast, cycloheximide did block recruitment due to LPS and Strep. 
pneumoniae, suggesting that in these cases new protein synthesis was required. 
Quantitative immunogold examinations demonstrated that, although in E. Coli 
pneumonia there is a greater than fourfold increase in ICAM -1 expression, there is no such 
increase in pneumococcal pneumonia (Burns and Doerschuk, 1994a). In addition, migrated 
cells show characteristic changes of activation in E. coli pneumonia, with decreased 1- 
selectin levels and increased expression of CD -18. This was not found in cells that were 
still intravascular. By contrast, both intra- and extra -vascular neutrophils showed these 
changes in pneumococcal pneumonia, illustrating very different use of the repertoire of 
adhesion molecules (Burns and Doerschuk, 1994). 
Simultaneous pulmonary and intradermal challenge with C5a and IL -1 a were used to 
compare the CD18 dependence at different sites (Hellewell et al, 1994). Neutrophil 
emigration in the skin in response to both stimuli was completely CD18 dependent. In the 
lung, IL -la induced neutrophil influx was partially inhibited by anti -CD18 antibody, whilst 
influx due to C5a was CD18 independent. 
Acute Pseudomonas pneumonia produced neutrophil influx that could be inhibited by 
anti -CD18 antibody (Kumasaka et al, 1996). A second instillate given after 7 days to a 
different portion of lung gave a similar neutrophil influx with the same CD18 dependency. If 
instead the second administration was made into the same lobe as the first, there was only 
15 -20 % of the initial neutrophil influx. Neutrophil influx in this recurrent pneumonia was 
shown to be CD18 independent. 
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In summary, neutrophil influx in the lung is variably dependent on ß, integrins. This 
depends on the stimulus, and whether it is a primary or recurrent inflammation. The exact 
timing of the stimulus may play a rôle. Neutrophil influx that is CD18- independent may 
require the participation of macrophages and new protein synthesis. 
1.14 Chemotaxis 
1.14.1 The concept of chemotaxis 
As described above, during the inflammatory response the circulating neutrophil 
shows a remarkable ability to linger at the site of inflammation and adhere to the vessel 
wall. It then migrates from this site through the tissue to the source of the inflammation. 
Clearly there must be some mechanism to attract or steer the neutrophil in the correct 
direction. Although it is mechanistically possible to imagine a series of adhesions which 
would direct random neutrophil movement, it has long been the predominant view that 
neutrophils respond to some sort of chemical gradient within the tissues. 
This process whereby a cell shows directed migration in response to a chemical 
substance is known as chemotaxis. The concept was first developed in the nineteenth 
century (see Harris, 1954). A variant on this has been more recently developed in which a 
chemical gradient is not obtained by soluble molecules, which might well be dispersed by 
blood and lymph flow in vivo. Instead, it is envisioned that chemicals are fixed onto the 
surfaces of cells or matrix proteins to establish a gradient, and cells migrate along this, the 
process of haptotaxis (Smith, 1992b). 
By 1954 when Harris had published his review, it had been established that bacterial 
products could cause directed movement of neutrophils in vitro and in vivo. However, no 
specific substances with this property had been isolated. In particular, Harris was sceptical 
as to whether the body itself produced any chemical substance in response to bacteria that 
was itself a mediator of chemotaxis. 
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Since then, a variety of methods of studying chemotaxis in vitro have been developed 
(Bignold, 1988). Most commonly used are a variation on Boyden chambers, in which 
differing concentrations of a test substance are placed on either side of a filter, and the 
ability of neutrophils to migrate through the filter in response to a concentration is assessed. 
More sophisticated methods using cellular monolayers grown on filters may also be used. 
These in vitro methods have been used to define a number of chemotactic substances. 
1.14.2 Chemotnxins 
Chemotaxins may be derived from the host or more or less directly from invading 
bacteria. The best known of the latter is formyl -methionyl -leucyl -phenylalanine (FMLP) 
(Marasco et al, 1984). This acts via specific receptors on the neutrophil cell surface, which 
have 7 transmembrane spanning domains and are G- protein linked. This has been found to 
be characteristic of a number of chemotactic receptors (see Caterina and Devreotes, 1991). 
Bacteria also produce a variety of less clearly defined chemotactic factors (Ras et al, 1990). 
Leukotriene B4 is an arachidonic acid metabolite that has been found to produce 
potent chemotactic effects in vitro (Palmblad et al, 1981). This effect was maximal at 10-6 
M. It also enhances adhesion to nylon fibres. This enhanced adhesion is an important aspect 
of chemotaxis. It appears to be mediated by fresh expression and upregulation of 
CDl 1b /CD18, and this expression seems to be carefully topographically controlled (see 
Smith, 1992b). 
A second well studied lipid mediator of chemotaxis is platelet activating factor (PAF) 
(Goetzl et al, 1980). This chemotactic and neutrophil activating molecule is particularly 
interesting as it is found not only as a free molecule, but also on the surface of activated 
endothelial cells. Binding of PAF to the neutrophil causes shedding of L- selectin and 
upregulation of CD18 integrins. Thus when neutrophils are brought into close contact with 
endothelial cells (for example during selectin adhesion in the systemic circulation or due to 
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mechanical factors with or without selectin adhesion in the pulmonary circulation) they will 
bind PAF and develop the adhesive mechanisms necessary for firm adhesion (see Butcher, 
1991, and Zimmerman et al, 1992). 
The complement fragments C5a and CSadesarg are important chemotaxins generated by 
activation of complement (Fernandez et al, 1978). Clearly bacterial invasion is likely to be 
associated with generation of these products. Studies of hypocomplementaemic mice urge 
some caution, though. The clearance rate of Staphylococcus aureus was independent of the 
complement status of the animal. The clearance rate of Streptococcus pneumoniae and 
Pseudomonas aeruginosa were decreased (Hendrick et al, 1982). However, only in the 
former could this be shown to be associated with decreased neutrophil influx to implicate 
complement's chemotactic (as opposed to opsonic) actions. 
A further cautionary note in extrapolation from these in vitro results is provided by 
study of the passage of neutrophils across naked filters, or filters with monolayers of either 
human umbilical cord endothelial cells (HUVEC), or kidney or lung epithelial cell lines 
(Casale et al, 1992). chemotaxis to FMLP, PAF and LTB4 was similar 
across each barrier, the rank order of potency depended on the nature of the barrier. 
Tumour necrosis factor alpha is another host- derived factor demonstrated to posses 
chemotactic actions (Ming et al, 1987). 
The overall relevance of these in vitro data is the finding that in 41 of 94 patients with 
recurrent infections, a defect of chemotaxis could be demonstrated (Ottonello et al, 1995). 
Of the factors described so far, although all are chemotactic for neutrophils, they are 
also significantly chemotactic for other inflammatory cells. This is a problem that was 
identified quite a while ago by Harris, who, in summing up his 1954 review of chemotaxis, 
identified the following as the second of his three key questions about chemotaxins: 
"How is the predominance of monocytes in certain lesions to be explained, if 
polymorphonuclear leukocytes and monocytes react chemotactically to the same stimuli ?" 
(Harris, 1954) 
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The discovery in the 1980s of a new class of compounds, the chemokines, caused 
great interest as a consequence, as the chemotaxis they produce seems to be much more cell - 
type specific (Bagglioni et al, 1989, Sherry and Cerami, 1991, and Strieter et al, 1994). The 
group is divisible into two subgroups on the basis of whether they have pairs of cysteine 
residues separated by a further amino acid (the C -X -C chemokines) or whether the cysteine 
residues are contiguous (the C -C chemokines). IL -8 was the first of the former to be 
characterised, whilst MCP -1 was the first of the latter. Although many additions have been 
made to each family since, it remains generally true that the C -X -C chemokines have a 
chemotactic influence predominantly on neutrophils whereas C -C chemokines 
predominantly influence mononuclear cells. 
It is therefore of great interest to ask whether IL -8 is involved in the huge neutrophil 
recruitment so characteristic of pneumonia. 
1.15 Interleukin-8 
1.15.1 Sources of interleukin 8 
1L -8 was first described as a monocyte product (Yoshimura et al, 1987). Macrophages 
can be induced to produce IL -8 by LPS from gram negative bacteria (Sylvester et al, 1990) 
and by other inflammatory mediators such as IL -1 and TNFa (Matsushima et al, 1988). 
Lipotechoic acid from gram positive bacteria can induce IL -8 production from monocytes 
cells and is likely to induce its expression by alveolar macrophages too (Standiford et al, 
1994). Within the lung it can be produced not only by macrophages, but also by epithelial 
cells (Abdelaziz et al, 1995), fibroblasts (Rolfe et al, 1991) and endothelial cells (Gran et al, 
1996). These resident cells do not respond directly to LPS to produce IL -8, but produce it in 
response to IL -1 f3 and TNFa. Thus they can be regarded as taking part in a network in 
which the macrophage exerts primary control. 
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Neutrophils are also a significant source of IL -8 (Bazzoni et al, 1991). Despite 
producing a significant increase in IL -8 mRNA in response to LPS, they release very little 
protein, but during active phagocytosis, they release significant IL -8. Although they can 
produce less IL -8 than macrophages per cell, their huge number at inflammatory foci means 
they may make a very significant contribution to the total IL -8 at such sites. 
Tracheal superfusion with Pseudomonas aeruginosa supernatant produced a 
neutrophil influx and increase in IL -8, both of which could be blocked by the CD18 
inhibitor NPC 15669 (Inoue et al, 1995), suggesting that the IL -8 was neutrophil derived. 
Migration of neutrophils alone does not seem to activate neutrophils sufficiently for IL -8 
release. If IL -8 itself was added to the perfusate instead of Pseudomonas aeruginosa 
supernatant then neutrophil migration occurred but recovered neutrophils did not show any 
increase in IL -8 mRNA. 
1.15.2 Receptors for IL -8 
Two functional neutrophil receptors for IL -8 have been discovered, termed IL -8R A 
and B. IL -8RA is specific for IL -8 whereas other chemokines such as gro act on IL -8RB. IL- 
8RB is downregulated during chemotaxis. Both are downregulated rapidly in the presence of 
exogenous IL -8, but levels of IL -8RA recover more rapidly. This has led to the suggestion 
that the former may be particularly important at sites of inflammation where levels of IL -8 
are high, whereas the latter might be more important in chemotaxis (Chuntharapai and Kim, 
1995). These receptors are themselves subject to control of expression, LPS decreasing and 
G -CSF increasing mRNA levels and 125I -IL -8 binding levels (Lloyd et al, 1995). 
In addition, there is a receptor on the erythrocyte which appears to be the Duffy blood 
group antigen. This is a promiscuous receptor that may bind a variety of different members 
of the chemokine family (Horuk et al, 1994). It is of particular interest as the erythrocyte 
receptor for malaria (Horuk et al, 1993).The function of this receptor is not clear. It 
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presumably acts to buffer the amount of free IL -8 within the plasma. To date, there have 
been no reports linking the lack of the Duffy blood group to any pathology related to 
impaired control or use of IL -8. 
The specific binding of IL -8 to endothelium has also been described (Rot et al, 1996). 
Here it may be presented to bound neutrophils to activate them in a similar fashion to that 
described for PAF (Zimmerman et al, 1992). Rot et al found that there were specific binding 
sites for IL -8 on post -capillary venules in the skin, but were unable to demonstrate binding 
to pulmonary vascular endothelium. They also found that no endothelial cells tested in 
culture (including HUVEC and primary dermal endothelial cultures) expressed binding 
sites. 
This may be important in the interpretation of in vitro experiments or extrapolation of 
experimental observations from one tissue to another. 
1.15.3 Actions in vitro 
IL -8 causes migration of neutrophils across naked filters in the classical assay for 
chemotaxis (Kurdowska et al, 1995). At higher concentrations, it also functionally activates 
neutrophils, causing activation of the respiratory burst (Walz et al, 1991) degranulation 
(Kurdowska et al, 1995), loss of L- selectin and upregulation of CD18 (Luscinskas et al, 
1992) , and increased phagocytosis (Detmers et al, 1991). Chemotaxis to IL -8 may be 
inhibited by endotoxin from a variety of bacteria (Bignold et al, 1991). 
When a filter coated with unstimulated endothelial or epithelial cells is used, IL -8 
also induces neutrophil migration (Smart and Casale, 1993). The duration of the response is 
greater than across naked filters. Anti -IL -8 antibody blocks the chemotaxis at any stage, 
showing that the prolonged migration is not due to secondary intermediary generation. 
Presumably this is due to binding of IL -8 and its continued presentation to the neutrophils, 
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though it should be remembered that cellular IL -8 binding sites have not been shown on 
cultured endothelial cells (Rot et al, 1996). 
IL -8 binds to basement membranes. Basement membrane on which confluent 
epithelial monolayers had been grown supported migration of neutrophils when an 
exogenous gradient was applied, but not alone (McCormick et al, 1995). However, if 
epithelial cells were exposed to Salmonella typhimurium before harvesting the basement 
membrane, this supported neutrophil flux in the absence of an externally applied gradient. 
This 'imprinting' of the basement membrane paralleled epithelial IL -8 release, could be 
blocked by anti -IL -8 antibodies, and was resistant to washing. This suggests that the 
membrane had tightly bound IL -8 which was able to act as a gradient, and might explain 
how signalling gradients are maintained in vivo despite volume flux. 
Despite the ability of IL -8 to induce neutrophil migration through unstimulated 
endothelial monolayers, it has been found to inhibit the adhesion of neutrophils to activated 
monolayers ( Hébert et al, 1990). This potentially anti -inflammatory action seems at least at 
first sight surprising given all IL -8's other documented pro- inflammatory effects. It was 
named the leukocyte adhesion inhibitory (LAI) effect. 
Further investigation showed that the LAI effect was shared with FMLP and C5a, but 
not with GM -CSF, LT B4 or PAF (Luscinskas et al, 1992). All these agents cause L- selectin 
shedding and CD18 upregulation, so this effect is not just due to shedding of L- selectin on 
ncutrophil activation. In addition, IL -8, FM1.P, and C5a were found to cause detachment of 
neutrophils already adherent to activated endothelial monolayers and to inhibit 
transmigration across them. 
Confocal microscopy demonstrates a rearrangement of F -actin during the LAI effect 
(Westlin et al, 1992). Treatment of neutrophils with cytochalasin B, which inhibits F -actin 
formation, inhibits the LAI effect. Clearly it is an active process, and it is reasonable to 
speculate that it plays a rôle in vivo. 
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In summary, IL -8 is a peptide which can be expressed by a wide variety of cells 
within the lung (and elsewhere), which causes neutrophil chemotaxis and neutrophil 
activation. In vitro, it can also be demonstrated to have some potentially anti -inflammatory 
activity by way of inhibiting neutrophil adhesion to activated endothelial cells. 
1.15.4 In vivo actions of IL -8 
Injection of IL -8 into the skin of humans and rabbits causes neutrophil recruitment 
(Leonard et al, 1991, and Hechtman et al, 1991), as does injection into the pleural space 
(Utsomiya et al, 1996). The latter showed that co- administration of actinomycin D did not 
inhibit IL -8- induced neutrophil influx (though it inhibited influx due to TNFa and IL -1(3), 
showing that IL -8 did not work by induction of further mediators. Although Rebeiro et al, 
1991 et al found that IL -8- induced neutrophil influx was macrophage dependent in the 
peritoneum and in subcutaneous airsacs, this study was performed in rats, which have no 
direct IL -8 homologue. 
Endo et al, 1991, found that IL -8 injection into the joint space produced a full 
inflammatory response, with a mononuclear influx following an initial neutrophil influx. 
This would not be directly predicted from the in vitro actions of IL -8. It may be due to 
secondary inflammation provoked by neutrophil- induced bystander damage, thus triggering 
normal inflammatory cascades. 
Hechtman et al, 1991 also showed that neutrophil influx due to intradermal IL -8 could 
be inhibited by simultaneous intravenous IL -8. This may be an in vivo manifestation of the 
leukocyte adhesion inhibitory (LAI) effect. This apparently anti -inflammatory action has 
also been seen in transfected mice over -expressing IL -8, in whom neutrophil influx to 
inflammatory sites is diminished (Simonet et al, 1994), and in cardiac 
ischaemia/reperfusion, when intravenous IL -8 protects against neutrophil influx and damage 
(Lefer et al, 1991). 
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The levels of IL -8 have been found to be elevated in a large number of diseases (see 
table 1 -1), both in the lung and elsewhere. 
TABLE 1 -1 Examples of disease states in which IL -8 is elevated 
Extra pulmonary; 
Psoriasis in the skin (Kulke et al, 1996), 
Behçet's disease in plasma (al- Dalaan et al, 1995) 
Post -cardiac transplant in the coronary sinus (Oz et al, 1995), 
During cardiopulmonary bypass in plasma (Kawahito et al, 1995) 
Osteomyelitis locally in bone and in the plasma (Klosterhalfen et al, 1996) 
Pulmonary, 
BAL from idiopathic pulmonary fibrosis (Nakamura et al, 1995), 
BAL from hypersensitivity pneumonitis (Sugiama et al, 1995) 
Induced sputum from asthma and chronic bronchitis (Keatings et al, 1996) 
BAL from the affected lung (but not the unaffected lung or plasma) in community acquired 
pneumonia (Boutten et al, 1996) 
BAL from pneumonia and ARDS (Chollet -Martin et al, 1993). 
The macrophage has been shown to be a source of abnormally high IL -8 in a number 
of circumstances (see table 1 -2). 
Table 1 -2 Diseases in which abnormally elevated macrophage IL -8 production 
has been shown 
Disease Reference 
Rheumatoid arthritis Endo et al, 1991 
Cystic fibrosis Strieter et al, 1993 
Pulmonary fibrosis Carre et al, 1991 
Inflammatory bowel disease Grimm et al, 1996 
This list of conditions in which elevated levels have been found is by no means 
comprehensive. However, the mere demonstration of high levels tells us little of the 
functional rôles of IL -8. In many of these conditions one would expect the levels of other 
cytokines and inflammatory mediators to be elevated too. Although to prove a role for IL -8 
in a given condition it must be possible to demonstrate its presence, the amount of IL -8 
present will say little about its functional importance compared to these other mediators. 
The finding that IL -8 levels correlate with neutrophil numbers in synovial fluid (Endo 
et al, 1991); broncho- alveolar lavage fluid of patients with ARDS and pneumocysitis 
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pneumonia (Villard et al, 1995) and sputum sol phase in asthma and bronchitis (Nocher et 
al, 1996) must be interpreted with caution. As neutrophils themselves produce IL -8, elevated 
IL -8 levels could be the result rather than the cause of increased neutrophil numbers. More 
convincing is the demonstration that macrophage IL -8 mRNA correlates with neutrophil 
numbers in pulmonary fibrosis (Carre et al, 1991), and that in Hodgkin's disease, there is a 
topographical relationship between macrophage IL -8 production and neutrophil influx (Foss 
et al, 1996). On the other hand, the lack of such a correlation in skin blister fluid (Follin et 
al, 1991) and bacterial pneumonia (Villard et al, 1995) does not necessarily argue against an 
important rôle for IL -8 in neutrophil influx. Even if neutrophil clearance remains constant, 
the neutrophils seen to have accumulated will have done so over a period of time, during 
which IL -8 levels could have been radically different than those measured at a single point. 
More usefully, the ability of anti -IL -8 antibodies to inhibit chemotactic activity of 
biological fluids has been assessed (see table 1 -3). Inhibition has been between 27 % and 
75 %, suggesting that although IL -8 contributes to chemotactic activity in these states, other 
factors are at least as important. 
Table 1 -3 Inhibition of chemotactic activity in biological fluids by anti -IL -8 
antibody 
Fluid (disease state) Inhibition (%) Reference 
Synovial fluid (rheumatoid arthritis) 27 -57 Koch et al, 1991 
Pleural fluid (LPS induced pleurisy) 65 -75 Brylan et al, 1994 
Pleural fluid (empyaema, parapneumonic 30 Antomy et al, 1993 
effusion) 
BAL (Cystic fibrosis) 30 Strieter et al, 1993 
Tracheal superfusate (Post antigen 75 Kaneko et al, 1996 
exposure) 
IL -8 has also been correlated with disease severity in ARDS (Groenweld et al, 1995) 
and cystic fibrosis (Strieter et al, 1993). In a group at risk of developing ARDS, very early 
elevated broncho- alveolar lavage IL -8 levels predicted those who would progress to disease 
(Donnelly et al, 1993). This suggests a causal relationship. 
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The most convincing data suggesting an important rôle for IL -8 in neutrophil 
recruitment comes from antibody inhibition studies. Anti -IL -8 antibody inhibits neutrophil 
influx after the addition of Staph. aureus to tracheal superfusates (Masson et al, 1995), LPS- 
induced pleurisy (Broaddus et al, 1994), acid aspiration (Folkesson et al, 1995) and immune - 
complex mediated glomerulonephritis, LPS and IL -1 induced arthritis, and lung reperfusion 
injury (Harada et al, 1994). All these studies measured total neutrophil accumulation, so did 
not measure influx specifically. In addition, they all administered antibody prior to the 
inflammatory stimulus (with the exception that in some experiments by Folkesson et al, 
1995, antibody was administered 1 hour after). Thus they give no information on the relative 
importance of IL -8 as the inflammatory response evolves. 
This has only been addressed by Collins et al, 1991. After intraperitoneal zymosan, 
peritoneal fluid was injected into rabbit dorsal skin and assayed for the ability to cause 
neutrophil recruitment. This in vivo chemotactic assay showed that within two hours, 
complement contributed most to neutrophil recruitment, but later, IL -8 and another similar 
molecule (later identified as gro Jose et al, 1991) were pre -eminent. 
In summary, IL -8 causes neutrophil recruitment when administered to tissues, but may 
inhibit it when administered intravenously. High levels have been associated with a number 
of disease processes, and sometimes this correlates with neutrophil numbers. The 
chemotactic activity of biological fluids from inflamed sites has chemotactic activity that 
can be inhibited only partially by anti -IL -8 antibody. Anti -IL -8 antibody generally inhibits 
neutrophil accumulation, but these experimental protocols have not determined whether the 
rôle of IL -8 varies with time. The one study that addresses this suggests that IL -8 is not 
always equally important throughout the inflammatory process. 
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1.16 The clearance of neutrophils from inflammatory sites 
Whilst there has been a huge interest over the past century and a half in the 
mechanisms of neutrophil recruitment to inflammatory sites, the mechanisms by which the 
vast numbers of cells which accumulate are subsequently removed has been very little 
studied until recently. In a three volume work reviewing experimental study of the 
inflammatory process published in 1974 , the only specific discussion of neutrophil 
clearance is a reference to the fact that 1011 neutrophils must be removed from the body per 
day during normal turnover (Zweifach et al, 1974). It was considered that the majority were 
lost into the gastrointestinal tract and from mucous membranes, but no consideration was 
given to the fate of the neutrophils once in the tissues. 
Others have acknowledged the problem. Heffron in his extensive monograph on 
pneumococcal pneumonia suggested that there must be an active process of'absorption', 
though he was unable to elaborate on the mechanisms that brought this about (Heffron, 
1939). As neutrophils have never been observed to leave the tissues following their 
migration there from the blood, it has often been presumed that they must passively 
degenerate and be cleared by scavenging macrophages (Hurley, 1983, and Sanui et al, 
1982). 
Such neutrophil engulfment by macrophages was seen in early studies of pneumonia. 
Loosli in observations on primates noted; 
"the polymorphonuclear leukocytes appeared early and in large numbers, but they began to 
degenerate and to be taken up by the mononuclear macrophages after 24 hours" 
(Loosli, 1942a) 
In fact, in an accompanying paper on pneumonia in the dog, he went on to observe of 
the neutrophils that: 
"although they were the most numerous cell type in the exudate up to 48 hours, many at this 
time had pycnotic (sic) nuclei and had been taken up by the mononuclear macrophages" 
(Loosli, 1942b) 
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Although it was not realised at the time, in retrospect Loosli's description of 
neutrophils with pyknotic nuclei being phagocytosed by macrophages was one of the earliest 
descriptions of a specific mode of cellular death that remained uncharacterised for more 
than 30 years, and undescribed in the neutrophil for nearly half a century. 
Neutrophils are known to contain a vast array of potentially histotoxic compounds. if 
neutrophils were to die passively at the site of inflammation, these would presumably be 
released. This would mean that acute inflammation would inevitably be associated with 
uncontrolled tissue damage, which might be regarded as a design fault in the system! It 
would also be likely to lead to further secondary generation of pro -inflammatory mediators. 
It is now known that cells in general die by one of two mechanisms; not just by passive 
necrosis but also by the far more controlled process of apoptosis (programmed cell death). 
1.16.1 Apoptosis and necrosis 
The term apoptosis was first used by Kerr and colleagues (Kerr et al, 1972). It is 
derived from a Greek word used to describe the falling of leaves from trees in the autumn, 
and was chosen as an expression of a natural mechanism of death as part of an ongoing life - 
cycle. 
It is now generally accepted that cell death occurs either by necrosis or by apoptosis, 
the morphological features of which have been extensively reviewed (Kerr et al, 1987, 
Wyllie et al, 1980). Necrosis is usually seen as a response to an unusual pathological 
process such as ischaemia or trauma. Confluent cells are often affected, with an associated 
secondary inflammation. Individual cells swell, as do their mitochondria. Ultrastructurally, 
there may be some evidence of nuclear pyknosis but this is not prominent or clearly defined. 
Membrane integrity is lost early, giving rise to inability to exclude vital dyes. 
Apoptosis is usually seen in irregularly distributed isolated cells. There is contraction 
of the cell with surface blebbing, an active process that has been named zeiosis. The cell 
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membrane retains its integrity, excluding vital dyes. The cytoplasm shows vacuolation 
without the gross mitochondrial dilation seen in necrosis. Indeed, the cell's cytoplasmic 
organelles characteristically are maintained intact. The chromatin undergoes condensation 
and contracts to form dense clumps around the nuclear membrane. There is then often 
fragmentation of the entire nucleus. In vivo these are taken up by macrophages, but if this 
does not occur (e.g. in cell culture) secondary degeneration occurs with swelling and lysis of 
the cells. Biochemically, the neutrophil breakdown is associated with inter -nucleosomal 
chromatin cleavage, giving a characteristic 'step- ladder' appearance on DNA gel 
electrophoresis. The description of apoptosis leading to nuclear pyknosis with subsequent 
uptake of the apoptotic cells by surrounding macrophages appears to be exactly Loosli's 
description of cells in pneumonia in 1942. 
1.16.2 Apoptosis of the neutrophil and its recognition by macrophages 
A number of reports of phagocytosis of neutrophils by macrophages have appeared 
over the past 30 years. Elicited mixed leukocytes from the guinea pig peritoneum mixed 
with Staphylococci produced such examples on electron- microscopy (Brewer, 1964). Later 
it was demonstrated that such phagocytosis was associated with aged neutrophils, implying a 
specific change in them allowing them to be recognised as senescent cells by the 
macrophages (Newman et al, 1982). Later, the morphological changes of the neutrophil as it 
ages were recognised to be those of apoptosis (Savill et al, 1989a). This was not mediated by 
the macrophage receptor associated with uptake of senescent erythrocytes or by Fc 
receptors, but by a novel charge- sensitive mechanism (Savill et al, 1989b). It was also found 
to be inhibited by antibodies to the vitronectin receptor, the avß3 integrin (Savill et al, 
1990). Additionally, antibodies to the thrombospondin receptor, CD36, also blocked the 
recognition of aged neutrophils. Thrombospondin is produced by macrophages and was 
shown to facilitate the interaction when added exogenously, and to adhere to neutrophils. It 
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was hypothesised that thrombospondin forms a molecular bridge between CD36 and the 
vitronectin receptor on the macrophage and an as yet unknown receptor on the neutrophil 
surface that appeared as apoptosis took place. 
The original work describing the importance of the thrombospondin and vitronectin 
receptor was performed using human peripheral blood monocytes, aged for 4 days in vitro. 
These cells gain a macrophage phenotype. Murine bone marrow -derived macrophages were 
found to use similar recognition mechanisms. However, inflammatory macrophages elicited 
by protease peptone or thioglycollate broth injection into the peritoneal cavity were able to 
ingest apoptotic neutrophils by a different mechanism (Fadok et al, 1992). This was 
inhibitable by phosphatidylserine, a membrane phospholipid that is usually confined to the 
internal aspect of the membrane, but has been found to be externalised in apoptotic 
lymphocytes. Thus the process of recognition and uptake of apoptotic neutrophils is 
different at different sites. It may even be that different mechanism are used in normal 
physiological homeostasis and pathological inflammation. 
Although macrophage uptake of senescent neutrophils has correlated well with 
morphological apoptosis in these experiments, changes leading to recognition and to DNA 
cleavage are not necessarily directly related in sequential fashion, but may normally proceed 
in parallel. That the two may be dissociated is demonstrated by mice transfected with the 
bc1-2 oncogene (Lagasse and Weissman, 1994). Normally bc1-2 expression is lost in mature 
neutrophils. In these mice it continued to be expressed. They showed diminished apoptosis, 
but normal neutrophil kinetics with continued macrophage ingestion of neutrophils. 
Neutrophil apoptosis differs from apoptosis in many other cells studied in that it is 
accelerated by protein synthesis inhibition by cyloheximide (Payne et al, 1994). However, 
other ATP /ADP ratios are preserved within the apoptotic neutrophil, whilst their glutamine 
and lactate decrease, suggesting that basic cellular respiration continues (Nunn et al, 1996). 
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It is suggested that normally a protein is produced that inhibits apoptosis and removal of this 
protein is the triggering factor for apoptosis. 
During the process of apoptosis, many neutrophil functions are altered. In response to 
FMLP there is decreased shape change, chemotaxis, degranulation, respiratory burst and 
phagocytosis of opsonised zymosan. Although this was partially due to loss of the FMLP 
receptor, this was not the entire explanation, as superoxide production was preserved in 
response to PMA (Whyte et al, 1993a). 
The adhesion molecules also show significant changes. L- selectin expression is 
decreased, whilst that of CD18 integrins is increased. Adherence to E- selectin is decreased, 
as is adhesion to fibrinogen, the latter demonstrating that the increased surface CD18 
molecules are functionally inactive (Dransfield et al, 1995). Surface expression of the 
FcyRIII (CD16) molecule is also decreased on apoptotic cells (Dransfield et al, 1994). 
All these processes conspire to make the apoptotic neutrophil relatively quiescent and 
isolated from potential activating factors in their environment. In addition, when they are 
phagocytosed by macrophages this does not lead to secondary activation of the macrophage, 
unlike other forms of macrophage phagocytosis (Meagher et al, 1989). The whole process of 
neutrophil apoptosis and uptake by macrophages as demonstrated in vitro thus has huge 
potential to act as an injury- limiting mechanism for neutrophil clearance. 
Teleologically speaking it is easy to see that modulation of neutrophil apoptosis and 
uptake by macrophages would be beneficial. Neutrophils recruited to an inflammatory focus 
must persist long enough to perform their protective function, which could mean 
prolongation of their life beyond that usually seen in the peripheral circulation. Having 
completed this task, it might then be beneficial to promote apoptosis, rendering the 
neutrophils relatively quiescent and preventing secondary damage, and promoting their 
clearance by macrophages. There is abundant in vitro evidence of the facility for just such a 
modulation to take place. 
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1.16.3 Modulation of neutrophil apoptosis and its recognition 
Many neutrophil activating agents act by raising intracellular calcium. Such an 
elevation causes decreased neutrophil apoptosis, whereas chelation of intracellular calcium 
increases apoptosis, opposite to the effects witnessed in many other cell types (Whyte et al, 
I 993b). This would lead one to expect that neutrophil activating agents would tend to 
decrease apoptosis, which is indeed what is generally found. This would be consistent with a 
prolongation of neutrophil functional activity at an inflammatory site where the 
concentration of mediators would be elevated. 
Conditioned medium from monocyte and bronchial epithelial cell cultures reduce 
apoptosis by the generation of GM -CSF and G- and GM -CSF respectively (Lee and Haslett, 
1994, and Cox et al, 1992). Neutrophils were taken from patients with paediatric 
malignancies treated with G -CSF in vivo, and aged in vitro. There, they too showed 
decreased apoptosis compared to controls (Adachi et al, 1994). 
Similar effects were also obtained with pure preparations of these cytokines (Colotta 
et al, 1992). This latter study also demonstrated that apoptosis was reduced by IFN -y, LPS 
and inactivated Streptococci. However, they found no effect of FMLP, C5a and IL -8. 
Others have found that C5a and FMLP inhibit apoptosis (Haslett, 1992 and Lee et al, 
1993). This is certainly consistent with the same group's findings on intracellular calcium 
concentrations. Apparent disagreement over the effect of IL -6 was resolved when it was 
shown that IL -6 indirectly decreases apoptosis by inducing PAF. In experimental conditions, 
with high neutrophil concentrations, sufficient PAF concentrations are induced by IL -6 to 
produce clear effects on apoptosis, whereas, when neutrophils are more dispersed, the 
increase is insufficient to give a clear effect (Biffi et al, 1996). Differences in second 
mediator generation by neutrophils cultured in different conditions could account for the 
differing observations on chemoattractants, though similar culture media and cell 
concentrations were used by each group. Haslett's group cultured the cells in suspension in 
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teflon bags, whereas Colotta et al cultured neutrophils in flat bottomed culture plates, which 
may have provided an additional adhesion signal that affected the response. IL -2 also delays 
apoptosis (Pericle et al, 1994). 
ATP and other adenosine products that may be released by activated platelets 
decrease neutrophil apoptosis (Gasmi et al, 1996). This may be important as platelets adhere 
to damaged endothelium at inflammatory sites and release mediators. 
Glucocorticoids inhibit neutrophil apoptosis. This is particularly interesting as they 
have the opposite effect on eosinophils, closely related members of the granulocyte lineage 
(Meagher et al, 1996). This indicates the high degree of specificity of the control 
mechanisms. 
During pneumonia there is likely to be a significant degree of hypoxia in the lung, 
particularly at sites with a dense cellular infiltrate. Hypoxia has been shown to decrease 
apoptosis, an effect that could be mimicked by catalase but not by superoxide dismutase, 
Trolox or methionine (Hannah et al, 1995). 
Conversely, oxidant stress caused by pharmacological depletion of GSH causes an 
increase in apoptosis that is inhibitable by N- acetylcyseine (Watson et al, 1996). This could 
be important in providing a feedback control of inflammation in areas exposed to high local 
reactive oxygen intermediaries generated by local inflammatory changes, and is one of the 
few stimuli shown to enhance neutrophil apoptosis. 
TNFa is the best known agent capable of enhancing neutrophil apoptosis (Takeda et 
al, 1993). In fact, subsequent studies have shown this to be rather more complex. Early 
neutrophil apoptosis (4 - 8 hours) is stimulated, but at late time points (21 hours) there is 
actually an inhibition of apoptosis (Murray et al, 1997). 
Fas ligand works through Fas (CD95), a member of the TNF receptor family. Fas is 
expressed by the neutrophil, and Fas ligand is also released by neutrophils, the only 
granulocyte to do so. Activating anti -Fas antibody induces neutrophil apoptosis, and Fas- 
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IgG chimeras partially suppress constitutive neutrophil apoptosis in vitro, suggesting that it 
may have a particularly important rôle to play (Liles et al, 1996). The in vivo expression of 
Fas and Fas ligand during acute inflammation has yet to be studied in great detail. 
A variety of proteases (pronase, chymotrypsin and trypsin) induce neutrophil 
apoptosis in vitro (Trevani et al, 1996). This provides a possible negative feedback control 
during inflammation. If there were excessive inflammation, active proteases might well 
increase. These would then feed back on the neutrophil to induce the refractory state of 
apoptosis, limiting further protease release. 
Interestingly, erythromycin (and not other antibiotics) has been found to enhance 
apoptosis (Aoshiba et al, 1995). It is also of unique utility in diffuse panbronchiolitis, a rare 
inflammatory disease of the airways confined to the Far East. It is interesting to speculate 
that erythromycin's efficacy could be due not only to its antibiotic but also to its anti - 
inflammatory actions by way of accelerating apoptosis. These workers correlated 
erythromycin's actions with an increase in cAMP, which contradicts the extensive 
pharmacological manipulations performed by others who correlated an increase in cAMP 
with a decrease in apoptosis (Rossi et al, 1995). The reason for the discrepancy is not 
apparent. The former group used electronmicrosopy to score apoptosis at 24 hours in 
culture, whereas the latter used CD16 expression at 21 hours, but it seems surprising that 
two studies should produce opposite conclusions on the basis of different scoring 
techniques. 
The modulation of neutrophil uptake by macrophages has also been examined. GM- 
CSF, IFNy, IL -113, TNFa, and TGFß1 all enhance the uptake of apoptotic neutrophils when 
added to macrophages in culture, both in terms of the proportion of macrophages ingesting 
cells and the number of neutrophils ingested per macrophage (Ren and Savill, 1995). Pre- 
treatment experiments established that mediators exerted their effect on the macrophage 
rather than on the neutrophil. Although the uptake appeared to be via the 
81 
thombospondin /vitronectin receptor mediated pathway, no changes in the expression of 
either receptor or thrombospondin expression was observed. A change in the functional 
status of the receptors was therefore hypothesised. 
There is thus abundant evidence that neutrophil survival can be modulated by a wide 
range of factors in vitro, and that the majority of inflammatory mediators inhibit apoptosis 
and lengthen life -span in the neutrophil. Uptake of apoptotic neutrophils by macrophages 
can also be modulated by inflammatory mediators. 
1. /6. -I Evidence for apoptosis in vivo 
Historical studies can in retrospect be seen to have been describing neutrophil 
apoptosis and clearance by macrophages. The engulfment of neutrophils was described by 
Metchnikoff in the 19th Century (see Savill, 1992). The work of Loosli describing 
'degeneration' of neutrophils with pyknotic nuclei which are taken up by macrophages 
during pneumonia has been described above (Loosli, 1942b). 
Neutrophils phagocytosed by macrophages were found to be quite prominent in joints 
inflamed by Reiter's syndrome (Perkin et al, 1966). Figures produced in these papers show 
engulfed neutrophils with condensed cytoplasm, with other neutrophil in varying states of 
degeneration. 
A resected spleen from a patient with thrombotic thrombocytopaenic purpura showed 
that neutrophils (as well as other blood cells) had been engulfed by macrophages (Kadri et 
al, 1975). 
Macrophage phagocytosed neutrophils were also described in childhood chronic 
benign neutropaenia (Parmley et al, 1981). In this case, neutrophil band forms were 
phagocytosed in addition to older neutrophils. Some of the plates produced appear to show 
the phagocytosis of non -apoptotic neutrophils. The process described in this disease seems 
unusual, and one wonders if a defect in the normal recognition process (for instance 
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neutrophils expressing surface changes normally associated with ageing early in their life - 
span) contributed to the disorder, but as apoptosis was not widely appreciated at the time 
(and had not been described in granulocytes) this was not investigated by the authors. 
The injection of a number of stimuli into guinea -pig peritoneum was followed after an 
interval by an increase in the number of macrophages showing evidence of ingested 
neutrophils. In some cases as many as 20 % of macrophages showed evidence of neutrophil 
ingestion (Sanui et al, 1982). The timing of the response depended on the initial stimulus, 
with thioglycollate broth or oyster medium producing a peak in 48 hours, whereas Listeria 
monocytogenes and Staphylococcus aureus produced a peak after 72 hours. 
Full appreciation of the importance of neutrophil apoptosis is difficult in vivo because 
on histological sections it is very difficult to detect. This is because the interval between 
morphological apoptosis and uptake by surrounding macrophages is short. It has been 
estimated that this period is usually of the order of 30 minutes. Apoptotic bodies may, for a 
longer, period be recognisable within the macrophage but breakdown is rapid, so this 
interval is of the order of a few hours at most (Ellis et al, 1991, Kerr et al, 1987, and Wyllie 
et al, 1980). Thus apoptosis can lead to a huge reduction in cell numbers over a period of 
time, but in static morphological images it will appear a rare event. In a study in which mice 
were administered anti -CD4 antibodies, it was found that apoptosis was caused leading to 
loss of 50 % of T cells over 48 hours (Howie et al, 1994). This was associated with a 
maximum of 1.33 % unequivocally apoptotic neutrophils at any one time, compared to 0.55 
% in controls. Thus, very small changes in the visible rate of apoptosis may have profound 
effects on overall cell kinetics. 
Despite these difficulties, a number of studies have been performed which suggest 
that the process is important in vivo. A histological study of the marrow of normal neonatal 
mouse bone marrow showed significant amounts of apoptotic neutrophils, with uptake by 
marrow macrophages (Sasaki et al, 1995). 
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Labelling of rabbit donor neutrophils with BrdU allowed their tracking when injected 
into donor animals. After several hours they became predominantly localised within the 
spleen. Extraction of DNA showed the BrdU- labelled neutrophil DNA to have been cleaved 
in the inter- nucleosomal pattern characteristic of apoptosis (Bicknell et al, 1994). This 
suggests that apoptosis is the normal limiting factor in the life span of the circulating 
neutrophil. 
Between 1 % and 11 % of neutrophils from inflamed synovial fluid were 
morphologically apoptotic, and synovial macrophages were observed to contain apoptotic 
neutrophils (Savill et al, 1989). Apoptotic neutrophils were also observed in broncho- 
alveolar lavage fluid from neonates with respiratory distress syndrome (Grigg et al, 1991). 
Two abstracts were presented to the American Thoracic Society describing the 
appearance of apoptotic neutrophils in the lung. In the first of these, approximately 2 % of 
neutrophils from patients with ARDS were apoptotic morphologically (Matute -Bello et al, 
1 996 ). Surprisingly the authors found that only 2 % of all apoptotic neutrophils were within 
macrophages. 
In the second abstract, the presence of apoptotic neutrophils in pneumococcal 
pneumonia is examined (Kutkoski et al, 1996). Here, the process of in situ end- labelling was 
used. This technique uses the characteristic double -stranded DNA breaks as a template for 
use of terminal transferase to add a label (Gold et al, 1994). (DNA breaks in early necrosis 
tend to be single stranded and thus not recognised by the transferase). This technique raises 
some questions as it is highly dependent on the phase of apoptosis or necrosis, the rapidity 
of fixation to prevent further DNA digestion post -mortem, and the degree of Proteinase K 
pre -treatment. Whether it is entirely applicable to intense inflammatory conditions is open to 
some doubt. Using this technique it was found that as many as 50 % of neutrophils in the 
lung were apoptotic. Fewer cells recovered by broncho- alveolar lavage were apoptotic, but 
these were assessed by more conventional morphological criteria, and numbers were not 
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specified in the abstract. Furthermore, it would be expected that more cells would exhibit 
apoptosis if assessed at an early molecular level rather than at a stage late enough to permit 
identification by gross morphological change. 
Injection of thioglycollate broth into guinea pig peritoneum produces a neutrophilic 
inflammation (Yamamoto et al, 1993). After a delay, an increase in the number of 
neutrophils observed within macrophages is seen as they are cleared following apoptosis. 
Co- injection with LPS delayed this peak by 24 hours, and neutrophil numbers were elevated. 
It was suggested that this shows the in vitro delay in apoptosis produced by LPS was being 
reflected in vivo. This is complicated by the fact that the LPS itself will produce an 
inflammatory action, so the change could be interpreted as being secondary to a larger initial 
inflammatory stimulus. This was not controlled for, so the results must be interpreted with 
caution. 
LPS instillation into the lungs of rabbits produced a brisk inflammatory reaction. In 
broncho- alveolar lavage there was found to be an initial peak in neutrophils at around 18 
hours, followed by an increase in the number of apoptotic neutrophils at around 24 hours, 
which coincided with an increase in the number of alveolar macrophages containing 
apoptotic bodies (Cox et al, 1995). This strongly suggests that the in vitro data 
demonstrating neutrophil apoptosis and macrophage uptake is relevant in vivo. 
As reviewed above, the majority of pro -inflammatory mediators studied appear to 
have an inhibitory influence on apoptosis. Despite this, synovial fluid taken from inflamed 
human joints was added to neutrophil cultures and found to increase rather decrease 
apoptosis, an effect unrelated to the levels of G- and GM -CSF in the fluid (Bell et al, 1995). 
This was true of neutrophils derived either from the peripheral blood or from the inflamed 
joints themselves. The mechanism of this effect is unclear, but it does certainly seem clear 
that factors present at inflammatory sites are capable of modulating apoptosis. 
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A combination of in vitro and in vivo techniques was used to further study the 
relevance of in vitro findings to neutrophil apoptosis in vivo. Neutrophil ageing was studied 
using neutrophils obtained from rats in a variety of different circumstances. Peripheral blood 
neutrophils from normal rats were compared with bone marrow derived neutrophils, 
peripheral blood neutrophils from animals during peritonitis induced by protease peptone, or 
inflammatory neutrophils from the peritoneum 7 or 12 hours after induction of peritonitis. 
Neutrophil apoptosis after 12 hours in vitro was inhibited in neutrophils taken from 
peripheral blood during inflammation, and in neutrophils taken from the inflammatory site 
12 hours after the induction of inflammation compared to normal peripheral blood 
neutrophils. Likewise, marrow neutrophils were relatively resistant to apoptosis. This 
overall pattern was closely mimicked by the ability of cycloheximide to induce apoptosis. 
This was greatest in normal neutrophils and relatively inhibited in inflammatory neutrophils. 
However, the ability of cycloheximide to enhance apoptosis was maintained in bone 
marrow neutrophils. TNF was able to enhance apoptosis as assessed at 3 and 6 hours in 
normal peripheral blood neutrophils, but this effect was not seen in other neutrophils, an 
effect that could not be attributed to change in overall receptor number (Tsuchida et al, 
1995). This suggests that the neutrophil's susceptibility to apoptosis may be controlled 
during normal physiological development and subject to further controls during 
inflammation. 
Taking the last two studies together it is interesting that neutrophils taken from 
inflammatory environments show different susceptibilities to apoptosis when cultured in 
similar conditions in vitro, whilst identical neutrophils can be altered by culturing them in 
biological fluids from inflammatory sites, suggesting that the final rate of apoptosis 
observed is a product of past and current environments of the neutrophil. This suggests a 
very dynamic control. 
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In summary, in vivo evidence to date is consistent with in vitro data showing that 
ageing neutrophils undergo apoptosis and are then ingested by macrophages. This has been 
shown to be modulated in complex ways that may be more complex and varied than is 
immediately apparent from purely in vitro results. 
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1.17 Experimental work 
Since the neutrophil is clearly a critical cell in pneumonia, experiments to investigate 
its behaviour further were performed. These were planned with particular considerations as 
follows: 
1) Although the neutrophil is important in all forms of acute inflammation, the unique 
structural and functional relationships of the neutrophil and the pulmonary circulation 
means that lessons learned from inflammation affecting other areas in the body cannot 
necessarily be directly applied to inflammation in the lung. 
2) Inflammation is an ongoing, evolving process. It is therefore appropriate to 
investigate it at different time points in its evolution, as the same mechanism utilised during 
early induction of inflammation (the first few hours having received the overwhelming focus 
of attention in the past) are not necessarily the same as those utilised at a later stage. This 
requires accurate timing of the onset of pneumonia. This makes an animal model of the 
disease invaluable, as the timing of onset in humans would be extraordinarily difficult to 
establish. 
3) As neutrophil clearance as well as recruitment appears to be an active process 
capable of specific modulation, mere counting of neutrophils within an inflammatory site 
will give limited mechanistic information. Numbers will depend on the integral with time of 
the difference between the rate of influx and the rate of efflux of neutrophils. A change in 
either parameter may be the cause of a change in total number. Indeed, if these parameters 
were to alter simultaneously, misleading conclusions could easily be drawn. If, for example, 
there were a large increase in clearance at the same time as a small increase in influx, total 
neutrophil numbers would fall. In most studies to date, this would have been regarded as 
evidence of decreased influx. It is clearly important to use techniques capable of resolving 
the two processes if at all possible. 
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4) As already discussed, pneumonia may be divided into community acquired and 
nosocomial pneumonia, each of which have different characteristic aetiologies, pathologies, 
and prognoses. There is ample evidence that the inflammatory process shows great 
specificity, so it is valuable to use models of each type of disease. In particular, it was noted 
that nosocomial gram negative pneumonia is characteristically associated with lung damage, 
whereas community acquired pneumococcal pneumonia is notable for the efficiency of 
restoration of lung architecture. In view of the fact that neutrophils may be responsible not 
only for host defence but also for bystander host damage it was hypothesised that tissue 
neutrophil burden might be greater in typical nosocomial pneumonia than in typical 
community acquired pneumonia, due either to prolonged neutrophil influx, delayed 
clearance, or a combination of the two. Inclusion of both types of pneumonia in 
experimental studies allows examination of this overall hypothesis. 
With these criteria in mind, a model of pneumonia using the New Zealand White 
Rabbit was selected. Streptococcus pneumoniae and Escherichia coli were selected as 
typical examples examples of CAP and NP respectively. 
could be simply and accurately placed intrabronchially via a fibre -optic bronchoscope, 
mimicking the aspiration that is thought to be the usual method of bacterial acquisition 
during development of pneumonia. This allows the onset of pneumonia to be accurately 
defined, and produce a localised pneumonia without excessive effect on the animals' general 
health. 
Neutrophils were then used from a donor pool and labelled with 1" indium chloride, 
and injected at specified intervals after induction of pneumonia. Gamma counting (either in 
a well -counter or by external scintigraphy) could then be used to follow the influx of these 
cells to the site of the pneumonia. To ensure that specific recruitment was measured rather 
than just a blood pool effect, autologous 99'ntechnetium- labelled erythrocytes were used to 
correct for this. Interventions then allowed study of their effect specifically on influx. The 
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CD' 8 adhesion molecule and IL -8 were selected for study in view of existing data 
suggesting important rôles for these two molecules during inflammation. 
Further studies were then performed to look for evidence of apoptosis in the clearance 
of neutrophils and additional in vitro experiments were performed to examine whether 
factors produced in vivo might be responsible for modulating neutrophil survival. 
The remainder of this thesis describes and discusses experiments performed with this 
model. 
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2. STUDIES OF NEUTROPHIL INFLUX 
2.1 Introduction 
As I have extensively discussed in the introductory chapter, neutrophils are recruited 
to areas of pneumonia where they provide valuable defence against invading pathogens. 
Inflammation always sees the paradox that whilst neutrophils perform this important 
defensive rôle, the array of toxic substances they are capable of producing means that their 
recruitment always risks bystander damage. It is thus essential that tight control be exercised 
over their numbers in the tissues. 
Pneumonia due to Streptococcus pneumoniae (pneus) is a typical example of 
community acquired pneumonia. It is also an archetypal example of beneficial inflammation 
in that it is usually followed by prompt and complete restoration of normal tissue structure 
and function. Pneumonia due to Escherichia coli (pneuE) is typical of nosocomial 
pneumonia. These pnemonias characteristically produce high levels of mortality, and are 
often associated with lung damage. It is hypothesised that a contributory factor in this is an 
excess neutrophil load. Either prolonged neutrophil influx, impaired neutrophil clearance, or 
both may lead to this. 
The experiments in this chapter concentrate particularly on defining the time course 
of neutrophil influx in rabbit models of the two types of disease, to see if the influx pattern 
differs. A more prolonged neutrophil influx in pneuE may contribute to an increased tissue 
neutrophil burden, with consequent increase in secondary tissue damage. 
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2.2 Methods 
Chemicals and plastics were obtained from Sigma, Poole, unless otherwise specified. 
2.2.1 Rabbits 
Specific pathogen free New Zealand White rabbits (Charles River Breeding, Margate) 
weighing approximately 3 kg were used as experimental subjects, and were housed in 
accordance with Home Office guidelines. They were allowed at least 2 days recovery post - 
transit prior to experimentation. 
In addition, a colony of rabbits of similar origin were maintained as blood donors, and 
these grew up to 8 kg. They donated a maximum of 64 ml of blood per session, with a 
minimum interval of 1 month between donations. Any animal with a haematocrit below 0.43 
had its next donation deferred for a further month. Animals showing any sign of ill health 
were not used. 
For blood donation, the rabbit ear was smeared with lignocaine /prilocaine anaesthetic 
cream (Emlá , Astra Pharmaceuticals, King's Langley). Animals were held in a custom 
made restrainer, and xylene applied to the ear tip to cause vasodilation. Fur was plucked 
from over the central ear artery, and a 19G hypodermic needle (Beckton Dickinson UK Ltd., 
Oxford) was introduced. Blood from this was directed into a 50 ml polypropylene centrifuge 
tube (Corning, Sigma, Poole) containing 8 ml of 3.8 % sodium citrate solution (Phoenix 
Pharmaceuticals) to a total volume of 40 ml per tube. 
2.2.2 Gamma well counter and gamma camera 
Gamma well counting was performed with a 1282 Compugamma CS counter 
(Wallac). This was used in multiple isotope mode to measure the 140 keV peak of 
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and the 247 keV peak of "indium. Fresh reference samples were used for 
each batch of counting, with automatic spillover and half -life corrections. 
Gamma camera imaging used a Siemens ZLC -3700 camera (Siemens Gammasonics, 
Inc, Des Plaines, Illinois, USA). A high energy, gallium collimator was used, with dual 
isotope acquisition using 140 + 20 keV and 247 + 20 keV windows. 
Routine imaging used whole animal posterior, static 300 second images, with animals 
prone, on a table a fixed distance from the gamma camera head. Data was analysed on -line 
using dedicated Bartec Unix 4.2 software on a Sun- 3/160M workstation. Assessment of lung 
activity utilised a lung region of interest (ROI) created using the same template in all 
studies. 
Figure 2 -1 Construction of lung regions of interest 
The figure shows a schematic diagram of a "indium gamma image, indicating lung, liver 
and spleen images. Superimposed on this is the template used for drawing lung regions of 
interest (ROI). The horizontal line is placed tangential to the dome of the liver. Vertical 
gradations allow this to be centred. A rectangular ROI is then created to match the pre - 
drawn lung ROI on the template.This was placed tangentially across the dome of the liver 
and centred, producing a rectangular ROI over the right lung field, clear of the liver. 
Lung activity 
(Wr 
L liver activity 
spleen activity 
lung ROI on template 
Template line 
tangential to liver 
dome, with lines for 
centering 
The count was normalised to 90 pixels, as the resolution used meant, even with the 
use of the template, slightly different numbers of pixels were included in the ROI. 300 
second scans were taken with no source in front of the gamma camera, and these 
background counts subtracted from controls. 
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Reference ROI's were created using the 99'ntechnetium image. The largest rectangle 
possible was constructed over the abdomen, whilst avoiding the liver, spleen, kidneys and 
midline vessels. 
Scintillation counting of rabbit cages and bedding revealed no loss of activity from 
the rabbits during the experiment. This allowed the whole animal images acquired to be 
used as measurement of total injected activity. As total activity and region activity were 
measured simultaneously, the need for half -life correction was eliminated. 
2.2.3 Isolation of rabbit neutrophils 
The neutrophil isolation procedure was based on that of Haslett et al, 1985a, later 
modified for rabbit neutrophils (Haslett et al, 1987). This was shown to produce neutrophils 
with little priming or activation. Blood obtained as described was centrifuged at 300g for 20 
minutes at room temperature (using an MSE centrifuge, Fisons, Crawley). The supernatant 
was aspirated and centrifuged at 2500g for 10 minutes to provide platelet poor plasma 
(PPP). 0.9 % saline was added to the blood cells to a volume of 50 ml. After mixing, this 
was allowed to sediment for 30 minutes. The leukocyte -rich supernatant was aspirated from 
above the sedimented erythrocytes, and centrifuged at 300g for 6 minutes. The sedimented 
cells were resuspended in 2 to 3 ml of PPP in 15 ml polyethylene centrifuge tubes. 
Stock Percoll® was diluted 9:1 with 0.9 % saline. Forty -three % and 53 % solutions of 
this were made in PPP, and 1 - 2 ml of each were successively underlayered beneath the 
leukocyte preparation using a Pasteur pipette. This discontinuous gradient was centrifuged 
for 10 minutes at 275g. Mononuclear cells collected at the upper gradient interface, and 
were aspirated and discarded. Neutrophils collected around the lower discontinuity, together 
with some erythrocytes. These were mixed with 10 ml PPP and centrifuged at 275 g for 10 
minutes. Erythrocytes in the cell pellet were lysed by the addition of cold 0.2 % saline for 30 
seconds, following which isotonicity was restored with an equal volume of 1.6 % saline, 
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using solutions sterilised by passage through 0.2µm filters. Ten ml of PPP was added before 
centrifuging the cells at 275g for 6 minutes. Cells were then washed with PPP. An aliquot 
was counted using a haemocytometer and duplicate 100111 cytocentrifuge preparations 
stained with Diff -Quik® for assessment of differential cell counts. Viability was assessed by 
adding 20111 to an equal volume of Trypan Blue. Cells were then assessed in suspension for 
their ability to exclude the dye. 
2.2.4 in Indium-labelling of neutrophils 
To study four rabbits, neutrophils from six tubes (196 ml) of donated blood were 
used. 8 - 12 MBq of 1 ' I indium chloride (Amersham International PLC, Amersham, Bucks.) 
was added to S411 of 4mM tropolone (2- hydroxy- 2,4,6 -cycloheptatrienone) in normal 
saline. This was allowed to chelate for 2 minutes before addition to the neutrophils, 
suspended in 40 -50 µl of PPP. Incubation occurred for 5 minutes at room temperature. Cells 
were then washed twice in 15 ml of PPP, before being resuspended in just over. 8 ml of PPP. 
Gamma activity was measured in the supernatant from the washes, and the total cells, using 
a dosimeter (Capintec radioisotope calibrator CRC -30BC, obtained from Delarese 
Electronics Ltd., Reading). Overall labelling efficiency was expressed as cell activity as a 
per centage of total activity. A 241l aliquot was saved as a reference sample, and 2 ml of 
cell suspension was used per animal. Syringes and tubing were counted in the dosimeter 
after injection to correct for retained activity. 
The isolation procedure used resulted in neutrophils with median purity of 95.1% 
(interquartile range 93.6 to 96.8) in a variety of experiments (n =40). Viability was > 99% as 
assessed by Trypan Blue exclusion. In the same collection of experiments, the median 
number of neutrophils injected per animal was 32.6 x 106 ( interquartile range 25.7 to 43.0 
x106). The labelling procedure had a median overall efficiency of 63.8 % (interquartile 
range 55.3 to 69.0). 
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2.2.4.1 Half -life and stability of In -wbc 
The stability of binding was studied in vitro and in vivo. In vitro, "indium labelled 
neutrophils (In -wbc) were maintained in platelet poor plasma on a roller -mixer. An aliquot 
was removed at intervals and mixed with 2 ml of normal saline. This was centrifuged for 6 
minutes at 300 g, and the supernatant (unbound) and the cell pellet (bound) fractions 
counted for activity in a gamma well counter. 
From a linear regression fitted to the data points, 78.3 % of 1 "In was cell -bound after 
21 hours. This shows there was a slow release of "In from the cells in vitro over a time 
period similar to that used in vivo. However, the vast majority of the ""In remained cell - 
bound, despite them being maintained in sub -optimal conditions. 
For the in vivo determination, blood samples were obtained from the central ear artery 
directly into EDTA- containing tubes (Sherwood Medical, Crawley) 21 hours after the 
injection of In -wbc in 4 animals. These were centrifuged at 300g, and the supernatant 
(unbound) and the cell pellet (bound) fractions counted for activity in a gamma well counter. 
After 21 hours, 70.3 %, 87.9 %, 85.3 % and 82.0 % (mean 81.3 %) of activity was bound, 
similar to that found in vitro. 
The half -life of In -wbc was also measured in vivo in two cases. After intervals, blood 
samples were taken into weighed tubes containing EDTA, commencing at 1 hour. The 
bound and unbound "tin fractions were counted as above, and from the weight of the 
sample bound "'In per ml of blood were calculated. The half -life of disappearance was 
calculated by fitting an exponential curve. 
y =b.e X.t 
where y = activity 
t = time after injection of In -wbc 
b = initial activity 
x = constant 
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One half -life after injection, y = 0.5 b (by definition) 
Therefore, the half -life, t,12 
ti/2 =_ ln 2 
x 
, is given by the following formula; 
Figure 2 -2 In vivo circulating half life of "indium labelled neutrophils 
The graph shows two experiments to determine the half -life of circulating In -wbc. Gamma 
well-determined cell bound t 'indium activity per gram of blood is shown, with a 
monoexponential curvefit in each case from which the half -life of circulating t indium 
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No samples were taken in the first hour to allow equilibration of the injected In -wbc 
with the general blood pool. Using this method on two occasions, good exponential fits were 
obtained (F = 247.21 and 297.93, p = 0.001 and 0.001). Half -lives of 11.8 and 7.2 hours 
were obtained. 
2.2.4.2 In vivo distribution of In -wbc 
Autoradiographs of inflamed lung were performed to further confirm that I I 'indium 
was predominantly cell bound in the lung after migration of labelled cells, as well as being 
cell bound in the circulation. 
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One half -life after injection, y = 0.5 b (by definition) 
Therefore, the half -life, t1,2 , is given by the following formula; 
t 1 p _ ln 2 
x 
Figure 2 -2 In vivo circulating half life of "indium labelled neutrophils 
The graph shows two experiments to determine the half -life of circulating In -wbc. Gamma 
well- determined cell bound "indium activity per gram of blood is shown, with a 
monoexponential curvefit in each case from which the half -life of circulating "indium i indiu
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No samples were taken in the first hour to allow equilibration of the injected In -wbc 
with the general blood pool. Using this method on two occasions, good exponential fits were 
obtained (F = 247.21 and 297.93, p = 0.001 and 0.001). Half -lives of 11.8 and 7.2 hours 
were obtained. 
2.2.4.2 In vivo distribution of In -wbc 
Autoradiographs of inflamed lung were performed to further confirm that "indium i indiu
was predominantly cell bound in the lung after migration of labelled cells, as well as being 
cell bound in the circulation. 
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2.2.4.2 In vivo distribution of In -wbc 
Autoradiographs of inflamed lung were performed to further confirm that "'indium was 
predominantly cell bound in the lung after migration of labelled cells, as well as being cell 
bound in the circulation. 
6 hours after instillation of Strep. pneumoniae into the right cranial lobe (as described 
below), In -wbc were injected into a rabbit via the marginal ear vein. The animal was killed 21 
hours later by overdose of intravenous pentobarbital. The heart and lungs were excised en 
bloc, and the pulmonary vasculature flushed twice with 30 ml of normal saline via the right 
ventricle. 
The lungs were then inflated with 4 % formal saline and fixed overnight. Lungs were 
then processed manually. Tissue was passed through ascending concentrations, then twice 
through xylene. They were then twice immersed in molten wax. 
3 AM sections were then cut and placed on glass slides. These were dewaxed in xylene 
and rehydrated by taking down to water through descending ethanol concentrations. Under a 
safe light, Ilford K5 emulsion was melted in a Coplin jar in a water bath. Slides were dipped 
in this, and the reverse wiped and allowed to air dry. They were kept in a silica gel- containing 
light -tight box for 3 days, before developing for 7 minutes in 1 part Phenisol plus 4 parts 
distilled water at 18 °c. After washing, they were fixed in 1 part Hypan fix in 4 parts of 
distilled water. Sections were then counterstained in haematoxylin and eosin (as below). 
Examination of autoradiographic section showed "indium was predominantly cell 
associated. It was not always possible to determine the cell type that the radioactivity was 
associated with, because of density of silver grains. When the cell type could be determined, 
radioactivity was usually associated with neutrophils, although on occasion activity was 
associated with alveolar macrophages. This was presumably because of macrophage 
clearance of ageing neutrophils. 
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Figure 2 -3 Autoradiographs of pneumonic lung 
The figure shows autoradiographs of a rabbit lung following instillation of Strep. pneumoniae. 
After 6 hours, "'indium -labelled neutrophils were injected. 21 hours later the animal was 
sacrificed and autoradiographs of the pneumonic lung performed. 
Images show photomicrographs obtained at x 400 original magnification. Silver grains are 
seen to be predominantly localised to four cells, showing "'indium remains mostly cell 
associated at the inflammatory site. 
One animal had E. coli instilled (see below) into the right lung. After 6 hours, "'indium 
chloride was chelated with troplonate as usual. However, instead of being incubated with 
neutrophils, this was injected directly into the subject animal. Autologous 99 "technetium- 
labelled erythrocytes (Tc -rbc) were injected as normal (see below). At the end of the study 
period, a gamma camera image was obtained as usual. 
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Figure 2 -4 Gamma camera images showing indium distribution with and 
without neutrophils 
The figure shows four gamma camera images obtained from two animals. On the left are 
°°technetium gated images (images 15 and 73). On the right are simultaneously acquired 
"'indium gated images (images 16 and 74). Images 15 and 16 are obtained from a rabbit with 
E. coli pneumonia, injected with In -wbc after 6 hours, and Tc -rbc 20 hours later, with images 
acquired after a further 5 minutes for equilibration. Images 16 and 74 are similar except that 
"indium chelated with tropolone was injected directly without incubation with neutrophils. 
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In figure 2.4, image 15 shows the 9911fic image from an animal with E. coli pneumonia. in the 
6 hour study group. The heart, lungs, liver, spleen, both kidneys and great vessels can clearly 
be distinguished. This shows the 9Tc was distributed throughout the blood pool, as would be 
expected from its conjugation with erythrocytes. "In was distributed in a very dint 
fashion_ There was activity over the liver and spleen, but there was little activity over kidneys 
and great vessels. There was marked activity over the pneumonic lung field, but not over the 
rest of the lungs or the heart. 
Image 73 shows the 99°7c image from the control animal injected with non -cell bound 
indium. The Tc -rbc distribution in this animal was as for the animal injected with 
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"'indium pre- incubated with neutrophils. Panel 74 shows the activity in the 'In image. 
This shows that when chelated ' "In- tropolonate was injected without incubation with 
neutrophils, it distributed in a very similar fashion to that of Tc -rbc. It distributes throughout 
the blood pool, with high activity throughout the lungs, heart, liver, spleen, kidneys and 
great vessels. No concentration of 1 'In was seen over the inflamed lung. 
This demonstrates that the distribution of the "In is dependent upon its binding to 
neutrophils. There is no concentration of free "In- tropolonate to inflamed lung on its own. 
Thus, any loss of "'In from In -wbc will result in an under- estimate rather than an over- 
estimate of ln-wbc recruitment. 
2.2.5 9Ji'Technetium labelling of erythrocytes 
The procedure was based on that developed by Zimmer, 1977. This needed to be 
modified due to the different composition of the stannous kit used. For optimal labelling, 2 -4 
µg or less of stannous ion were required in 4ml of whole rabbit blood. Greater amounts gave 
declining efficiency. Thirty-two µg gave under 10% efficiency. 
For the preparation of Tc -rbc, 4.5 ml of autologous blood was obtained from the 
central ear artery and collected into a 15 ml polyethylene centrifuge tube containing 1000 U 
of heparin (5000U /ml, Multiparin ®, CS Pharmaceuticals, Wrexham). Ten ml of 0.9% 
sodium chloride for injections was added to a vial of Technescan® (containing 11.9 mg of 
sodium pyrophosphate and 3.4 mg tin(II) chloride, Mallinkrodt Medical UK, Round 
Spinney, Northampton) and 10 µl of this added to the whole blood. This was incubated for 
10 minutes on a roller- mixer, then centrifuged at 300 g for 10 minutes. A 19 G hypodermic 
needle on a 2ml syringe (Plastipak ®, Beckton Dickinson UK Ltd., Oxford) was used to 
aspirate 2 nil of packed cells. Two ml of sodium 99mpertechnetate in normal saline (freshly 
generated from an Amertech II, 40 GBq generator, Amersham, Bucks., by Radiopharmacy, 
Royal Infirmary of Edinburgh), containing approximately 5 MBq of activity, was added to 
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the packed cells and mixed for a further 10 minutes on the roller mixer. Ten ml of normal 
saline were added and thoroughly mixed. This was centrifuged at 275 g for 6 minutes. Cells 
were washed a second time in normal saline before being resuspended in normal saline to 2 
ml. The activity of the wash supernatants and the cells was assessed in the dosimeter for 
calculation of binding efficiency. 
Using this procedure, a median of 86.1 % efficiency (interquartile range 73.8 % to 
90.3 % ) was obtained. 
2.2.5.1 Half -life and stability of Tc -rbc 
In vitro, Tc -rbc were maintained on a roller mixer at room temperature over 24 hours. 
Aliquots were removed at intervals, and centrifuged at 250g for 6 minutes. The bound (cell 
pellet) and unbound (supernatant) fractions were counted in a gamma well counter. Binding 
was >97% at all times. 
In vivo, Tc -rbc were injected into 2 animals and approximately 1 ml of blood was 
taken from the central ear artery at intervals up to 22 hours into a weighed tube containing 
EDTA. Binding was measured as for the in vitro samples and was found to be over 97 % in 
all cases. 
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Figure 2 -5 In vivo half life of 99'ntechnetium labelled erythrocytes 
The graph shows cell associated 99intechnetium at intervals after the injection of autologous 
Tc -rbc in two animals. Monoexponential curves are fitted to the data, and half -lives 
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The calculated half -lives were only 11.7 and 12.4 hours. From this, the decline in 
activity during the lhour duration of use in the experiments would be approximately 5.5 %. 
Extrapolating back to zero time gave initial apparent volumes of distribution of 131.6 and 
165.4 ml. 
2.2.5.2 In vivo distribution of Tc -rbc 
As noted previously, Tc -rbc followed the expected blood pool pattern of distribution 
as determined by gamma camera images. 
2.2.6 Preparation of bacteria 
Bacterial plates were kindly prepared by Mr. Graham Williamson, Department of 
Medical Microbiology, Royal Infirmary of Edinburgh Trust. Streptococcus pneumoniae 
(NCTC 7465) was subcultured onto blood agar (Unipath Ltd., Basingstoke), and cultured 
overnight at 37° C in 5 % CO2. Escherichia coli (NCTC 10418) was subcultured onto 
MacConkey's medium (Unipath Ltd., Basingstoke), and cultured overnight at 37° c in air. 
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Immediately prior to use, bacteria were suspended in PBS without cations, and the optical 
density of the solution adjusted to 0.25 at 550 nm using a spectrophotometer (Cecil CE292 
series 2, Cambridge). Previous investigation by the Department of Microbiology shows this 
results in a suspension of 108 organisms per ml. 
2.2.7 Induction of pneumonia 
For the induction of pneumonia, anaesthesia was induced using ketamine, 70 - 100 
mg /kg (Ketalar ®, Parke- Davis, Pontypool) and xylazine 15 - 20 mg/kg (Rompun ®, Bayer, 
Bury St Edmunds) intramuscularly. An Olympus fibreoptic bronchoscope (Olynpus Optical 
Co., London) was passed through a custom made doweling mouth guard into the trachea. A 
nylon catheter (Beveridge, Edinburgh) was passed through the biopsy port and directed into 
the most dorsal part of the right cranial lobe until it met resistance, then withdrawn slightly. 
0.5 ml of bacterial suspension was injected through this, followed by 1.5 ml of air to clear 
the dead space. The passage of the bronchoscope and instillation of bacteria took about 30 
seconds per animal, ensuring minimal stress. 
Rabbits were nursed with the inoculated side dependent to help limit bacterial spread. 
Using this protocol, rabbits remained systemically well, and continued to eat and 
drink normally. Usually, slightly diminished activity was seen only on the day following 
inoculation. 
2.2.8 Overall pattern of experiment 
Studies of neutrophil influx were carried out as shown in figure 2.6. After 
bronchoscopic instillation of either Strep. pneumoniae or E. coli, a period of time (x hours 
in figure 2.2) elapsed during which pneumonia proceeded without intervention. "'indium - 
label led neutrophils prepared as described were then injected via a 21 gauge Butterfly 
needle (Abbot Ireland, Ltd., Sligo, Ireland) into a marginal ear vein to test the migration of 
neutrophils from this time. Experimental groups were named by this time, the elapsed time 
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from induction of pneumonia to injection of In -wbc, although it should be realised that 
migration occurs in a time window commencing at this time. Unbronchoscoped animals 
were used as controls, and pneumonia was studied in 6, 30 and 80 hour groups. 
20 hours later, rabbits were re- anaesthetised using a similar protocol, and 
"'technetium-labelled erythrocytes prepared as described were injected, via a 19G butterfly 
needle, into a marginal ear vein. 5 minutes were allowed for equilibration before acquisition 
of a 300 second static dual isotope gamma camera image. 1 hour after the injection of 
99i'techentium- labelled erythrocytes, animals were killed by slow intravenous injection of an 
overdose of Pentobarbital. The abdomen was then opened rapidly and a 1 ml reference 
blood sample was removed from the inferior vena cava into a weighed serum tube 
(Sherwood Medical, Crawley). 
The abdominal vessels were sectioned and the heart and lung dissected free en bloc. 
30 ml of normal saline were flushed through the pulmonary vasculature via a 19 G needle 
placed in the right ventricle, to rinse out free intravascular cells. The main bronchus was tied 
off using 2/0 Mersilk (Ethicon, Edinburgh). A portion of large bore extension tube was then 
secured in the trachea, and the right lung lavaged twice through this using 30 nil aliquots of 
chilled normal saline. Each aliquot was instilled and returned thrice to ensure good mixing, 
and kept on ice until processed. 
The lungs were then fixed overnight by inflation with freshly prepared 4 % 





































































































































































































































Broncho- alveolar lavage fluid was weighed to assess return. Of this, 5 ml was saved 
for gamma well counting. Duplicate cytocentrifuge preparations were made using 200 µl 
aliquots, at 300 rpm for 4 minutes in a cytocentrifuge (Shandon, Runcorn). They were fixed 
in methanol for one minute and stained using Diff -Quik® stain (Baxter Healthcare, Thetford, 
Norfolk). Differential cell count was calculated from the mean obtained from the assessment 
of at least 500 cells on each preparation. Total leukocytes were assessed by counting in a 
haemocytometer. Reference blood samples were weighed. 
The following day, tissue was dissected into blocks and counted in a gamma well 
counter, together with aliquots of broncho -alveolar lavage, reference blood and reference In- 
wbc. 
Controls values were obtained by assessing neutrophil influx into un- bronchoscoped 
rabbits, after preliminary experiments showed instillation of PBS alone produce 
inflammation one to two orders of magnitude lower than that caused by bacteria. 
2.2.9 Expression of results 
Bronchoalveolar lavage recovery of neutrophils and alveolar macrophages were 
expressed as total amount recovered on broncho- alveolar lavage, e. g. 
Neutrophil recovery = 
(Leukocytes per ml) x (ml BAL recovered) x (neutrophil fraction of total leukocytes) 
The I l l indium- labelled neutrophil counts in a tissue were corrected for intravascular 
blood volume by subtraction of expected llneutrophil accumulation, which was in turn 
calculated from the tissue 99mtechnetium-labelled erythrocyte counts and the ratio of 
indium to 99mtechnetium counts in reference blood. This corrected value was then 
normalised, and expressed as a per centage of that injected, thus: 
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Total injected activity 
"In activity in right lung 
99' Tc activity in right lung 
99mTc activity per gram reference blood 






Tissue indium influx = {(InRL - (TcRL x [InRef / TcRefl) / InTot} x 100 
Analogous calculations were performed using broncho- alveolar lavage 991 "Tc and In 
activity to assess neutrophil influx into lavage, and using lung ROI 99mTc and "In activity 
with reference ROI 99mTc and "'In activity to assess neutrophil influx by external 
scintigraphy. 
Six hour values for total neutrophils and alveolar macrophages recovered by broncho- 
alveolar lavage, and neutrophil influx as assessed by tissue gamma well counting, external 
scintigraphy and broncho- alveolar lavage counting failed to differ significantly from normal 
distribution using the K -S test in either pneuS or pneuE. Parametric statistics were therefore 
utilised to assess differences in means, and an a priori decision was made to ustilise 
parametric testing in chapters 3 and 4, where methodolgy was very similar. In this chapter, 
differences in means were tested using one -way analysis of variance to test for an effect of 
time with Scheffe's post hoc analysis to test for significant differences from control 
(unbronchoscoped) values. Statistical values were calculated using the SPSS /PC+ 4.0.1 
statistical package, with the exception of medians and interquartile ranges, which, being 
unavailable on this package, were calculated using Microsoft Excel version 5.0. 
2.2.10 Histology 
Ms. H. Caldwell, Department of Pathology, Edinburgh University Medical School, 
kindly prepared lungs for histological examination. After fixation over night in 4 % formal 
saline, the right cranial lobe was bisected along its longest axis, and each portion divided 
108 
into three. Remaining lobes were also divided into portions of roughly 1 cm3. These were 
kept in formal saline for 2 to 3 weeks whilst radioactivity decayed. Lung pieces were 
transferred to Tissue -Tec cassettes and onto a Vacuum Impregnating Processing machine 
(VIP) overnight on a pre -programmed cycle, passing through various solutions of ethanol, 
xylene and wax. Tissue pieces were then removed and transferred to an ice tray and allowed 
to set into the wax. 
Sections were then taken down to water, and stained in Harris's hamatoxylin for 3 -4 
minutes. After washing with water, sections were differentiated in 1 % acid alcohol for 5 - 
10 seconds, and rehashed. They were then blued up in Scotts Tap Water for 1 to 2 minutes, 
and washed again, before staining with alcoholic /aqueous eosin, rewashed, dehydrated, 
cleared and mounted. 
2.3 Discussion of methods 
2.3.1 Pneumonia 
Pneumonia was induced with either Streptococcus pneumoniae or Escherichia coli. 
These are typical examples of agents causing community acquired pneumonia (which is 
characteristically self -limiting) and nosocomial pneumonia (which is characteristically more 
damaging). 
The method of instillation, using intrabronchial placement using fibre -optic 
bronchoscopy, was chosen for four reasons. Firstly, it mimicks aspiration, which is thought 
to be the usual mode of infection, much more closely than methods involoving 
aerosolisation of innoculates. Secondly, there is no surgical procedure involved, unlike 
techniques involoving tracheotomy, and it is thus less stressful. Thirdly, by causing a 
localised pneumonia, it allows a profound inflammation to be studied without an appreciable 
mortality; animals remain systemically quite well during the course of pneumonia. Fourthly, 
the position of the pneumonic area was constant. This may be important, as different areas 
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of the lung are characteristically affected by different disease processes. This is probably 
due to regional differences in ventilation and perfusion. 
2.3.2 Use of 11 indium- labelled neutrophils for studies of neutrophil influx, with 
particular reference to gamma camera imaging 
As has been alluded to previously, the number of tissue neutrophils present is a 
balance of their rate of influx and their survival and rate of clearance. Quantitation of 
neutrophil number by counting their number in a tissue or by measuring a marker of their 
presence such as total myeloperoxidase will thus only yield limited kinetic and mechanistic 
information. If a change in number cannot be attributed specifically to a perturbation' of 
influx or clearance, then inferences drawn from studies of numbers alone may lead to 
dangerous errors. 
A way to dissect influx more specifically is to introduce some labelled cells into a 
system. The behaviour of those cells at the time of introduction can then be studied by 
examining the distribution of the label. If this is done comparatively early after the 
introduction of the labelled cells then this will be predominantly an influx signal. Even if 
there is some breakdown of the labelled cells in situ, or they begin to be cleared (for 
instance by macrophages) at an inflammatory site, this may permit their continued detection, 
presuming there is no significant transfer of free label or scavengers of labelled cells away 
from the inflammatory site during the course of study. 
In the past, a variety of labels have been used. However, 1111n labelled neutrophils 
(In -wbc) have been widely used both in clinical and research applications. (Peters et al, 
1983, Peters, 1992, MacNee et al, 1989, Rinaldo et al, 1988 and Haslett, et al, 1987). The 
isotope 111In is an attractive cell labelling agent as several techniques exist which permit 
its use for labelling leukocytes with high efficiency. It emits 173 and 247 keV gamma rays 
with high external photon yields, which is suitable for both gamma well counting and 
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external scintigraphy. It has a half -life of 67 hours which is long enough to track cells, but is 
short enough in clinical studies to prevent excessive dose exposure to subjects (McAfee et 
al, 1984, and Thakur et al 1984). Generally, labelling is found to be stable and specific. The 
main concern with studies using labelled cells is that the label perturbs the cells in some 
way, and this modifies their in vivo behaviour. In addition, the labelling procedures used to 
date are not specific for neutrophils. Whilst for clinical studies the use of mixed cell 
populations may suffice, particularly if the patient has a leukocytosis (Palestro et al, 1992), 
this non -specificity means neutrophils must first be isolated from whole blood. This in turn 
may induce subtle perturbations that could affect in vivo behaviour. 
2.3.2.1 Neutropliil isolation. 
The effect of different neutrophil isolation procedures has been studied in detail 
(Haslett et al 1985). Using human blood these workers found that neutrophils prepared by 
erythrocyte sedimentation in dextran followed by separation on a discontinuous plasma - 
Percoll density gradient produced cells that were minimally primed or activated. This was 
assessed by the minimal shape change produced and the minimal priming exhibited for the 
production of superoxide or lysosomal enzyme release, as well as the maximal response to 
chemotactic agents. Preparation by other methods, and in particular separation on Ficoll- 
Hypaque gradients was found to produce cells which were primed or partially activated, 
behaving as if exposed to a low dose of bacterial lipopolysaccharide. 
Later, this method was adapted to the isolation of rabbit cells (Haslett et al, 1987). 
(The rabbit equivalent of neutrophils are actually heterophilically staining, but are referred 
to here as neutrophils in analogy with, and for easy comparison to other species). The rabbit 
neutrophils are of slightly different density from human neutrophils, necessitating slightly 
different density gradients. In addition, their density overlaps with that of erythrocytes. This 
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necessitates the use of a hypotonic lysis stage after removal of the purified neutrophil 
population from the density gradient. 
Although Lane et al, 1982, found that hypotonie lysis caused rabbit neutrophils to 
circulate with a different pattern from cells that had not undergone this procedure, Haslett et 
al, 1987, found neutrophils underwent identical patterns of circulation with or without a 
lysis step. Unlike Haslett's group, Lane's group used Ficoll -Hypaque for cell separation this 
may have primed or partially activated the cells. This may also have rendered them more 
susceptible to damage by hypotonie lysis. Additionally, they used oxine rather than 
tropolonate for indium chelation, and this may be a further, synergistic mode of injury (see 
below). 
For studies described in this thesis, cells were therefore isolated using the method of 
Haslett et al. 
2.3.2.2 Labelling method 
For labelling purposes, indium is first chelated with a lipophilic compound. This 
allows indium free access to the cell. There, the indium separates from the chelating agent 
and binds to proteins in the cytosol or in the nucleus (Thakur, 1977). It is a worry that the 
nuclear binding in particular could cause radiotoxicity to the neutrophil. In fact, the 
neutrophil has turned out to be remarkably resistant to radiation effects (Holley et al, 1974). 
High enough doses do prove to produce morphological changes and to inhibit chemotaxis 
and phagocytosis. The doses required to produce any effect are very much higher than those 
to which cells are typically exposed in labelling studies (Segal et al, 1978). 
Two main chelators of indium have been used; oxine (8- hydroxyquinoline) and 
tropolone (2- hydroxy- 2,4,6 -cyloheptantrien -1 -one). Both of these are known to have some 
toxicity. Oxine has been used as a topical fungicide, antiseptic, antiperspirant and 
spermicide, whilst natural copper chelates of tropolone give antibacterial properties to cedar 
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and redwood (McAfee et al, 1984). With these facts in mind there is clearly cause for 
concern that these compounds are toxic when used for labelling. In addition, indium -oxine 
labelling in the presence of plasma gives very high indium -transferrin binding (Thakur et al, 
1977). This means cell labelling must be done in plasma -free conditions. Removing cells 
from their natural environment may also cause some abnormality of function. 
To assess the toxicity of these compounds as part of the cell labelling process, both in 
vitro and in vivo studies have been performed. 
2.3.2.2.1 In vitro studies 
Neutrophil labelling using II I indium -oxine must been done in plasma free conditions 
because of the marked ability of the chelate to label transferrin. This has given concern that 
this isolation from its normal environment may predispose the neutrophil to damage during 
the process. Although I II indium -tropolonate shows some affinity for transferrin too, this is 
sufficiently low for efficient cell labelling in the presence of plasma when cell 
concentrations are high (Danpure et al, 1982, McAfee et al, 1977). 
When examined in vitro, there have been contradictory data on the toxicity of the two 
compounds. For example, chemotaxis and phagocytosis were found to be impaired by oxine 
but not tropolonate in one study, (Burke et al, 1982), whereas another study found there to 
be no difference in chemotaxis in vitro or in vivo, with excellent viability as assessed by 
ability to exclude vital dyes (Das et al, 1988). Others have found ' indium- oxine- labelled 
neutrophils to show normal chemotaxis and phagocytosis, with low basal and high 
stimulated ability to generate superoxide (Selby et al, 1991). 
The apparent contradiction is probably explained by subtle differences in techniques 
and reagents. Burke, et al, noted that cadmium produced toxic effects on the neutrophil in 
tiny doses. It may be present together with other trace elements as part of the "indium 
preparation, as it forms part of the target in its generation. 
113 
Although no clear differences in toxicity have been demonstrate, the fact that 
labelling can take place in more physiological conditions (i.e. the presence of plasma) using 
tropolonate means it is nevertheless preferred on theoretical grounds. 
2.3.2.2.2 In vivo studies 
Damaged neutrophils are likely to be removed early from the circulation. Thakur et al, 
1977. confirmed this by showing heat damaged In -wbc were removed from the circulation 
on passage through the lungs. The circulating half -life has therefore been used as an index 
of neutrophil health. 
Cohen et al, 1982, found ex vivo 'indium- oxine- labelled neutrophils and in vivo 
tritium pulse labelled cells had very similar half -lives of 4.08 and 4.03 hours respectively. 
Other studies have found values of 5.6 + 2 hours using "'indium/oxine labelling (Lane et al, 
1982), 4 hours using "'indium /tropolone labelling (Haslett et al, 1987), and 6.7 hours using 
51chromium labelling (Doerschuk et al, 1987). The overall consistency of values despite the 
use of varying techniques suggests the cells circulate normally and are thus minimally 
damaged by labelling. 
Ex vivo exposure of 11indium- labelled neutrophils to trace amounts of LPS produces 
increased pulmonary retention of these cells on reinjection (Haslett et al, 1987). If labelled 
cells were significantly damaged, such subtle effects would be masked. 
Reinjected In -wbc are often 'held up' in the lung (e.g Thakur et al, 1977, MacNee et 
al, 1989, and Warshawski et al, 1986). Some have argued pulmonary hold up of In -wbc is 
wholly artefactual. In a large series of clinical studies, various degrees of lung hold up and 
subsequent hepatic and splenic uptake could be related to the technique of labelling, with 
minimal hold -up seen with "'indium /tropolone labelling, which was therefore felt to be the 
optimum agent (Saverymuttu et al, 1983). 
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Hold up might also be caused by clumping of labelled cells prior to reinjection, 
particularly as autoradiography has demonstrated clumped cells are more likely to be 
heavily labelled (Puncher and Blower, 1995), but autoradiography of the lung did not 
demonstrate this (Lichter et al, 1984). 
Nevertheless, studies examining changes in initial holdup have produced coherent 
data. Initial holdup is increased, and subsequent washout decreased, after cigarette smoking 
(MacNee et al, 1989) and during ARDS (Warshawski et al, 1986). This data is consistent 
with the proposed involvement of the neutrophil in smoking- induced emphysema and in 
ARDS. 
Neutrophils are undoubtedly physiologically delayed during passage through the lung, 
as has been demonstrated by studies utilising non -labelled as well as labelled cells (see 
general introduction). Release of sequestered In -wbc from the lungs occurs after adrenaline 
infusion (Haslett et al, 1987, and Muir et al, 1984), mirroring normal physiology. 
There is also an increased pulmonary In -wbc sequestration after inflammatory stimuli, 
mirroring the behaviour of unlabelled cells. Injection of pneumococcal lysates produced In- 
wbc sequestration specifically in the lungs, but not in the brain, heart, liver, spleen or 
kidneys (Goldblum and Reed, 1985). This selectivity is not merely the result of retention at 
the first vascular bed that is encountered; whilst intra- arterial injection of In -wbc does result 
in transient local neutrophil retention, there is also pulmonary retention, and the rate of 
washout from the lungs is much less than from the local vascular bed (Williams et al, 1989). 
Likewise, during dialysis, In -wbc are selectively sequestered in the lung (Becker et al, 
1989). 
Thus although excessive pulmonary sequestration may reflect neutrophil damage, In- 
wbc also sequester in a way that mirrors normal cells. 
There is no doubt that neutrophils are recruited to a wide variety of inflammatory foci. 
It has been suggested that on the basis of clinical observation that In -wbc prepared using 
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tropolone chelation may localise more rapidly than those using oxine chelation (Peters et al, 
1983), no trial has ever shown a difference between the two. 
Overall, in vivo studies show that In -wbc neutrophil using either technique of 
chelation circulate with normal half -lives, sequester reversibly in response to appropriate 
stimuli and localise to sites of inflammation. Detailed studies of pulmonary kinetics suggest 
a marginal benefit to using tropo lone as chelating agent. 
2.3.2.3 Cell labelling and behaviour in this study 
Tropolonate was used as the chelating agent in the current study. With this agent, 
good labelling efficiencies were obtained, with excellent cell viability. The calculated half - 
lives of 11.8 and 7.2 hours are relatively long but of similar order to those found by others. 
As discussed, cell damage during labelling is likely to lead to abbreviation of half -life rather 
than prolongation, suggesting cells used in these experiments were undamaged. 
indium- labelled neutrophils used in this study did show some loss of activity during 
the course of the experiment, around 20 % being lost in vivo and in vitro. This is higher than 
that reported by others, e.g. Haslett et a1,1987, found more than 98 % remained cell bound 
after 24 hours using the same methods. The reason for the discrepancy is not clear. 
Importantly, chelated "indium did not localise to actively inflamed areas if not 
previously incubated with cells at high concentration. There was no loss apparent from urine 
or faeces when cages were checked with a scintillation counter. It seems likely that the 
II indium -tropolone binds to transferrin and remains intravascular. Autoradiography 
confirmed that radioactivity within the lung was largely cell- associated. The net result of 
this will be to underestimate the recruitment of neutrophils slightly (each neutrophil will 
carrying less activity), but there is no reason to suppose any treatment group will be 
differentially affected. Thus comparisons should still be valid. 
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The use of neutrophils from donors could potentially give erroneous results if rabbits 
were sensitised to histocompatability mismatches. Such effects have been described in 
humans, where early lung retention was increased in alloimmunized patients (Dutcher et al, 
1990). There is no reason to think the rabbits in this study would be alloimmunised, not 
previously having received transfusion of blood products, and heterologous neutrophils were 
found to behave indistinguishably from autologous cells in other studies in the rabbit 
(Haslett et al, 1987). 
2.3.2.4 99 "'technetium- labelled erythrocytes 
In many vascular beds, inflammation is associated with vasodilation. This results from 
prostaglandins, calcitonin gene -related peptide (CGRP) and other substances released 
locally (Brain et al, 1985) as well as by neural reflexes. It allows defensive macromolecules 
and cells increased access to the inflammatory site. In the lung, the blood flow is often found 
to decrease (Downey et al, 1988). This may help protect against the hypoxia that would be 
the result of perfusion of unventilated lung units. These vascular flow changes might well be 
associated with changes in intravascular volume. In order to correct for this, Tc -rbc were 
infused. This allowed calculation of the expected neutrophil blood pool at the pneumonic 
site, and subtraction of this from the neutrophil total to give a measure of specific 
recruitment. 
Tc -rbc prepared using a minor modification of the method of a clinically utilised in 
vitro method (Zimmer, A. M., 1977) showed excellent stability of binding. However, the in 
vitro half -life of the erythrocytes was very short, determined to be around 12 hours on the 
two occasions studied. This no doubt indicates a degree of in vitro damage during 
preparation. However, this represents only just over a 5 % loss during the 1 hour between 
injection and euthanasia. Effete erythrocytes are cleared by the spleen, and counts of activity 
in this organ were not used in any calculations. There is no reason to presume the other 
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erythrocytes were not evenly distributed around the circulation. This is supported by the 
initial apparent volume of distribution which was compatible with the intravascular volume. 
If damaged erythrocytes were immediately sequestered in the lung, the apparent volume of 
distribution would be large. 
2.3.2.5 Pattern of neutrophil recruitment, and location of neutrophil excess 
The distribution of In -wbc was assessed 21 hours after injection. The methods used 
measured the neutrophils accumulating in the right, pneumonic lung in excess of that 
expected from its blood content, compared to neutrophil content of peripheral blood. This 
therefore potentially includes sequestered neutrophils, interstitial neutrophils and airspace 
neutrophils. The relatively long interval chosen helps to ensure the signal was 
predominantly related to migration rather than sequestration of neutrophils. The interval 
between injection of In -wbc and assessment of their distribution is at least 2 circulating 
neutrophil half -lives. The sequestered pool is in dynamic equilibrium with the circulating 
pool, so the sequestered pool should also be small at the end of this time. 
For similar reasons, the majority of recruitment of labelled neutrophils is likely to 
commence early in this time period, for the simple reason that there will be far fewer 
available for recruitment towards the end of the study period. Thus although recruitment is 
assessed over a 21 hour time window, measures will be heavily weighted towards 
recruitment occurring early in this time frame. 
Some local neutrophils may reach the airspaces not by active recruitment, but by 
haemorrhage. To a large extent this will not be corrected by the use of Tc -rbc to assess 
blood pool, as these are only injected in the last hour of the study. However, although 
histological sections sometimes show some evidence of intra- alveolar haemorrhage, the 
number of neutrophils was always greatly in excess of the number of erythrocytes in the 
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inflamed lung. As the converse is true in the blood, the vast majority of neutrophils must be 
actively recruited and thus any such error will be negligible. 
2.4 Results 
2.4.1 Macroscopic and histological appearance of pneumonia 
Macroscopically, both pneuS and pneuE produced a consistent pattern of pneumonia. 
A darkened, indurated area of inflammation was produced about 1 cm in diameter in the 
right cranial lobe. The area of induration sometimes extended into the apex of the caudal 
lobe on the right, and sometimes encroached slightly into the intermediate lobe. There was 
never any gross inflammation in the left lung. 
Histologically, pneus and pneuE produced broadly similar patterns of pneumonia. No 
clear difference was observed between inflammatory cell numbers in the two types of 
pneumonia, though the localised nature of the lesion, and the variation of histological 
appearances across the area of inflammation, would necessitate the use of extensive 
morphometry to convincingly demonstrate other than gross differences in cell numbers. 
Normal rabbit lung showed fine alveolar walls with a paucity of intra- alveolar cells (figure 
2.7). In sections taken from areas of from the 6 hour group (therefore killed at 27 hours 
after induction of pneumonia), there was a dense cellular infiltrate into the airspaces so that 
in large areas alveoli were entirely cellular and contained no air (figure 2.8). At this time, 
large numbers of neutrophils could be seen, although there appeared to be a considerable 
increase in mononuclear cells too. It appeared there were areas in which the neutrophil 
infiltrate would predominate, and others in which the mononuclear cells would predominate. 
The alveolar walls were clearly more cellular too. They contained mostly mononuclear cells 
representing macrophages, alveolar epithelial cells and fibroblasts, but some neutrophils 
were present too. 
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In the 30 hour group (killed at 51 hours), there appeared to be proportionately fewer 
neutrophils in the infiltrate (figure 2.9), whilst in the 80 hour group (killed at 101 hours) 
there were comparatively few neutrophils left (figure 2.10). A dense mononuclear cell 
infiltrate remained. In a few animals examined at after 189 hours, the inflammatory infiltrate 
was composed almost entirely of mononuclear cells (figure 2.11). It was becoming much 
less marked, and overall there was the impression that the lung was more aerated, though 
formal morphometric analysis was not undertaken. 
The appearances thus are seen to be those expected during an acute pneumonia. There 
is an initial, profound inflammatory state characterised by significant numbers of 
neutrophils. This is followed by a predominantly mononuclear infiltrate, and then resolution 
commences. 
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Figure 2 -7 Histology of normal lung 
The photomicrographs show the appearance of normal lung. The upper photomicrograph is at 
an original magnification (om) of x 100, the lower plate at an om of x 400. The alveolar walls 
are thin and there is a paucity of intra- alveolar cells. 
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Figure 2 -8 Histology of pneumonia after 27 hours 
The photomicrographs shows the appearance of pneus after 27 hours. There is an intense 
inflammatory infiltrate, with a marked predominance of neutrophils. (Upper om x100, lower om 
x400) 
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Figure 2-9 Histology of pneumonia after 51 hours 
The photomicrograph shows the appearance of pneuS after 51 hours. There is an intense 
inflammatory infiltrate, with neutrophils less prominent than formerly. (Upper om x100, lower 
om x400). 
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Figure 2-10 Histology of pneumonia after 101 hours 
The photomicrograph shows the appearance of pneuS after 101 hours. The inflammatory infiltrate 
is less marked, and neutrophils are comparatively scanty. (Upper om x100, lower om x400). 
of- .-4,0 :i. t A V - l Al; . 
- , 1 41;ii ar ' ' 
* 
' af, ,.., 
.:;:''7.'" 





poi 40,- 4.4 
, -4 
47- 
r e 44.41k. 0 
4 4 ' 
* 4 414, 4. ,.. # 
#4. 
. . 4,,,, # ' 
,. #1# 
4 
4 a "1:4 to*#,,*4 * # ,.p ,,,k4, " 
4 , 
SI, 




41 , . '4. * 'It,* ,,. ,.4 _.,: 
' ,,, 4#. " df- !'''' 
, ' ,` 04, -4.'' 4,,,,. ' 2 #. i * 
40 ' 
1, 4, ' 1.-' 1 NZ* 
44.. 
'4' -4, r .1' 
124 
Figure 2 -11 Histology of pneumonia after 189 hours 
The photomicrograph shows the appearance of pneuS after 189 hours. The inflammatory infiltrate 
has clearly declined, and the majority of inflammatory cells are mononuclear cells. (Upper om 
x100, lower om x400) 
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2.4.2 BAL neutrophil content 
Figure 2 -12 Broncho -alveolar lavage neutrophil recovery 
The graph shows the total number of neutrophils recovered from BAL at various time points 
in each type of pneumonia. The graphs show means, error bars SEM, n =14 to 17 per group. 
The legend shows the significance of the effect of time for each group (ANOVA). * 
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In control rabbits that were unbronchoscoped, there were very few neutrophils in the 
bronchoalveolar lavage (mean 0.42 x 105+ 0.11 x 105 SEM). In PneuS, ANOVA showed 
that there was a significant effect of time (p= 0.0093). The maximum number of neutrophils 
in BAL were found in the 6 hour group, i.e. 27 hours after pneumonia induction (12.38 x 105 
+ 4.36 x 105). Post hoc analysis using Scheffe's test indicated this to be significantly raised 
above control levels. At later time points, the BAL neutrophil levels were not significantly 
elevated above controls. Overall, the trend was for a peak at the earliest time point, 
followed by a decline. 
In pneuE, there was also a significant effect of time on neutrophil number in BAL 
(p= 0.006). The highest number was found in BAL taken from the 30 hour group, i.e. 51 
hours after the onset of pneumonia (16.74 x 105+ 5.27 x 105). Post hoc analysis showed 
that neutrophil numbers in BAL were significantly elevated above control in the 6 and 30 
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hour groups. Overall, the trend was for an increase that was sustained so it was at least as 
high in the 30 hour group as the 6 hour group before declining. 
2.4.3 BAL alveolar macrophage content 
Figure 2 -13 Broncho -alveolar lavage macrophage recovery 
The graph shows the total number of alveolar macrophages recovered from BAL at various 
time points in each type of pneumonia. The graphs show means, error bars SEM, n =14 to 17 
per group. The legend shows the significance of the effect of time for each group 
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Large numbers of alveolar macrophages were recovered from BAL of control 
animals (10.22 x 106 + 1.09 x 106). There was a significant effect of time in both pneuS and 
pneuE (p= 0.0132 and p <0.0001 respectively). In both types of pneumonia, there was little 
change until the 80 hour group, i.e. 101 hours after the induction of pneumonia. In this 
group there was a significant increase in the number of BAL alveolar macrophages in both 
pneuS and pneuE. 
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2.4.4 Tissue In-wbc influx 
Figure 2 -14 Neutrophil influx assessed by gamma well counts 
The graph shows the amount of neutrophil influx into the right, pneumonic lung at different 
time points in each type of pneumonia, as assessed post mortem by tissue well counts. The 
graphs show means, error bars SEM, n =14 to 17 per group. The legend shows the 
significance of the effect of time for each group (ANOVA). * represents a significant 




















In unbronchoscoped control animals, only a mean of 0.25 % (+ 0.04 % SEM) of In- 
wbc were recruited to the lung. In pneuS and pneuE there was a significant effect of time (p 
= 0.0001 and p < 0.0001). In pneuS there was a significant increase in the 6 hour group 
(mean 5.78 % + 1.62 % SEM). Following this there was a marked decline. In pneuE, there 
was a significant increase not only in the 6 hour group but also in the 30 hour group. In fact, 
the mean influx of In -wbc was greater in the 30 than the 6 hour group (4.14 % + 1.27 % and 
3.73 % + 0.83 %) before declining thereafter. 
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2.4.5 Gamma camera assessed In -wbc influx 
Figure 2 -15 Neutrophil influx assessed by external scintigraphy 
The graph shows the amount of neutrophil influx into the right, pneumonic lung at different 
time points in each type of pneumonia, as assessed by ante -mortem gamma scintigraphy. 
The graphs show means, error bars SEM, n =14 to 17 per group. The legend shows the 
significance of the effect of time for each group (ANOVA). * represents a significant 
difference from control at p <0.05. 
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Gamma camera images generally confirmed the pattern seen with tissue gamma well 
counts. No net influx of In -wbc was seen in control, unbronchoscoped animals. In fact, the 
correction produced an apparent 'negative' influx (mean -1.63 % + 0.55 SEM). Possible 
reason for this are examined in the discussion section. 
There was a significant effect of time in both pneuS and pneuE groups (p = 0.0001 
and p < 0.0001). In pneuS, there was a significant increase in the 6 hour group (mean 5.37 % 
+ 1.46 SEM). In later groups there was a marked decline. 
In pneuE, there was a significant increase compared to control not only in the 6 hour 
but also in the 30 hour group. In fact In -wbc in the 30 hour group (2.79 % + 0.81) was 
almost as high as the 6 hour group (3.26 %+ 0.92) before declining. 
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2.4.6 I,z -ivbc influx into BAL 
Figure 2 -16 Neutrophil influx into broncho -alveolar lavage fluid 
The graph shows the amount of neutrophil influx into broncho -alveolar lavage fluid from the 
right, pneumonic lung at different time points in each type of pneumonia. The graphs show 
means, error bars SEM, n =14 to 17 per group. The legend shows the significance of the 


















There was hardly any In -wbc into broncho -alveolar lavage in control, 
unbronchoscoped animals (mean 0.001 % + 0.003 %). There was a significant effect of time 
in both pneuS and pneuE (p = 0.0054 and 0.0347). In the pneuS there was a significant and 
marked increase at 6 hours (0.207 % + 0.87), followed by a marked decline. In pneuE, there 
was also a significant increase at 6 hours (0.058 % + 0.018). In later groups there was no 
longer a significant increase. 
2.5 DISCUSSION 
2.5.1 Histological appearances 
The general light microscopic appearances of inflamed lung were not quantitatively 
examined. It was clear there was an intense inflammation of the affected lobe that 
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progressed from a neutrophil predominance to a mononuclear predominance before 
resolution commenced. Thus, the model produced the classical appearances of pneumonia. It 
was possible to confirm from macroscopic appearances that inoculates were consistently 
placed in the dorsal part of the right cranial lobe. 
2.5.2 BAL neutrophil content 
The total number of neutrophils recovered from broncho- alveolar lavage peaked early 
in pneuS, before declining steeply. This was rather different from the pattern seen in pneuE 
where there was a more prolonged elevation of neutrophil numbers. 
As discussed earlier, this on its own gives no mechanistic information; it could be due 
to differences in either influx or clearance of the cells, or indeed changes in both. It does 
however support the hypothesis that a larger lung neutrophil burden may contribute to the 
greater damage to the lung often seen in gram negative pneumonias (Coalson, J., 1995). 
Such differences do not seem to have been explicitly addressed in the literature. 
However, work as yet available only in abstract form (using tissue morphometry in a similar 
rabbit model) agrees that the number of neutrophils in the lung remains elevated for longer 
in pneuE than in pneuS (Kutkoski et al, 1996). 
2.5.3 BAL alveolar macrophage content 
In both types of pneumonia, total broncho- alveolar lavage recovery of alveolar 
macrophages remained unaffected until the 80 hour group (i.e. in broncho -alveolar lavage 
fluid obtained 101 hours after induction of pneumonia). A significant delayed elevation is 
consistent with classical observations of pneumonia (e.g. Loosli 1942a). 
2.5.4 Influx of"' indium labelled neutrophils into areas of pneumonia 
This was assessed both post mortem by tissue gamma well counting and ante mortem 
by external gamma scintigraphy. 
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Using both methods, the pattern of influx observed was similar. In pneuS there was an 
initial marked increase in labelled cell influx, but this markedly declined at both later time 
points. In pneuE, neutrophil influx followed a different pattern, with neutrophil influx being 
as high in the 30 hour as the 6 hour time point. 
The magnitude of the peak influx measured by the two methods was similar, lending 
validity to the measures. That they were not identical is to be expected on a number of 
accounts. There may be changes in blood pooling ante mortem, and the pulmonary 
vasculature was flushed before tissue counting. In addition, the entire lung was counted in 
the tissue gamma well counter. The region of interest studied on external scintigraphy only 
includes the more cranial portion of the lung, as the region of interest had to be constructed 
clear of the dome of the liver, which had significant activity. External scintigraphy was 
performed before, but tissue well counts after bronchoalveolar lavage. This would have 
removed some of the recruited cells. Rabbits with pneumonitis induced by C5f had only 
about 1 to 2 % of neutrophils present in the airspaces (as determined by morphometry) 
removed by broncho- alveolar lavage (Downey et al, 1993), so in fact differences due to this 
should be small. 
Curiously, control rabbits had an apparent deficit of neutrophils in the lung when 
assessed by external scintigraphy. If Tc -rbc were detained in the pulmonary vasculature 
either because of aggregation or damage, this could produce such effects as the relative 
excess of 99mTc counts would give rise to over -correction. In addition, external scintigraphy 
was undertaken after 5 minutes of equilibration of erythrocytes, whereas tissue counting 
was performed after an hour, which could allow some redistribution. As discussed, the 
limited apparent volume of distribution of Tc -rbc indicates there was no gross retention. 
More likely is the effect of spillover between the 
99mTc and In windows on the gamma 
camera, which was not corrected for. As spillover was greater for "In to 
99mTc windows 
than vice versa, correction of a highly vascular area such as the lung using data from less 
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vascular abdominal viscera could lead to over -correcting of blood volume. This would also 
tend to blunt the recruitment signal seen, as spillover of windium activity would lead to 
overestimation of blood volume at the inflamed site. Tissue well counts did utilise a 
correction for spillover. Such spillover is not a linear function of activity, so correction 
factors are in themselves no guarantee of accuracy. Thus it was felt appropriate to utilise 
measures with and without correction and to compare them. That these technically disparate 
methods indicate similar patterns of response actually lends support to the overall result. 
At maximal influx, around 5 % of labelled neutrophils were recruited to the 
pneumonic area. This compares quite favourably to the finding on morphometric and 
physiological measurement that only 1 -2 % of neutrophils delivered to an area of 
pneumococcal pneumonia are actually recruited during the first 8 hours of disease 
(Doerschuk et al, 1994). 
2.5.5 Influx of Ill indium labelled neutrophils into airspaces during pneumonia 
Influx of indium labelled neutrophils into the airspaces of lungs was assessed by 
measuring their accumulation in broncho -alveolar lavage fluid. PneuS produce a similar 
influx pattern to that seen with external gamma scintigraphy or tissue well counting. There 
was a high initial peak, with a rapid subsequent fall. 
PneuE produced a slightly different pattern. There was significant elevation only at 6 
hours, but by 30 hours this was non -significant, unlike the other measures of neutrophil 
influx which were significantly elevated in the 30 hour group too. This could demonstrate 
that at later time points more of the recruited neutrophils are interstitial, adhere more firmly 
or are otherwise less available to broncho -alveolar lavage. Indeed, broncho -alveolar lavage 
produced a mean of just 0.91 % of labelled cells compare to tissue well counts in this group 
compared to 1.51 to 3.86 % in other groups, even though histology shows the majority of 
neutrophil accumulation to be to the airspaces rather than the interstitium. These figures are 
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incidentally in good overall agreement with the morphometrically calculated recovery of 1 - 
2 % of intra- alveolar neutrophils by broncho -alveolar lavage (Downey et al, 1993). The data 
from broncho- alveolar should be interpreted with some caution as it is potentially subject to 
greatest errors. The gamma counts are relatively low, so subject to more intrinsic variation. 
In addition, if inflammation is intense, the non -compliant lung tissue will divert lavage fluid 
to more compliant areas of the lung. In pneuE, 30 hour " indium labelled neutrophil influx 
into BAL was actually not much less than at 6 hours, and its failure to reach significance 
statistically may be misleading. 
2.5.6 Comparison with other studies 
A previous study demonstrated maximal neutrophil influx to pneuS between 2 and 6 
hours, with none occurring after 24 hours, which is in broad agreement with this study 
(Jones et al, 1994). In a dog model of pneumococcal pneumonia, continuing neutrophil 
recruitment as assessed by 4 hour retention of "'indium -oxine- labelled neutrophils in the 
lung was seen at 24 hours (Lichter et al, 1984). The large signal they saw is relatively late 
compared to this study. However, they instilled pneumococci in arrowroot in order to avoid 
its dispersion, and this may well have change the kinetics considerably. 
There have been two clinical studies using "indium-labelled cells and gamma 
scintigraphy in patients with pneumonia. 5 patients with lobar pneumonia showed no excess 
pulmonary uptake, whereas patients with lung abcess did demonstrate pulmonary neutrophil 
influx (Saverymuttu et al, 1985). Patients in this study had symptoms between 2 days and 4 
weeks prior to examination, so the lack of influx is perhaps not surprising, and is certainly 
compatible with the current findings. 
In a study of patients with acquired immunodeficiency syndrome undergoing nuclear 
medicine investigations for fever, 10 patients had focal pulmonary uptake on either 
" " indium- neutrophil scans or 67gallium citrate scans (Fineman et al, 1989). 7 of these had a 
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final diagnosis of broncho -pneumonia, and of these five had evidence of neutrophil influx 
on In -wbc imaging. Unfortunately clinical details are sparse, and the timing of the scans in 
the disease is not clear. The positive scans seen in this study as opposed to those of 
Saverymuttu et al may be due to different timing, the fact that broncho- pneumonia rather 
than lobar pneumonia was studied, or to the fact that one study used patients who were HIV 
positive. Unfortunately the lack of detail does not allow firm conclusions to be drawn. 
2.5.7 Mechanism of difference of neutrophil influx patterns 
The mechanism leading to an end to the influx of cells to an inflammatory site is not 
clear. In an experimental arthritis model it appeared a loss of chemoattractant activity was 
important. Re- challenging the joint after an interval produced a similar response, with no 
evidence of loss of sensitivity to suggest production of an inhibitor or desensitisation of the 
recruitment process (Haslett et al, 1989). On the other hand, rechallenge of the lung with 
Pseudomonas aeruginosa within a week of an earlier challenge produces a much impaired 
neutrophil recruitment that seems to be associated with a local loss of ability to use the 
CD18- mediated path of adhesion, and the development of an alternative much less efficient 
pathway (Kumasaka et al, 1996). Whether the differences between the study relate to the 
longer time point examined in the latter study, differences due to stimuli used, or differences 
in the vascular beds studied is not at all clear. 
Removal of the inciting stimulus may be important. Certainly in ongoing bronchial or 
intra- pulmonary sepsis there is ongoing neutrophil influx (Saverymuttu et a1,1985, Currie et 
al, 1985). However, ongoing neutrophil recruitment may also be seen after intrapulmonary 
instillation of bleomycin, which is presumably rapidly cleared (Haslett et al, 1989). That the 
neutrophil response is not merely a function of the continued presence of a stimulus is 
suggested by further lines of evidence. In complement -deficient mice, clearance of 
Staphylococci from the lungs was unaffected, as was the neutrophil response. Impaired 
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clearance of pneumococci was correlated with a decreased neutrophil recruitment, whereas 
although Pseudomonas clearance was greatly impaired there was a normal neutrophil 
response (Hendrick et al, 1982). In addition, 13 different strains of Pseudomonas aeruginosa 
were found to have 4 different clearance patterns, with a variety of different histological 
patterns being produced. No clearance pattern could be related to production of a particular 
histological type (Southern et al, 1970). 
It is notable that differences of bacterial persistence have been shown. 4 hours after 
aerosolisation, 7 % of Strep. pneumoniae within the lung were viable, compared to 89 % of 
E. coli (Jay et al, 1976). Using a combination of radiolabels to track mass clearance, 
quantitative culture, and tetracyclines to inhibit in vivo growth, they were able to show this 
was due to a combination of more rapid intrapulmonary growth and decreased killing of E 
coli compared to Strep. pneuomoniae. 
These persistence studies were performed using nebulised bacteria. Using lower 
innoculates of bacteria administered as a bolus, marked proliferation of Strep. pneumoniae 
was seen over 24 hours(Ansfield et al, 1977). 
In the experiments presented here, bacterial viability was not assessed, so its 
contribution cannot be directly judged. 
The mechanism of the prolonged neutrophil influx demonstrated in pneuE compared 
to pneuS is thus unclear, although a contribution of increased persistence is possible. 
2.6 SUMMARY 
1. A rabbit model of localised pneumonia was established. This gave the expected 
pattern of inflammation, commencing with an inflammatory infiltrate that was initially 
neutrophilic but later was predominantly mononuclear, before resolution commenced. 
Recovery of cells from broncho -alveolar lavage showed the total neutrophil load was 
maximal in the 6 hour group and decreased thereafter. In pneuE, neutrophil numbers 
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remained high in the 30 hour group, imposing a greater overall neutrophil burden in pneuE 
than pneuS. 
2. Neutrophils labelled with IIIindium- tropolonate were prepared to protocols that had 
previously been shown to produce cells with normal physiological functions. Cells used in 
these studies had a circulating half -life of around 10 hours, a little longer than, though 
roughly commensurate with, previous studies. Although there was some loss of binding of 
label over the course of the study, localisation to sites of inflammation was determined by 
external scintigraphy to be dependent on labelled cells, and label in the tissues was cell 
associated. 
3). Autologous erythrocytes labelled with 99mtechnetium had a short circulating half - 
life indicating some damage, but had a normal initial apparent volume of distribution, 
suggesting they were evenly distributed around the vasculature. 
4) Using assessment by gamma scintigraphy or tissue gamma well counts, the 
neutrophil influx in pneuS was found to be high at 6 hours and decline thereafter. The influx 
in pneuE was maintained in the 30 hour group before falling. 
5). Neutrophil influx into broncho -alveolar lavage fluid was similar in pneuS and 
pneuE. This apparent difference from other assessments may relate to a smaller number of 
cells in the airways being accessible to lavage at 30 hours in pneuE, or the greater inherent 
variability of lavage measures. 
6). Overall, the more prolonged increase in total number of neutrophils in pneuE than 
pneuS is seen to reflect differences in influx patterns. The mechanism for this is uncertain, 
although some data suggests greater intrapulmonary survival of Strep. pneumoniae than E. 
coli. Although the more prolonged neutrophil influx demonstrated might then be regarded as 
an appropriate response to prolonged bacterial challenge, it is suggested it the increased lung 
neutrophil burden over time may give rise to the greater lung damage classically associated 
with gram negative pneumonia. 
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3. THE ROLE OF THE CD18 ADHESION MOLECULE 
IN NEUTROPHIL INFLUX IN PNEUMONIA 
3.1 Introduction 
In the lungs, neutrophils migrate specifically from the capillaries, as opposed to the 
post -capillary venules in the systemic circulation (Downey et al, 1993). Before they can 
accomplish this, circulating neutrophils must first adhere to the vascular endothelium. 
As reviewed in the main introduction, selectins and 32 integrins are thought to be of 
critical importance in migration from the systemic circulation (see Butcher, 1991, Furfaro et 
al, 1992, and Smith, 1992b). The situation in the pulmonary circulation is less clear cut. In 
pneumococcal pneumonia there is, for instance, doubt that any of the selectins or that 32 
integrins are involved in adhesion and migration at all (Doerschuk et al, 1990 and Mizgerd 
et a1,1996), when other as yet undiscovered molecules are presumably important. 
The variety of adhesion molecules available with their different characteristics and 
dynamics means that there is great potential for careful modulation of neutrophil influx in 
vivo. Progressive changes in the way adhesion molecules are controlled and utilised may be 
a crucial way in which the neutrophil influx increases, peaks and declines, and may be 
essential to the efficient termination of recruitment. 
The expression of selectins on activated endothelial cells varies with time. P- selectin 
is rapidly translocated from intra- cellular stores in Wiebel -Palade bodies, appearing on the 
cell surface in minutes (McEver et al, 1989). E- selectin requires new protein synthesis for 
expression and as a consequence its appearance is delayed, being expressed maximally after 
4 to 6 hours (Bevilaqua et al, 1989). Expression then decays so it is no longer expressed 
after 24 hours. The potential relevance of this in vivo is demonstrated by the finding that 
anti -P- selectin antibody blocks neutrophil accumulation in response to thioglycollate 
139 
induced peritonitis early in the disease, but only inhibits neutrophil accumulation later if E- 
selectin is absent (Labow et al, 1994). 
The expression of ICAM -1, the immunoglobulin superfamily member that acts as the 
most important 132 integrin counter- receptor on the endothelial cell, is constitutively 
expressed at low levels, but cell activation leads (via new protein synthesis) to increased 
expression. This takes several hours, but is maintained as long as activating factors are 
present in culture, and certainly beyond 24 hours (Dustin et al, 1989). An example of the 
potential in vivo relevance of this is provided by the finding that CD18- dependent neutrophil 
influx in response to LPS is associated with increased ICAM -1 expression on pulmonary 
capillary endothelium, whereas CD18- independent neutrophil influx in response to Strep. 
pneumoniae is not (Burns et al, 1994). 
The regulation of neutrophil surface 32 integrin molecules is rapidly modulated both 
by increased surface expression, by translocation of preformed molecules to the cells 
surface, and by functional changes in expressed molecules (see Dransfield, 1991). L- selectin 
is rapidly cleaved from activated neutrophils (Kishimoto et al, 1989). 
The vast majority of studies of ß2 integrin function in vivo have examined its rôle very 
early in the inflammatory process, usually within 4 to 12 hours of its onset or even earlier. 
In the few studies continued beyond this time, there is certainly evidence that the 
requirement for 132 integrins in neutrophil accumulation during inflammation changes with 
time. Instances of this have been found in studies of regions supplied by both the systemic 
circulation (Winn and Harlan, 1993) and the pulmonary circulation (Kumasaka, 1996). 
(Strictly, the latter actually examined change in use of ß2 integrins with time in recurrent 
pneumonia, rather than during the evolution of the process on a single occasion). However, 
both these studies measured total neutrophil numbers. As discussed, this may reflect either 
influx or clearance rate changes. As well as mediating cell adhesion, integrins participate in 
signalling information about the external environment into the cell (Erle and Pyetal, 1992), 
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and it is certainly conceivable that this could modulate neutrophil apoptosis and hence 
clearance. Thus, blocking CD18 function could have additional or alternative effects on 
neutrophil numbers in tissues than just those produced by inhibiting adhesion. 
One study has used "indium labelled cells to examine the effect of anti -CD18 
antibodies on neutrophil kinetics at different time points (McCandless et al, 1994). This 
study examined the response produced 4 or 24 hours after intravenous administration of 
LPS. They measured initial pulmonary retention and half -life of clearance of neutrophils 
from the lungs. Thus they were measuring a sequestration rather than a migration signal, but 
the finding that increased sequestration was CD18- dependent late (after 24 hours) but not 
early (after 4 hours) is interesting, particular as it is the opposite to the change in CD18 
dependency seen in some models of peritonitis by Winn and Harlan. This apparent 
difference could arise for a number of reasons; a difference when measuring a sequestration 
rather than a tissue accumulation signal, a difference between types of stimuli used, a 
difference intrinsic to the pulmonary as opposed to the systemic circulation, or a difference 
between local and systemic administration of inflammatory stimulus. 
Accumulation of neutrophils in the lung in pneuS is already known to be unaffected 
by the presence of anti -CD18 antibody in rabbits (Doerschuk et al, 1990). Doerschuk et al 
found anti -CD18 to significantly inhibit neutrophil accumulation over 4 hours in response to 
LPS instilled intrabronchially, but this was not examined thereafter. Attention was therefore 
focused in this study on pneuE. Neutrophil influx was specifically examined by measuring 
the accumulation of donor II 'indium labelled cells (as in the experiments described in 
chapter 2) at 6 and 30 hours. The inflammatory process was allowed to proceed normally 
until the injection of the anti -CD18 antibody, 6.5e, 15 minutes prior to administration of 
labelled cells. Thus, any change in CD18 dependency would be unlikely to be due an 




The antibody used for these experiments, 6.5e, was kindly donated by Celltech Ltd., 
Slough. It is an anti -human CD18 antibody known to cross react with rabbit CD18 (Galea- 
Lauri et al, 1993), and is a monoclonal mouse IgG1. It was supplied in PBS at a 
concentration of 2.4 mg/ml, and contained 39 Eu /ml of endotoxin. In previous studies in the 
guinea pig, 2.4 mg/kg were shown to significantly inhibit neutrophil recruitment to the skin 
in response to zymosan activated palsma (Teixera, M. M. et al, 1994). Whole animal studies 
using 6.5e to inhibit neutrophil recruitment in rabbits suggest 1 mg/kg causes significant 
inhibition of neutrophil recruitement (M. Robinson, personal communication). Preliminary 
experiments were performed to check that neutrophil surface CD18 saturation was achieved. 
3.2.1 In vitro assessment of antibody binding 
Rabbit neutrophils were placed in a round- bottomed 96 well polypropylene flexiwell 
plate at 2 x 105 per well. Cells were pre- incubated on ice with 100111 of 10 % normal rabbit 
serum (from donor rabbits) in assay buffer (PBS with cations, 0.2 % (w /v) BSA and 0.1 % 
(w /v) sodium azide). They were washed with 1000 of assay buffer, followed by buffer only, 
MOPC (control antibody, derived from ATCC clone, courtesy I. Dransfield, Rayne 
Laboratory, Edinburgh) to a dilution of 1:25 in assay buffer, or 6.5e to a dilution of 1:80, 
1:40, 1:20, 1:10 and 1:5 were add to six wells each. These mixtures were incubated for 30 
minutes on ice, before being washed twice with assay buffer. Sheep anti -mouse IgG -FITC 
conjugated antibody (a -m FITC) (Scottish Antibody Production Unit, Carluke) was added in 
assay buffer to a dilution of 1:100, 1:50 and 1:25, each in duplicate for each primary 
antibody condition. These were incubated on ice for 30 minutes, then washed twice with 
assay buffer. Neutrophils were then fixed with 1001.1.1 of 2 % (v /v) formaldehyde (BDH 
Laboratory Supplies, Poole). A Coulter flow cytometer (Epics Profile II, Coulter 
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Electronics, Luton) was used to assess antibody binding. Neutrophils were gated on using 
forward and side scatter characteristics, and results expressed as mean fluorescence. 
Figure 3 -1 In vitro binding of 6.5e 
Isolated rabbit neutrophils were treated with either a control antibody (MOPC) or ascending 
doses of 6.5e as primary antibody, with sheep anti -mouse FITC as secondary antibody at one 
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PBS and MOPC controls resulted in virtually no neutrophil associated fluorescence, 
except with the highest concentration of a -m FITC, when a little non -specific binding began 
to be apparent. Antibody 6.5e resulted in a marked increase in fluorescence, even at a 
dilution of 1:80, indicating a marked specific binding to neutrophils. 
3.2.2 In vivo antibody binding 
Varying regimes of 6.5e dosage were used, as indicated below. Before and at intervals 
after injection of 6.5e, 2 ml blood samples were collected into tubes containing EDTA 
anticoagulant and immediately transferred to ice. These were centrifuged at 300g for 6 
minutes at 4 °c. The buffy coat was aspirated using a transfer pipette and washed with normal 
saline. In the first experiment, the cell pellet was then split between 6 wells of a 96 well 
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flexiwell plate, and processed as for the assessment of in vitro antibody binding. Duplicate 
wells had either no antibody, or 1:40 or 1:20 dilutions of 6.5e added as primary antibody. 
1:50 dilution of a -m FITC were then used as secondary antibody. Gating on neutrophils 
during flow cytometry eliminated contaminating erythrocytes, lymphocytes and monocytes 
and allowed mean fluorescence of neutrophils to be measured. In the first experiment, no 
significant difference in mean fluorescence was obtained between samples after the addition 
of 1:40 or 1:20 dilutions of 6.5e, so further experiments used only 1:40 dilutions. 
The difference between mean fluorescence with and without additional in vitro 6.5e 
represents the number of unbound surface CD18 molecules, and allows assessment of the 
degree of saturation of these molecules by 6.5e in vivo. The greater the increase in 
secondary antibody binding caused by additional in vitro 6.5e, the greater the in vivo 
desaturation of surface CD18. 
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Figure 3 -2 Saturation of CD18 in vivo (1) 
Blood samples were taken immediately prior (t = 0 hrs) and at intervals following the 
administration of 1 mg /kg 6.5e to a rabbit. Either 0, 2.5 or 5 µl of additional 6.5e were added 
in vitro to this, and the presence of bound 6.5e detected by sheep anti -mouse F1TC antibody. 
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The first such experiment showed that before injection of 6.5e, there was some 
background binding of a -m FITC. Addition of 2.5 .tl or 5 µl of 6.5e in vitro resulted in a 
marked increase in binding of a -m FITC, showing there were large numbers of exposed 
CD18, as expected. There was little difference in binding produced with either amount of 
added antibody, showing the lower amount was saturating even for control cells, and this 
was used in subsequent experiments. At 15 minutes and 5 hours after injection of 
6.5ebinding of a -m FITC to buffy coat neutrophils in the absence of any in vitro addition 
of 6.5e was increased, showing that 6.5e was binding in vivo. However, there was a small 
increase produced by the addition of 6.5e in vitro, showing binding was not saturated in 
vivo. By 9 and 23 hours, a -m FITC binding to buffy coat neutrophils without additional 6.5e 
returned to control levels. It was markedly enhanced by the addition of further 6.5e showing 
a large degree of desaturation. It was notable that at all time points, the maximum amount of 
a -m FITC binding produced by saturating amounts of 6.5e was less than in control cells, 
demonstrating that the total surface expression of CD18 by neutrophils was depressed by 
injection of 6.5e. This is presumably secondary to receptor crosslinking and internalisation. 
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It was surprising the binding seen was not more marked, in view of the fact that 
similar doses had produced significant effects on neutrophil migration in other models (M. 
Robinson, personal communication), and had usually been found to be saturating in a variety 
of animal models. Two further similar experiments were therefore performed with the same 
dose of 6.5e. 
Figure 3 -3 a) and b) Saturation of CD18 in vivo (2) 
Similar experiments were performed as shown in Figure 3 -2, with 1 mg/kg 6.5e being 
injected at t = 0, except that only 0 or 2.5 ul of 6.5e were added to buffy coat in vitro. Each 
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The first experiment showed almost complete saturation of CD18 to the end of the 
experiment at 9 hours. The second experiment was extended to 24 hours and showed 
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virtually complete saturation throughout. The experiments also showed the previously 
demonstrated decrease in total surface CD18 expression after 6.5e administration in vivo. 
Thus, two out of three experiments showed 1 mg/kg of 6.5e to saturate neutrophil 
CD18 in vivo. The third experiment did not show saturation to be complete, and showed 
little binding of 6.5e to surface CD18 after 9 hours. Therefore the regime of 6.5e 
administration selected for the main experiments was 1 mg/kg initially to ensure immediate 
saturation of CD18, followed 6 and 12 hours later by doses of 0.5 mg/kg. A final experiment 
was performed to ensure CD18 saturation by 6.5e throughout the 21 hours of the 
experimental. Blood samples were taken immediately prior to injection of 6.5e at 6 and 21 
hours, and again at the end of the 21 hour period of the experiment to ensure full CD18 
saturation at all time points. The experiment confirmed this was achieved. 
Figure 3 -4 Saturation of CD18 in vivo (3) 
The graph is as for figures 2.4 a) and 2.4 b), except that in the animal studied, after an initial 
dose of 1 mg/kg 6.5e, blood sampling at 6 and 12 hour time points was followed by a further 
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3.2.3 Assessment of in vivo distribution and half -life 
Antibody 6.5e was injected intravenously into animals at a dose of 1 mg/kg initially 
and at 0.5 mg /kg at 6 and 12 hours in two animals, and similar volumes of PBS were 
injected into two further animals as controls. 5 minutes after the initial injection of 6.5e or 
PBS, I indium labelled neutrophils prepared as described were injected intravenously. Two 
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ml arterial blood samples were taken into tubes with EDTA anti -coagulant at intervals 
thereafter, and immediately transferred to ice. Samples were weighed to allow correction for 
volume. They were centrifuged at 300g for 6 minutes, and plasma aspirated from cells. 5 ml 
of normal saline was added, and the blood was re- centrifuged and the cell -free supernatant 
aspirated. Gamma activity of the cells was determined using a tissue gamma well counter. 
An exponential curve was fitted to variation of cell bound activity with time. The half -life 
of labelled cells was determined as described in the previous chapter. 
21 hours after injection of ' ' ' indium- labelled neutrophils, their distribution was 
assessed using gamma scintigraphy. Lung regions of interest were constructed as described, 
whilst liver and spleen regions of interest were drawn freehand. The remaining activity 
(predominantly in the blood pool and the marrow) was calculated by subtraction of the other 
ROI's from the total. 
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Figure 3 -5 Effect of 6.5e on In -wbc half -life 
The graph shows cell -associated "'indium per ml. of blood sample at intervals in four 
rabbits after injection of labelled cells. In two of these, administration of labelled cells was 
preceded by administration of 6.5e 1 mg/kg, followed by 0.5 mg/kg at 6 and 12 hours. The 
other two received PBS control. Monoexponential curves are shown fitted to the data, and 
from these the half -lives of the injected neutrophils were calculated giving the results shown 
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Counts obtained in four animals studied produced good exponential fits in all cases (F 
= 76.77, 69.71, 247.21 and 297.93, p = 0.003, 0.004, 0.001 and 0.001). Half -lives for 
clearance of In -wbc calculated using the method above showed values of 9.8 and 12.4 hours 
after 6.5e administration and 11.8 and 7.2 hours after PBS control. 
The overall pattern of distribution of In -wbc was very similar in animals that had 
received 6.5e and PBS. In particular, the proportion of In -wbc in the right lung was similar 
in 6.5e and PBS treated animals (2.22 and 2.11 % in 6.5e treated and 2.04 and 2.10 % in 
PBS treated animals). 
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Figure 3 -6 The effect of 6.5e on neutrophil distribution in vivo 
The graph shows the percentage of indium-labelled neutrophils in various organs 21 hours 
after injection, as determined by gamma scintigraphy, for four animals. In two cases animals 
received injections of 6.5e at the doses of 1, 0.5 and 0.5 mg /kg at 0 (prior to labelled cell 
administration), 6 and 12 hours respectively, and in the other two cases animals were 
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3.2.4 Overall experimental plan 
The experimental plan was based on that for 6 and 30 hour influx studies of pneuE, as 
described in chapter 2, except for the additional use of 6.5e or PBS control. Animals were 
treated as pairs, with each receiving "'indium- labelled neutrophils and E. coli suspension 
from the same pools. 5 minutes prior to the injection of "'indium- labelled neutrophils, one 
rabbit received 1 mg /kg of 6.5e intravenously, and 6 and 12 hours later received further 
aliquots of 0.5 mg /kg. The other received equivalent volumes of PBS as control. 
3.2.5 Presentation of results 
Neutrophil influx data was calculated as described in chapter 2. Paired t -tests were 


















































































































































































































































































3.3 Discussion of methods 
3.3.1 Binding of 6.5e by neutrophils in vitro and in vivo 
Experiments performed in vitro confirmed specific binding of the anti-CD18 molecule 
6.5e occurred to the surface of the rabbit neutrophil. Further experiments demonstrated that 
binding also occurred in vivo, and that administration of 1 mg 6.5e usually resulted in 
saturated binding of cell surface CD18 for 21 hours. However, as in one case binding was 
not saturated at late time points, additional doses of 0.5 mg were given at 6 and 12 hours, 
which was shown to saturate binding. 
An additional effect was noted. Total surface CD18 expression was usually depressed 
in blood taken after 6.5e administration as compared to that taken before. This is likely to be 
due to internalisation of the receptor /antibody complex, without matching re- expression. 
Whether this has functional ramifications is not entirely clear, but neutrophil activation is 
usually characterised by upregulation of CD18 expression, and I am unaware of any other 
manipulation of the neutrophil that gives CD18 expression below that seen on the 
unactivated peripheral blood neutrophil. It therefore seems unlikely that this change 
represents cell activation. 
3.3.2 Effect of 6.5e on neutrophil kinetics and distribution in vivo 
A further question as to whether treatment of neutrophils with 6.5e changes the 
function of the cells other than as a result of CD18 blockade is raised by the fact that the 
6.5e was used as a whole antibody. After binding to CD18 on the neutrophil surface, its Fc 
portion is exposed. It is possible that this could interact with cells of the mononuclear - 
phagocyte system to cause phagocytosis of the neutrophils, or that it could lead to activation 
of complement with damage to the neutrophils. Previous studies in rabbits have not 
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suggested this to be the case, although a slight decrease in circulating neutrophil count has 
been observed in guinea pigs (M. Robinson, personal communication). 
This was investigated further by comparing the circulating half -life of''' indium 
labelled neutrophils in animals treated with 6.5e or PBS as control. No difference in ha H i re 
was shown in this sensitive test of neutrophil integrity. In addition, gamma scintigraphy of 
these animals demonstrated that the neutrophil distribution between each lung, the liver, the 
spleen and elsewhere (predominantly the blood and marrow) was unchanged by 6.5e 
treatment. Very subtle differences in treatment during "indium labelling of neutrophils 
leads to significant differences in in vivo kinetics and distribution (Saverymuttu et al, 1983). 
This clearly shows 6.5e has no non -specific detrimental effect on the neutrophil, and that 
following its administration, equal numbers of neutrophils will be available in the blood 
stream to be recruited as in controls. 
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3.4 Results 
3.4.1 BAL neutrophil recovery 
Figure 3 -8 The effect of 6.5e on neutrophil recovery from broncho -alveolar 
lavage 
The graph shows the total number of neutrophils recovered from broncho- alveolar lavage 
fluid from the right lung of rabbits with pneuE. Rabbits in 6 hour and 30 hour groups, 
treated with 6.5e or PBS control, are shown. Data shows mean, error bars SEM, n = 7 per 

















There was no statistically significant difference in total neutrophil recovery from 
bronchoalveolar lavage induced by pneuE between animals treated with 6.5e and with PBS. 
There was a clear trend to inhibition of neutrophil recovery in response to 6.5e treatment in 
both groups. 
Historical data from unbronchoscoped controls was used to calculate mean inhibition 
as for this and other data categories as follows: 
Overall inhibition of neutrophil influx (per cent) 
Neutrophil numbers in pneuE with 6.5e treatment 
Neutrophil numbers in pneuE with control treatment 
Neutrophil numbers unbronchoscoped controls 
1= ( I - 1PMN6 5e - PMNcontL ) x 100 
[PMNPBS - PMNcom] 
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Calculated thus, mean inhibition of total neutrophil recovery in the 6 hour group (i.e. 
at 27 hours) was 42.2 % and mean in the 30 hour group (i.e. at 36 hours) was 71.8 %, 
indicating the trend towards inhibition of neutrophil recovery by 6.5e. 
3.4.2 BAL alveolar macrophage recovery 
Figure 3 -9 The effects of 6.5e on alveolar macrophage recovery from broncho- 
alveolar lavage 
The graph shows the total number of alveolar macrophages recovered from broncho -alveolar 
lavage fluid from the right lung of rabbits pneuE. Rabbits in 6 hour and 30 hour groups, 
treated with 6.5e or PBS control are shown. Data shows mean, error bars SEM, n = 7 per 


















The total recovery of alveolar macrophages from broncho- alveolar lavage in pneuE 
was unaffected by 6.5e in both the 6 and 30 hour groups. 
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3.4.3 In -wbc influx as assessed by tissue gamma well counting 
Figure 3 -10 The effects of 6.5e on neutrophil influx as assessed by tissue gamma 
well counts 
The graph shows the influx of neutrophils into the right lungs of rabbits with pneuE as 
assessed by corrected tissue 11m indium counts. Rabbits in 6 hour and 30 hour groups, treated 
with 6.5e or PBS control are shown. Data shows mean, error bars SEM, n = 7 per group. P 








Anti -CD 18 
Time after pneumonia induction (hrs) 
6.5e administration significantly diminished In -wbc influx into pneuE in both 6 and 
30 hour groups as assessed by tissue gamma well counting (p = 0.017 and p = 0.029). Mean 
inhibition was 68.4 % in the 6 hour group and 72.7 % in the 30 hour group. 
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3.4.4 In -wbc influx as assessed by external gamma camera imaging 
Figure 3 -11 The effects of 6.5e on neutrophil influx as assessed by external 
gamma scintigraphy 
The graph shows the influx of neutrophils into the right lungs of rabbits with pneuE as 
assessed by corrected "'indium  indi counts on external gamma scintigraphy. Rabbits in 6 hour 
and 30 hour groups, treated with 6.5e or PBS control are shown. Data shows mean, error 
bars SEM, n = 7 per group. P values between treated and untreated groups using paired t 














Time after pneumonia induction 
6.5e administration significantly diminished In -wbc influx into pneuE in both 6 and 
30 hour groups as assessed by external gamma camera imaging (p = 0.034 and p = 0.029). 
Mean inhibition was 56.6 % in the 6 hour group and 39.2 % in the 30 hour group. 
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3.9.5 In -wbc influx as assessed by broncho -alveolar lavage well counts 
Figure 3 -12 The effects of 6.5e on neutrophil influx as assessed by gamma well 
counts of broncho- alveolar lavage fluid 
The graph shows the influx of neutrophils into the right lungs of rabbits with pneuE as 
assessed by corrected "'indium counts on gamma well counting of broncho- alveolar lavage 
fluid. Rabbits in 6 hour and 30 hour groups, treated with 6.5e or PBS control are shown. 
Data shows mean, error bars SEM, n = 7 per group. NSD = no significant difference 


















When In -wbc influx in response to pneuE was assessed by gamma well counting of 
bronchoalveolar lavage, there was no significant difference between 6.5e and PBS control 
treated animals, either in 6 or in 30 hour time points. The response was very variable, but 
there was a trend to inhibition of In -wbc influx. Mean inhibition of influx in the 6 and 30 
hour groups was 31.7 % and 49.1 %. 
3.4.6 Results of studies of the effect of 6.5e on neutrophil influx to pneuE - 
conclusions. 
Neutrophil influx into pneuE was significantly (though not completely) inhibited by 
the anti -CD18 antibody 6.5e, as assessed by the accumulation of In -wbc measured by either 
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tissue gamma well counting or external scintigraphy. This was as true in the 30 as the 6 hour 
group, varying measures demonstrating between 50 and 70 % inhibition. 
Neither total neutrophil numbers recovered by broncho- alveolar lavage, nor 
neutrophil influx into the airspaces as assessed by In -wbc accumulation into broncho- 
alveolar lavage showed significant inhibition by 6.5e. Both showed a trend to inhibition by 
6.5e, but in both cases the magnitude (approx. 30 -50 %) was rather less than the inhibition 
of In -wbc influx as assessed by tissue gamma well counts and external gamma scintigraphy. 
3.5 Discussion 
3.5.1 Effect of 6.5e on neutrophil and alveolar macrophages, and neutrophil 
influx 
6.5e was not shown to cause a statistically significant reduction in the total numbers 
of neutrophils from broncho -alveolar lavage. There was, though, a strong trend to reduction, 
and the lack of statistical significance is almost certainly due to the large variability found in 
the results. As noted in the discussion of chapter one, only about l to 2 % of airspace cells 
are recovered from broncho -alveolar lavage, which may lead to significant variability. This 
is likely to be especially true in non- uniform inflammation. Inflamed areas of the lung are 
less compliant, and fluid will be diverted away from the inflamed area. Variability of access 
of fluid to the inflamed site may create sampling errors. In addition, intra- alveolar cells are 
likely to be not entirely free and separate, but bound to one -another and to epithelial cells. P2 
integrins may well be important in this, and penetration of 6.5e into inflamed areas may 
affect this binding. Thus, sampling by broncho- alveolar lavage may be less consistent in the 
presence of anti -CD 18. In addition, it should be emphasised that the 6.5 e was only present 
during part of the duration of the experiment. In the 6 hour group, it was not present for the 
first 6 hours, but was present from hour 6 to hour 27. In the 30 hour group, it was not 
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present for the first 30 hours, but was present from hour 30 to hour 51. Particularly in the 
latter group, this will lead to a masking of any modulation of influx in terms of total 
neutrophil numbers. In view of all these factors it is not surprising that the antibody does not 
produce statistically significant decreases in lavage neutrophil number. The clear trend to 
inhibition is certainly not inconsistent with the hypothesis that anti -CD18 antibody reduces 
neutrophil influx. 
6.5e, as expected, produced no effect on alveolar macrophage number in broncho- 
alveolar lavage. 
Both ante mortem external gamma scintigraphy and post mortem tissue gamma well 
counting showed neutrophil influx to be inhibited by 6.5e in both 6 hour and 30 hour groups. 
Both methods showed inhibition to be around 60 % in the 6 hour groups. However, external 
scintigraphy showed an inhibition of neutrophil influx by 39.2 % whilst tissue gamma well 
counting showed an inhibition of neutrophil influx by 72.7 %. As noted in the discussion 
to chapter one, technical differences in the two methods as well as the fact one method uses 
ante mortem and one post mortem assessment make exact concordance unlikely. Overall it is 
clear that neutrophil influx is significantly inhibited, though not completely blocked, in both 
the 6 and 30 hour groups. The combined average inhibition found by the two methods in the 
6 hour group was 62.5 % and in the 30 hour group was 55.9 %. These very similar values do 
not support the hypothesis that there is a significant change in the relative utilisation of ß2 
integrins during pneuE. 
Influx of neutrophils into broncho- alveolar lavage fluid as assessed by gamma well 
counting showed no statistically significant inhibition by 6.5e. There was a non -significant 
trend for inhibition in both time groups. As discussed above, measurements of cells 
recovered from broncho- alveolar lavage are intrinsically more likely to show variability than 
tissue counts, especially when anti -CD18 antibodies are used. In addition, relatively low 
levels of gamma activity were being counted in broncho- alveolar lavage compared to tissue, 
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again leading to greater intrinsic variability in the method. It is likely that the lack of 
statistically significant inhibition demonstrated using broncho- alveolar lavage fluid is due to 
this variability of results, and the trend of the results (mean inhibition of neutrophil influx of 
31.7 % and 44.7 % in 6 and 30 hour groups) would certainly support this contention. The 
alternative explanation is that neutrophil accumulation in tissues is inhibited by CD18, but 
that a second CD18-independent mechanism exists for the transfer of cells from tissue to 
airspaces, and that this second process is saturated even with the decreased tissue neutrophil 
accumulation after CD18 blockade. This seems unlikely, particularly as the majority of 
accumulated neutrophils are seen histologically within the airspaces rather than the 
interstitiurn. 
3.5.2 Comparison with other studies 
Previous study of LPS instillation (rather than instillation of live E. coli) into the lung 
produced a neutrophil influx over the following 4 hours in rabbits. Pre -treatment with an 
anti -CD18 antibody produced a mean decrease of intra- alveolar neutrophils assessed 
morphometrically of 72 %. Over such short time periods this is very likely to represent an 
inhibition of neutrophil influx rather than survival, especially given the fact that normal 
lungs possess very few intra- alveolar neutrophils (Doerschuk et al, 1990). This partial 
inhibition observed is of a very similar magnitude to that seen in the current study. 
Doerschuk et al also showed that the increased number of intra- alveolar neutrophils 4 hours 
after intra- bronchial instillation of PMA was almost completely abolished by treatment with 
anti -CD18 antibody, suggesting that in pneumonitis due to LPS (and presumably in pneuE 
too) there is a CD18- independent as well as a CD18- dependent mechanism of recruitment. 
In the same series of experiments, neutrophil influx in response to hydrochloric acid or 
Strep. pneumoniae were found to be entirely CD18- independent. 
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The effect of anti -CD18 antibody on neutrophil influx (as assessed by accumulation 
of 1" indium- labelled neutrophils) in response to intra- bronchial C5a or IL-la has also been 
investigated (Hellewell et al, 1994). Influx in response to C5a could not be significantly 
inhibited by anti -CD18 antibody, whereas that due to IL -la could, although this inhibition 
was incomplete. Generation of both of these inflammatory mediators would be expected 
during pneumonia and they may thus contribute to the induction of the CD18- independent 
influx (and also, in the case of IL -la, to CD18- dependent influx too) observed. 
As discussed in the introduction to this chapter, the pulmonary sequestration of 
iii neutrophils in response to intravenous LPS was found to be CD 18- 
independent at 4 hours, but CD18- dependent at 24 hours (McCandless et al, 1994). It would 
be surprising if the mechanism of the sequestration of neutrophils changed without this 
being reflected in a change in neutrophil influx, as neutrophils must be sequestered prior to 
migration. The apparent contradiction between McCandless et al's findings and the current 
study are likely to be due instead to the systemic rather than local administration of 
inflammogen, and the fact that LPS was used rather than live E. coli. 
In the rabbit peritoneum, the effect of anti -CD18 antibody on the number of 
neutrophils recovered from peritoneal lavage 4 or 24 hours after instillation of protease 
peptone or live E. coli was assessed in rabbits (Winn, R. K. and Harlan, J. M., 1993). 
Accumulation of neutrophils was found to be predominantly CD18- dependent at 4 hours, 
but was CD18- independent at 24 hours. Once again, it should be emphasised that these were 
measurements of total neutrophil number rather than specifically of influx, and caution 
should be exercised in equating the two. 
In addition, in the study of Winn and Harlan, anti -CD18 antibody was administered 
prior to the induction of the inflammatory response. It is possible that over the next 24 hours 
inflammation was induced to proceed via an abnormal pathway. The development of CD 18- 
independence at 24 hours could be viewed as an adaptive response to CD18 blockade rather 
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than a natural progression of the inflammatory process. In fact, they found that although the 
total number of neutrophils present at 4 hours was decreased, at 24 hours it was unchanged. 
Hence, there had been some 'catch up', implying there was indeed an adaptive response of 
some nature to CD18 blockade. 
It is unclear whether the differences between the current study and that of Winn and 
Harlan relate primarily to difference in inflammatory site, or to differences between 
measuring neutrophil influx and total numbers, or differences between inflammatory 
processes modulated early in their evolution or allowed to develop naturally. Although other 
studies explicitly demonstrate differences between CD18 utilisation in areas supplied by 
systemic and pulmonary circulations and make this a perfectly plausible explanation, the 
'catch up' in neutrophil numbers after 24 hours of CD18 blockade in the peritoneum raise 
serious question as to whether the blockade induced alternative pathways. This clearly has 
important implications for the possible therapeutic use of CD18 blockade as an anti - 
inflammatory manoeuvre. 
Experiments have suggested that macrophages may be important in the induction of 
CD18- independent migration. This is provoked by the finding that the macrophage -rich lung 
has been demonstrated to exhibit neutrophil influx that is CD18- independent or only 
partially dependent migration to a wide variety of stimuli, including hydrochloric acid, 
Strep. pneumoniae, LPS, C5a and IL -la, whereas only PMA induced neutrophil migration 
seems to be fully CD18- dependent at this site (Doerschuk et al, 1990, and Hellewell et al, 
1994). By contrast, both these studies showed similar stimuli produced neutrophil 
accumulation in sites supplied by the systemic circulation (which contained fewer 
macrophages) that was completely CD 18- dependent. 
This suggestion has been supported by several lines of evidence. Firstly, Strep. 
pneumoniae induced accumulation of neutrophils in the peritoneum is normally CD18- 
dependent, but can be induced to be CD18- independent by prior induction of peritoneal 
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macrophages by protease peptone injection or transplantation of macrophages from inflamed 
peritoneum of other animals (Mileski et al, 1990). 
Secondly, in Winn and Harlan's study of the neutrophil influx into the peritoneum 
discussed above, administration of antibody against VLA -4 in addition to anti -CD18 
antibody prevented the development of CD18- independence of neutrophil accumulation at 
24 hours. This antibody does not bind to neutrophils, but binds to monocytes and in 
conjunction with anti -CD18 blocks their accumulation at inflammatory sites. Thus, the 
inhibition of late, CD1 8- independent neutrophil accumulation after administration of anti - 
VLA-4 is suggested to be secondary to the inhibition of monocyte recruitment. 
Thirdly, Pseudomonas aeruginosa produces an acute pneumonia in which neutrophil 
influx is CD18-dependent. Recurrent pneumonia after one week, induced in the same 
portion of the lung, and produced at a time of increased alveolar macrophage numbers there, 
produces neutrophil accumulation that is CD18- independent (Kumasaka et al, 1996). 
It does seem therefore that the macrophage is important in the induction of CD18- 
independent mechanisms of neutrophil accumulation when this occurs. 
In the current study, neutrophil influx was largely (but not completely) CD18- 
dependent at 6 hours, and this remained equally true at 30 hours. There was no evidence that 
modulation of the use of ß, integrins occurs during the course of pneuE. 
3.6 Summary 
1) The anti -CD18 antibody, 6.5e, was used to investigate the CD18 dependency of 
neutrophil influx early (6 hours) and late (30 hours) after the induction of E. coli 
pneumonia. 
2) It was confirmed that 6.5e shows specific binding to the neutrophil surface in vitro. 
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3) Intravenous injcction of 6.5e at an initial dose of 1 mg /kg followed by further doses 
of 0.5 mg/kg after 6 and 1'2 hours produced complete saturation of neutrophil surface CD 18. 
Total CD 18 expression was decreased. 
4) This regime of 6 5e administration produced no change in neutrophil half -life or 
pattern of distribution in control rabbits. 
5) Neutrophil influx to pneuE was inhibited by 6.5e in 6 and 30 hour groups as 
assessed by tissue gamma well counting and external scintigraphy. The inhibition was 
incomplete, implying a contribution of CDl 8- independent mechanisms. The degree of 
CD18- dependence was unchanged in the 30 hour compared with the 6 hour group. There 
was no evidence to support the hypothesis that control of the degree of utilisation of CD 18- 
dependent and independent pathways during evolution of inflammation is a significant way 
in which the progression of the.% inflammatory process is controlled. 
6) The apparent difference between this and the progressive CD18 independence of 
neutrophil influx in the peritoneum in response to E. coli and protease peptone (Winn, R. K. 
and Harlan, J. M., 1993) may be due to the different sites studied. Other exist, 
including the possibility that the presence of anti -CD18 antibody throughout the 
inflammatory response (as in the study of Winn and Harlan) itself induces the development 
of CD18- independent means of neutrophil recruitment. 
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4. THE EFFECT OF ANTI -RABBIT IL -8 ANTIBODY ON 
NEUTROPHIL INFLUX 
4.1 Introduction 
In vitro, neutrophils show the capacity for directed movement in response to a 
chemical gradient. This is known as chemotaxis (Harris, 1954, Caterina and Devreotes, 
1991, and Zigmond, 1989). 
As reviewed in the general introduction to this thesis, a variety of chemotactic 
substances have been known for some time, including LTB4, C5a and bacterial products 
such as FMLP. These factors are not only chemotactic for the neutrophil but also for 
monocytes. The initial phase of inflammation is characterised by selective neutrophil 
accumulation, and this specificity was hard to account for on the basis of action of these 
'traditional' chemotaxins. This has led to great interest in the more recently characterised 
chemokines. This family of mediators is split depending on characteristic structural motifs 
into the C -X -C chemokines (which include IL -8) and the C -C (archetypally MCP -1). The 
former characteristically cause selective neutrophil (and, to a lesser degree, lymphocyte) 
chemotaxis, whilst the latter cause selective monocyte chemotaxis (Leonard and Yoshimura, 
1990). 
It has long been presumed that once the neutrophil is immobilised by adhesion to 
vascular endothelium at the site of inflammation, it is induced to migrate into the tissues by 
the establishment of a chemotactic gradient (Harris, 1954). It has more recently been pointed 
out that stable chemical gradients may be difficult to achieve in the presence of fluid fluxes 
which may occur in vivo, and that chemotactic molecules may not be free, but fixed and 
presented on the surface of cells or on extracellular matrix in the process of haptotaxis (Rot, 
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1996 and Smith, 1992b), nevertheless the concept of chemotaxis retains some overall 
validity. 
As well as inducing neutrophil chemotaxis, IL -8 has a variety of neutrophil activating 
activities, including stimulation of reactive oxygen intermediary generation, degranulation 
and phagocytosis. However, in addition to these proinflammatory activities, it also inhibits 
neutrophil migration across activated endothelium, and may in some circumstances inhibit 
influx to inflammatory sites in vivo (see general introduction for references). Clearly its rôle 
and importance in vivo need to be carefully examined. 
IL -8 levels have been found to be elevated at a wide variety of inflammatory sites, 
including the lung, and in some cases this has been correlated with the number of 
neutrophils present. Functional interpretation of this finding is complicated by the fact that 
neutrophils may in themselves generate significant amounts of IL -8, so elevated IL -8 levels 
may be the result not the cause of increased neutrophil numbers (Bazzoni et al, 1991). 
Nevertheless, data has been produced to show anti -IL -8 antibody blocks in vitro chemotactic 
activity of biological fluids obtained from inflamed lungs, and that anti -IL -8 antibody may 
inhibit neutrophil influx into the lung (referenced in the general introduction). 
A number of studies have been performed relating specifically to pneumonia. 
Chemotactic activity has been assessed in broncho- alveolar lavage fluid from patients with 
pneumonia (Hopkins et al, 1989). Three different chemotactic factors were identified; LTB4, 
C5a and a factor with a molecular weight of around 10 kDa. The latter was presumably IL -8, 
but this had not been well characterised at the time. These samples were taken from patients 
with pneumonia at various stages of evolution. This is certainly interesting, but it is difficult 
to be certain how accurately such in vitro tests relate to in vivo functions. Bound molecules 
acting to promote haptotaxis rather than chemotaxis might be grossly under -represented in 
samples from inflamed sites, so that the importance of soluble chemotaxins in promoting 
directed movement in vivo might be grossly over -represented. 
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Increased IL -8 levels have been found in broncho- alveolar lavage fluid from patients 
with CAP (Boutten, 1996) and pneumonia requiring ventilatory support in the intensive care 
unit (Chollet- Martin, 1993). The latter study, but not the former, demonstrated elevated 
levels of plasma IL -8, the difference perhaps being accounted for by the difference in 
severity in the patients studied. 
A further study of IL -8 level in broncho- alveolar lavage fluid demonstrated an 
elevation during pneumonia (Villard et al, 1995). They also showed that levels were similar 
to those found in ARDS and Pneumocystis pneumonia, but neutrophil levels were much the 
highest in bacterial pneumonia. They also demonstrated a correlation between IL -8 level and 
neutrophil numbers in ARDS and Pneumocystis pneumonia, but not in bacterial pneumonia. 
This indicates that there is no simple universal relationship between IL -8 and neutrophil 
presence, which in turn implies the function of IL -8 (and particular its importance compared 
to other chemotaxins) varies in different situations. 
These studies suggest there might be a rôle for IL -8 in bacterial pneumonia. However, 
as they are all clinical studies, the timing of onset of disease is very difficult to define. In 
addition, patients were studied at different times during the evolution of their disease, and it 
is difficult to assess the relative contribution of IL -8 at different times in the inflammatory 
process. 
Anti -IL -8 antibodies have been found to inhibit neutrophil influx when given before 
or just after acid instillation into the lung in rabbits (Folkesson, H. G., Matthay, M. A., 
Hébert, C. A., and Broaddus, V. C., 1995). No such experiments have been performed in 
bacterial pneumonia. In addtion, there is very little data examining whether the relative 
functional importance of IL -8 may change during the evolution of the inflammatory process. 
A study was therefore performed to assess the effect of anti -IL -8 antibody on specific 
neutrophil influx in pneuS or pneuE, at 6 or 30 hours. The experimental procedure was 
analogous to that described in chapter three in which the effect of anti -CD18 antibody on 
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neutrophil migration was assessed. The inflammatory process was allowed to develop 
unmodified for 6 or 30 hours as appropriate. Anti -IL -8 antibody was then administered prior 
to the administration of "indium-labelled indium- labell neutrophils. Specific influx of these cells to the 
pneumonic lung was then assessed as in previous experiments, with correction for blood 
pool effects by the use of autologous 99'°technetium- erythrocytes. 
4.2 Methods 
4.2.1 Studies with anti -IL -8 antibody 
Rabbit recombinant IL -8 and mouse monoclonal anti -rabbit IL -8 antibody were 
provided under agreement with Genentech, Inc., San Francisco, USA. The antibody, 
ARIL.8.2, produced from clone 6G4.2.5, binds rabbit IL -8 with high affinity and cross 
reacts with human IL -8, but shows no affinity for other human chemokines (gro, platelet 
factor -4, ß- thromboglobulin), other human cytokines (TNF -a, IL-1P) or other chemotactic 
factors (FMLP and C5a) (Broaddus et al, 1994). (Unfortunately, it is not possible to test 
against other rabbit chemokines, because these have mostly yet to be isolated). It is a whole 
lgG2a antibody. It was supplied at a concentration of 5.6 mg/ml in PBS and contained 0.12 
eu /ml of endotoxin. IL -8 was supplied at 1.7 mg /ml in PBS, with an endotoxin content of 
1.31 eu /ml. 
4.2.1.1 In vitro action of ARIL.8.2 
The in vitro activity was then checked by flow cytometrically assessing its ability to 
antagonise IL -8- induced neutrophil shape change. Neutrophils were prepared as described 
above. 100 µl aliquots of 108 per ml in Hanks Buffered Salt Solution with cations, with 10 
mM MOPS (morpholinopropanesulphonic acid) were added to polystyrene test tubes (LP2 
tubes, Merck, Lutterworth). Eight samples each were prepared with PBS control, and with 
IL -8 added to a final concentration of 109, 10 -8, and l0-' M. PBS control, and ARIL.8.2 to 
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final dilutions of 1:50, 1:25 and 1:10 were added to duplicates from each set of eight. The 
final volume was made up to 200 µl with PBS. 
The tubes were incubated at 37 °C with 5 % CO2 for 30 minutes, following which they 
were fixed by the direct addition of 12 µl of 40 % (v /v) formaldehyde. 
Neutrophils were then examined for shape change flow cytometrically. A plot of 
forward scatter against log side scatter produced a well demarcated population of non -shape 
changed neutrophils with low forward and log side scatter characteristics. This was gated on 
in the plots for control neutrophils. Shape changed neutrophils produced an increase in 
forward scatter. Neutrophils showing forward scatter above the control gate were expressed 
as percentage of total neutrophils to give the percentage of shape- changed neutrophils. 
Thirty-five per cent of neutrophils were shape -changed at rest. In the absence of 
antibody, maximum shape change (88.2 %) was produced by 104 M IL -8 (see figure Figure 
4 -1). This could be returned to at least as low as control levels with a 1:50 dilution of 
ARIL.8.2. Although 10-' M IL -8 produced slightly less shape change (77.1 %) this required 
1:10 a dilution of antibody in order to return shape change to control values. Higher 
dilutions were only partially effective. 
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Figure 4 -1 In vitro action of ARIL.8.2 
The graph shows the effect of anti -IL -8 antibody on IL -8 induced neutrophil shape change. 
The x -axis shows concentration of IL -8, with graph series showing decreasing dilutions of 
anti -IL8 antibody. Data shows mean per cent shape change, assessed flow cytometrically, 
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A further and less expected finding was that there was a tendency at all except the 
highest dose of IL -8 used for increased concentrations of antibody to produce shape change 
less than control values. Even control cells could have their shape change reduced by 
addition of antibody. This may represent autocrine or paracrine effects of IL -8 produced by 
the neutrophils. 
4.2.1.2 Overall experimental plan for experiments examining the effect of anti -IL- 
8 antibody 
The overall experimental plan for experiments to assess the effect of ARIL.8.2 on 
neutrophil influx was very similar to the experiments using anti -CD18 antibody (see Figure 
4 -2). 6 and 30 hour groups were studied, for pneuS and pneuE. 5 minutes prior to injection 
of ' I I indium- labelled neutrophils, one of a pair of animals received 2 mg/kg ARIL.8.2, the 
other PBS as control. Antibody treated and PBS control pairs received In -wbc and bacterial 
inoculates from the same pools. 
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indices of neutrophil influx were calculated as before, with differences between 
antibody and PBS control treated animals being evaluated by paired t- tests. 
In addition, further gamma camera images and blood samples were obtained during 
the course of the experiment, as detailed below. 
4.2.2 Effect of high dose ARIL.8.2 antibody on neutrophil influx 
One set of experiments (one pair of animals per treatment group) was performed using 
the higher dose of 6 mg/kg ARIL.8.2. Measures of neutrophil influx were obtained as 
before. The method of comparison with studies using 2 mg,kg of ARIL.8.2 is described in 
















































































































































































































































































4.2.3 Neutrophil clearance experiments 
The early clearance from the lungs of "indium- labelled neutrophils was examined in 
studies using 2 mg/kg of antibody. Dynamic, single isotope external gamma camera images 
were acquired using 247 ± 20 keV windows. 15 sequential images were acquired, over 20 
seconds each, commencing at the same time as "indium-labelled neutrophil injection. 
Equal rectangular regions of interest were create around the left and right lung using the 
fourth image. A mono -exponential curve was fitted to this to describe the rate of clearance 
of labelled cells from the lung, so that: 
y = activity in ROI at a given time 
t = time in seconds 
b = initial activity in ROI 
a = clearance coefficient 
y = b.e-au2o 
Results are expressed as the clearance coefficient, a. Non -parametric analysis is 
employed, using Wilcoxon's Rank Sum test to compare paired samples, Kruskall -Wallis test 
for multiple samples and Mann and Whitney test for unpaired samples as appropriate. 
4.2.4 Imm un oh istoch emistry 
Sections for immunohistochemistry were kindly prepared by Ms. H. Caldwell, 
Department of Pathology, University of Edinburgh Medical School. Paraffin embedded 
sections from 6 hour pneuS animals with or without ARIL.8.2 treatment were used for 
immunohistochemical examination, to look for evidence of areas of concentrated binding of 
ARIL.8.2 which could occur if tissue binding of IL -8 occurs. Sections of human lung were 
exposed to 1:5 normal rabbit serum in TBS, incubated in mouse anti -human epithelial 
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membrane antigen (Dako, High Wycombe) and (after washing in TBS) used as positive 
controls. 
Sections were then incubated with normal rabbit serum and washed twice. They were 
incubated in biotinylated goat anti -mouse antibody (Sigma, Poole) diluted 1:200 in TBS for 
30 minutes. After washing in TBS, they were incubated in avidin /bioitn -HRP for 30 minutes 
as per the suppliers instructions (Dako), and re- washed. Endogenous peroxidase was 
blocked with glucose oxidase, using 20 minutes incubation in a solution containing 3 -D 
glucose 100mM, glucose oxidase 100 U /ml, sodium azide 10mM and 100 mM PBS. After a 
further wash, sections were incubated with diaminobenzidine substrate solution, 0.5 % 
(w /v). After rinsing in tap water, sections were counterstained with 0.1 % Methyl Green. 
After dehydration, sections were mounted for examination. 
4.2.5 Plasma and broncho- alveolar lavage IL -8 levels 
From a random selection of pairs of animals treated with 2 mg/kg of ARIL.8.2 or PBS 
control (weighted to give even distribution across groups), 2 ml blood samples were taken 
into tubes containing EDTA immediately prior to administration of antibody, and 
immediately post mortem. These were placed on ice until centrifuged at 2500g for 10 
minutes at 4 °C. Plasma was aspirated, ensuring no erythrocytes were removed, and stored in 
1.5 ml Eppendorf tubes at -70 °C until assay for IL -8 content. 
Broncho- alveolar lavage fluid from each animals in this experiment was centrifuged 
at 2500g for 6 minutes at 4 °C. Aliquots of 1.5 ml of supernatant were stored in Eppendorf 
tubes at -70 °C until assay for IL -8. 
IL -8 assays were kindly performed by Genentech, Inc., under the direction of Dr. C. 
Hébert, using standard ELISA procedures described previously (Folkesson et a1,1995). 
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4.2.6 In vivo studies of neutrophil influx into the skin 
In four pairs of animals in the experiment using 2 mg/kg of ARIL.8.2, the effect of 
ARIL.8.2 on neutrophil influx to the skin was examined. The dorsal skin of the rabbit was 
shaved. Immediately after administration of ARIL.8.2 or PBS control, 2 sites were injected 
intradermally with 3 x 10 -9 moles of recombinant rabbit IL -8 in 100 µl of PBS without 
cations, and two sites were injected with 100111 PBS without cations as control. This 
procedure was repeated just prior to the injection of 99'ntechnetium labelled erythrocytes. 
Thus, IL -8 was injected early (allowing 21 hours for In -wbc migration) or late (allowing 1 
hour). Immediately post- mortem, 1 cm. diameter portions of skin were excised from the 
injection sites. ''1indium and 99'ntechnetium activities were measured by gamma well 
counting and corrected for weight of the sample. Calculations exactly analogous to those 
performed for the lung were carried out, to subtract the expected blood pool from total 
indium activity, and thus measure the specific influx of labelled neutrophils into the skin. 
The mean of duplicate samples was determined. Results were expressed ratio of neutrophil 
influx in response to IL -8, and the neutrophil influx in response to PBS. The median of this 
value for the four experiments performed is quoted. 
There was a large In -wbc influx in response to intradermal IL -8 given 21 hours ante 
mortem in non -antibody treated control animals, but there was no response to intradermal 
IL -8 given 1 hour ante mortem to either control or antibody treated animals. ARIL.8.2 
markedly inhibited the 21 hour response. 
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Figure 4 -3 Neutrophil influx into skin in response to intra- dermal IL -8 
The graph show neutrophil influx into the skin, as assessed by tissue gamma well counting, 
in response to intra- dermal IL -8 (3 x 10 -9 moles) or PBS control. Animals were treated with 
ARIL.8.2 or control. Duplicate assessments were performed in each rabbit and the mean 
determined. The result is expressed as the ratio of neutrophil influx in response to IL -8 and 
to PBS. The median of four such experiments is presented for each data point. 
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Timing of injection of IL-8 
4.3 Discussion of methods 
PBS control 
Anti -IL -8 
4.3.1 In vitro activity of ARIL.8.2 
Chemotaxins cause neutrophils to change shape. The ability of anti -IL -8 to antagonise 
IL -8 induced neutrophil shape change was used to prove that the antibody had IL -8 blocking 
activity in vitro as supplied. Shape change was assessed flow cytometrically, a method 
found to give close correlation with manual counts (Cole et al, 1995), and to correlate well 
with chemotaxis as assessed by Boyden chambers. 
In the experiment performed there was a relatively high level of basal neutrophil 
shape change, indicating some initial cell activation. Addition of IL -8 caused additional 
shape change as expected, with an optimum dose of 10-8M. Antibody ARIL.8.2 dose 
dependently inhibited neutrophil shape change. In fact, higher concentrations of ARIL.8.2 
sometimes decreased shape change beyond control levels. As noted the neutrophils 
exhibited some basal activation. It is possible they were themselves producing IL -8, and in 
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control cells this was acting by autocrine or paracrine pathways to produce shape change. 
Inhibition of this would reduce control shape change. Overall, it is clear ARIL.8.2 dose 
dependently inhibits the action of IL -8 in vitro. 
4.3.2 In vivo activity of ARIL.8.2 
A dose of 2mg/kg ARIL.8.2 was used for the main study of the effect of the antibody 
on neutrophil influx in pneumonia. This was used because previous studies have 
demonstrated a reduction in the number of neutrophils in inflamed sites using this antibody 
at such a dose (Folkesson et al, 1995). Broaddus et al, 1994, showed 1 mg/kg ARIL.8.2 
markedly inhibited neutrophil influx during endotoxin induced pleurisy, although this was 
given in conjunction with 200 µg ARIL.8.2 instilled into the pleural space The reduction 
seen in the former study was apparent even at the end of 24 hours, and in the latter it 
continued to the end of the study, at 6 hours. 
Intradermal IL -8 caused neutrophil influx into the skin when injected early (allowing 
21 hours for migration) but not when injected late (allowing 1 hour for migration). Similar 
results have been found with commensurate IL -8 levels in sheep, dogs, mice and man 
(Seow et al, 1994, Zwahlen et al, 1994, Zhang et al, 1995, and Hechtman et al, 1991, 
Leonard et a1,1991, respectively). In these studies, the earliest time at which neutrophil 
accumulation was detected was 30 minutes. The lack of accumulation seen after 1 hour in 
the current study is likely to be due to the relative lack of sensitivity of the technique used, 
compared to histological scoring or total tissue myeloperoxidase used in the other studies. 
Antibody ARIL.8.2 was able to inhibit neutrophil influx into the skin in response to 
intradermal IL -8. This confirms that, as expected, it is able to antagonise IL -8 induced 
neutrophil influx, as assessed by accumulation of In -wbc, in vivo. 
The main experimental plan used in this chapter is very similar to that used in chapter 
3 to assess the effect of the anti -CD18 antibody, 6.5e, and similar general considerations 
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apply. The methods are further discussed in the main discussions section for this chapter, in 
the light of the results obtained. 
4.4 Results 
4.4.1 Effect of standard dose ARIL.8.2 on neutrophil influx into lung during 
pneumonia 
One untreated animal from the 30 hour E. coli group died during the study, so this and 
its paired animal were excluded from analysis. 
4.4.1.1 Effect of ARIL.8.2 on total neutrophil recovery from broncho- alveolar 
lavage 
There was no significant difference in total neutrophil recovery from broncho- 
alveolar lavage fluid in either type of pneumonia at either time point. Overall no trend to 
enhancement or inhibition of neutrophil recovery was apparent. 
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Figure 4 -4 Effect of ARIL.8.2 on neutrophil recovery from broncho -alveolar 
lavage 
The graph shows the total recovery of neutrophils from total broncho- alveolar lavage in 
pneuS and pneuE. 6 hour and 30 hour groups are shown, in animals treated with either 
ARIL.8.2 or PBS control. Data shows the mean, error bars SEM, n =7 per data point (except 
30 hour pneuE, n =6). P values are given for each group comparing antibody treated animals 
with PBS treated controls, using paired t tests. 
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4.4.1.2 Effect of ARIL.8.2 an total alveolar macrophage recovery from broncho- 
alveolar lavage. 
Figure 4 -5 Effect of ARIL.8.2 on alveolar macrophage recovery from broncho- 
alveolar lavage 
The graph shows the total recovery of alveolar macrophages from total broncho -alveolar 
lavage in pneus and pneuE. 6 hour and 30 hour groups are shown, in animals treated with 
either ARIL.8.2 or PBS control. Data shows the mean, error bars SEM, n =7 per data point 
(except 30 hour pneuE, n =6). P values are given for each group comparing antibody treated 
animals with PBS treated controls, using paired t- tests. 
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The administration of ARIL.8.2 had no significant effect on the number of alveolar 
macrophages recovered from broncho- alveolar lavage in either type of pneumonia, in either 
time group. There was no overall trend to either increased or decreased numbers apparent. 
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4.4.1.3 Effect of ARIL.8.2 on neutrophil influx as assessed by tissue gamma well 
counting. 
Figure 4 -6 Effect of ARIL.8.2 on neutrophil influx as assessed by tissue gamma 
well counting 
The graph shows the neutrophil influx into the right lung as assessed post mortem by tissue 
gamma well counting in pneuS and pneuE. 6 hour and 30 hour groups are shown, in animals 
treated with either ARIL.8.2 or PBS control. Data shows the mean, error bars SEM, n =7 per 
data point (except 30 hour pneuE, n =6). P values are given for each group, comparing 
antibody treated -animals with PBS treated controls, using paired t tests. 
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ARIL.8.2 produced no significant effect on In -wbc into pneuS or pneuE, as assessed 
by tissue gamma well counting. However, in both time groups in pneuS and pneuE, the In- 
wbc influx was greater in antibody- treated than in PBS control animals. 
Historical data from unbronchoscoped controls was used to calculate mean change in 
influx for this and other data categories as follows: 
Overall change of neutrophil influx (per cent) = Aid 
Neutrophil influx after ARIL.8.2 = PMNaIL -8 
Neutrophil influx after control treatment = PMNPBs 
Neutrophil influx in unbronchoscoped controls = PMNcont 
Aid - ( JPMNaIL-8 - PMNcónIL ) x 100 
[PMNPBS - PMNcont] 
182 
The changes of mean neutrophil influx after ARIL.8.2 treatment in 6 and 30 hour 
groups in pneuS were 153.0 %, 183.3 % respectively, and in 6 and 30 hour groups in pneuE 
were 128.9 % and 160.3 % respectively. 
4.4.1.4 Effect of ARIL.8.2 on neutrophil influx as assessed by external gamma 
scintigraphy 
Figure 4 -7 Effect of ARIL.8.2 on neutrophil influx as assessed by external 
scintigraphy 
The graph shows the neutrophil influx into the right lung as assessed ante mortem by 
external scintigraphy in pneus and pneuE. 6 hour and 30 hour groups are shown, in animals 
treated with either ARIL.8.2 or PBS control. Data shows the mean, error bars SEM, n = 5 
per data point in 6 hour groups, n = 4 per data point in 30 hour groups. P values are given 
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Administration of ARIL.8.2 produced no significant affect on neutrophil influx as 
assessed by external gamma scintigraphy. However, in three out of 4 groups there was a 
trend for increased In -wbc influx after treatment, the only exception being the 30 hour 
pneuS group. The augmentation of mean In -wbc influx calculated as for the data obtained 
with tissue gamma well counts was 130.1 %, 86.6 %, 138.0 % and 120.7 % for 6 and 30 hour 
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pneuS and 6 and 30 hour pneuE groups respectively. (Collection of data on al! 7 sets of 
experiments was precluded by gamma camera malfunction). 
4.4.1.5 Effect of ARIL.8.2 on broncho -alveolar lavage neutrophil influx as 
assessed by BAL gamma well counting 
Figure 4 -8 Effect of ARIL.8.2 on broncho -alveolar lavage neutrophil influx as 
assessed by tissue gamma well counting 
The graph shows the neutrophil influx into the right lung as assessed post mortem by tissue 
gamma well counting of broncho -alveolar lavage in pneuS and pneuE. 6 hour and 30 hour 
groups are shown, in animals treated with either ARIL.8.2 or PBS control. Data shows the 
mean, error bars SEM, n =7 per data point (except 30 hour pneuE, n =6). P values are given 
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There was no significant effect of ARIL.8.2 on In -wbc as assessed by gamma well 
counts in any group. Overall, there was no trend either to inhibition or augmentation of In- 
wbc influx. 
4.4.2 Effect of high dose anti -IL -8 on neutrophil influx into lung during 
pneumonia. 
The standard dose of 2 mg/kg ARIL.8.2 used in the initial experiments produced no 
inhibition of neutrophil influx as assessed by any of the methods used. Further studies were 
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undertaken to examine whether a higher dose of ARIL.8.2 might produced measurable 
inhibition of neutrophil influx. Only one set of experiments was undertaken for practical 
purposes; the experiments required very large amounts of antibody. An antibody- treated and 
PBS control pair of animals was examined at each time point for both types of pneumonia, 
with three measures of neutrophil influx obtained in each animal as with the low dose 
studies. This gave 12 paired measures of neutrophil influx. Influx was greater in the treated 
animal than its PBS treated control pair in 7 measures, and was less in 5. 
Table 4 -1 The effect of high dose ARIL.8.2 on neutrophil influx in pneumonia 
The table shows whether neutrophil influx measures were increased or decreased in high - 
dose (6mg/kg) anti -IL -8 antibody treated rabbits than in PBS treated controls, in pneuS and 
pneuE, in 6 and 30 hour groups. 
Value higher in ARIL.8.2 treated than PBS control 
V Value lower in ARIL.8.2 treated than PBS control 
ln -wbc as assessed 
by: 




BAL gamma well 
counts 
6 hr pneuS A 
6 hr pneuE V A 
30 hr pneuS 
30 hr pneuE A A 
To compare data of animals treated with high dose (6 mg/kg) ARIL.8.2 directly with 
data from the studies using standard dose (2 mg/kg) ARIL.8.2, the ratio of influx 
measurement in each treated animal and its matched control was examined. The ratio 
obtained with high dose treatment was compared with the interquartile range for such ratios 
obtained in the standard dose studies. The value obtained in the high dose study fell above 
the interquartile range for the standard dose study in 5 cases, within it in 4 cases, and below 
it in 3 cases, 
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Overall, the data with the two doses of ARIL.8.2 were very similar. Even with the 
very high dose of 6 mg/kg ARIL.8.2, no trend to inhibition of neutrophil was seen. 
Data for measures of neutrophil numbers in broncho -alveolar lavage fluid likewise 
failed to show any tendency to decrease with high dose ARIL.8.2 treatment. 
4.4.3 Lung clearance coefficients for neutrophils 
Figure 4 -9 Neutrophil lung clearance coefficients 
The graph shows the initial clearance coefficient of neutrophils from the right lung in pneuS 
and pneuE in 6 and 30 hour groups. Lung region of interest "'indium activity was measured 
every 20 seconds from 1 to 5 minutes after injection of "'indium- labelled neutrophils, and a 
monoexponential curve fitted to change in activity with time. The time constant is plotted 
for ARIL.8.2 treated or PBS control rabbits, for both pneuS and pneuE. Data shows medians 
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In 24 animals equally distributed across groups, the clearance rate of In -wbc from left 
and right lungs was assessed by gamma scintigraphy. The activity over each lung field was 
measured each 20 seconds from 60 to 300 seconds after injection of In -wbc. A 
monoexponential curve was fitted. Good fits were obtained. 
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Table 4 -2 Summary of monoexponential goodness of fit for clearance data. 
The table shows the medians and interquartile ranges for the residual squares, F statistics, 
rid values for monoexponential fits to neutrophil clearance from the lui (n = 
Rsq F Significance 
Lower quartile 0.4195 7.265 <0.0001 
Median 0.6035 15.205 0.003 
Upper quartile 0.7847 38.012 0.0237 
At each time point in both types of pneumonia, the clearance coefficient for the right 
lung was higher in ARIL.8.2 treated than in untreated animals. This did not reach statistical 
significance in any individual group using Wilcoxon's Rank Sum test. This may be due to 
small numbers (n = 6 in each group) so the data was also pooled, and the clearance 
coefficients of left and right lungs in animals treated with ARIL.8.2 and with PBS control 
was examined. 
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Figure 4 -10 Neutrophil lung clearance summary 
The graph shows pooled data from pneuS and pneuE 6 and 30 hour groups. Data is 
presented for initial neutrophil clearance coefficient for the right and left lungs from animals 
treated with ARIL.8.2 and controls (as described in figure 3.10). The data is presented as 
medians and interquartile ranges, n = 24 per group. There was a significant difference 
between the groups (p = 0.029, Kruskall -Wallis test). * shows group differing from all 
others on post hoc testing with Mann and Whitney test (p <0.05); no significant differences 
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There was a significant difference between the clearance coefficient for In -wbc from 
the four groups (p = 0.0291 by Kruskal -Wallis test). Mann -Whitney test showed the 
clearance coefficient was significantly lower in the right lung of PBS control animals than 
the right lung of ARIL.8.2 treated animals, and the left lung of either animals. This shows 
that In -wbc were cleared more slowly from lungs with pneumonia than normal lungs, and 
this abnormality could be corrected by administration of ARIL.8.2. 
4.4.4 Immunohistochemistry of pneumonia 
Binding of IL -8 to vascular endothelium has been observed. If this occurs during 
pneumonia, it is possible that the ARIL.8.2 binds here secondarily. Immunohistochemical 
staining of the lung was therefore performed, using sheep anti -mouse antibody to detect any 
localised ARIL.8.2. No evidence of such tissue localisation could be detected. 
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Figure 4 -11 Immunohistochemistry of pneumonia 
The photomicrographs shown were taken at an om of x400. The top photomicrograph shows 
normal human lung stained with mouse anti -EMA as a positive control for the biotinylated goat 
anti -mouse IgG second antibody. Clear staining of the epithelial membrane is apparent. 
The lower left photomicrograph shows lung from an animal in the 6 hour pneuE group that 
received intravenous ARIL.8.2, and the lower right photomicrograph shows its PBS treated 
control pair. No localised second antibody mediated staining is shown, demonstrating ARIL.8.2 is 
not localised to inflamed lung in vivo. 
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4.4.5 Plasma and broncho- alveolar lavage IL -8 levels. 
4.4.5.1 Plasma IL -8 levels 
Figure 4 -12 Levels of IL -8 in plasma 
The graph shows the plasma levels of IL -8 in pneuS and pneuE in 6 and 30 hour groups. 
Measurements were taken immediately before injection of ARIL.8.2 ( "early ") or 
immediately post mortem ( "late "). Data is presented as medians and interquartile ranges. n = 











6, PneuE 30, PneuS 
Time (hrs), type of pneumonia 
30 PneuE 
PBS trued (Early) 
PBS trued (Late) 
Anti -IL-8 trued (Early) 
Et Anti-IL-8 treated (Late) 
Plasma IL -8 was measured immediately prior to administration of anti -IL -8 or PBS 
control (early) or immediately post mortem (late) in a random selection of treated and 
control pairs (n = 2 to 5 pairs per group). Because of the small number of samples, data was 
not subjected to formal statistical analysis. Early, IL -8 was below the limits of detection in 
both types of pneumonia in both 6 and 30 hour groups. IL -8 was detectable late in PBS 
controls only in some animals in the 30 hour pneuE group. By contrast, IL -8 was present at 
the late sampling point at high levels in nearly all animals after ARIL.8.2 treatment. This 
was true in all groups. 
Overall, the data show that in both types of pneumonia at both time points, the 
administration of ARIL.8.2 was associated with an increase in plasma IL -8. Pooling all data, 
the early IL -8 was undetectable, but rose to a median of 653.4 pg/ml immediately post 
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mortem in animals receiving ARIL.8.2. In PBS controls, plasma IL -8 was also undetectable 
early, but no elevation was detected in samples taken immediately post mortem (median 
undetectable). 
4.4.5.2 BAL IL -8 levels 
Figure 4 -13 Broncho -alveolar lavage IL -8 levels 
The graphs show plasma IL -8 levels in broncho- alveolar lavage fluid from the right lung 
form 6 and 30 hour groups of animals with pneuS and pneuE. Data series are presented for 
animals treated with ARIL.8.2 or PBS control. Data is shown as medians with interquartile 
ranges, n = 7 per group (except the 30 hour pneuE group where n = 6). P values are shown 
for comparison of treated and untreated pairs using Wilcoxon's signed rank test. 
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Broncho -alveolar lavage IL -8 levels were measured in all animals. Median IL -8 was 
undetectable in PBS controls. Median IL -8 was elevated in 3 of the 4 study groups in 
ARIL.8.2 treated animals (the exception being the 30 hour pneuS group). This only reached 
significance in the 30 hour pneuE group. 
Pooling the data, IL -8 was higher in bronchoalveolar lavage from ARIL.8.2 treated 
animals than in PBS control (p = 0.01625, n = 26, Wilcoxon's signed rank test). 
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4.5 Discussion 
9.5.1 Effects of 2 mg /kg ARIL.8.2 on broncho -alveolar lavage cell numbers and 
neutrophil influx 
In the data presented, it is clear there is an outlying data point in the 6 hour pneuS 
group. In one case there was a dramatically and unusually high influx of neutrophils that 
was reflected in all measures, including total neutrophil recovery from lavage. This was 
unusual not just for this study, but was also markedly different from values reported in 
chapters two or three. As it is not clear why this occurred, the data point has been retained in 
the primary analysis. Re- analysis without this data point has been performed, and in no case 
does this materially affect the significance of results, or reverse any trend. 
The administration of 2 mg /kg ARIL.8.2 produced no effect on the total number of 
neutrophils recovered from broncho- alveolar lavage fluid. As discussed in chapter three with 
regard to anti -CD 18 antibody, the fact that the antibody is present for only part of the 
duration of the inflammation, together with variability intrinsic to the method of broncho- 
alveolar lavage, do not necessarily mean this is incompatible with an effect on neutrophil 
influx, even if clearance rates remain constant. However, no trend could be discerned at all. 
ARIL.8.2 produced no effect on the number of alveolar macrophages recovered from 
broncho -alveolar lavage fluid. In view of the fact that IL -8 has never been shown to be 
chemotactic for the monocyte /macrophage lineage, this is entirely expected. 
More unexpected was the finding that ARIL.8.2 had no significant effect on the influx 
of neutrophils to the lung as assessed by tissue gamma well counting. Indeed, there was a 
clear trend at both time points, and in both types of pneumonia, for increased neutrophil 
influx. Similar non- significant trends were seen in 3 out of 4 groups when neutrophil influx 
was assessed by ante mortem gamma scintigraphy. 
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In view of these findings and the previously discussed technical limitations of the 
method, it was not surprising that neutrophil influx as assessed by gamma well counting of 
broncho -alveolar lavage fluid gave no statistically significant change. No trend was apparent 
either. 
It has been noted earlier that the antibody used in this experiment causes reduced 
neutrophil accumulation to the pleura after instillation of LPS (Broaddus et al. 1994). It also 
inhibits neutrophil accumulation in the lung after hydrochloric acid instillation (Folkesson et 
al, 1995). In the latter, this was true even after 24 hours, using the same dose of antibody as 
in the current study. In the 3 kg rabbits, assuming a blood volume of 70 ml /kg, 2 mg/kg 
antibody would be diluted approximately 1:250. In vitro, 1:50 dilution of antibody was 
found to completely inhibit the action of as much as 10-8M IL -8, the optimum dose for 
induction of neutrophil shape change. In vivo, the highest plasma level of IL -8 measured at 
any time was 10-1°M, and in all cases measured prior to ARIL.8.2 administration was less 
than 1.6 x 10-12M, the lower limit of detection of the assay used for plasma estimations. 
Both previous experiments and extrapolation from in vitro results suggests that in the blood, 
ARIL.8.2 is present in sufficient amounts to block the IL -8 activity present. 
It is much more difficult to calculate relevant tissue concentrations. Transfer of 
antibody into inflamed tissue as a consequence of increased vascular permeability is to be 
expected. Broncho -alveolar lavage IL -8 levels was rarely more, and often less, than 10-1° M. 
Although this represents a dilution of epithelial lining fluid, it seems likely antibody should 
be present in sufficient quantities to significantly inhibit IL -8 at least at close to sites of 
neutrophil emigration because of vascular leak in the capillaries at sites of inflammation. 
If released IL -8 is tissue bound to a significant degree, its local activity might exceed 
that which is apparent by measurement of its concentration in biological fluids. The lack of 
localised binding of ARIL.8.2 at the site of inflammation demonstrated by 
immunohistochemistry makes this highly unlikely. 
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Nevertheless, it is important to ensure the lack of inhibition of neutrophil influx by 
ARIL.8.2 during pneumonia is not due to inadequate dosage. Therefore further experiments 
were performed with higher doses of antibody. 
4.5.2 Effects of 6 mg/kg ARIL.8.2 on broncho- alveolar lavage cell numbers and 
neutrophil influx 
Pairs of animals were treated with 6 mg/kg ARIL.8.2 or PBS control, a dose of 
antibody that should produce approximately 1:90 antibody dilution intravascularly. One pair 
each was studied for 6 and 30 hour groups in pneuS and pneuE. To facilitate comparison 
with low dose (2 mg /kg ARIL.8.2) studies, the ratio of neutrophil influx in the treated to the 
untreated animal was calculated, and compared to the interquartile ranges for similar values 
in the low dose study. Some values fell above, some below and some within the interquartile 
range, showing the high dose antibody produced similar results over all. Certainly no trend 
to inhibition of neutrophil influx could be discerned. There is thus no evidence that an 
inadequate dose of ARIL.8.2 explains its inability to inhibit the neutrophil influx. 
4.5.3 Does the experiment measure neutrophil influx? 
The validity of the basic experimental method has already been discussed in chapter 
two. "'indium has been shown to remain predominantly cell bound during the course of the 
experiment. Injection of chelated "'indium without incubation with cells results in its 
distribution throughout the blood pool, without accumulation at the inflammatory site as 
determined by gamma scintigraphy, whereas chelated "'indium pre- incubated with 
neutrophil leads to its localisation at the inflammatory site. Autoradiography of the lung 
shows "'indium within the tissues to be predominantly cell associated. 
In addition, as discussed in chapter three, the anti -CD18 antibody 6.5e produced a 
readily detectable inhibition of neutrophil influx with a very similar experimental protocol. 
This was consistent with its known actions in vitro and in other in vivo experiments. 
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Therefore this model measures neutrophil influx, and is capable of detecting its 
modulation by specific interventions. It must be concluded that systemic inhibition of IL -8 is 
incapable of inhibiting neutrophil influx at 6 or 30 hours in pneuS or pneuE; indeed, it may 
actually enhance it. 
It is notable that after gut ischaemia -reperfusion, preliminary data shows the anti -IL -8 
antibody used in this study inhibits neutrophil influx to post -ischaemic gut, but not influx 
into the lung (C. Hébert, personal communication). Other studies (utilising different 
antibodies) have shown inhibition of neutrophil influx after direct ischaemia -reperfusion of 
the lung (Harada et al, 1994), where the mechanisms may be different. 
4.5.4 Effect of ARIL.8.2 on neutrophil clearance from the pulmonary vasculature 
As extensively discussed in the general introduction, neutrophil passage through the 
lungs is constrained by mechanical factors, and thus the neutrophils pass through the lungs 
relatively slowly. Most studies have found that because of this, some I "indium labelled 
neutrophils are temporarily retained in the lungs after injection, and only gradually 
equilibrate with the circulating pool. The rate of decrease in the number of II indium 
labelled neutrophils in the lung was measured using external gamma scintigraphy. This 
showed that neutrophils were cleared relatively slowly from the right, pneumonic lung 
compared to the non -inflamed left lung. As discussed, neutrophil sequestration seems to be 
due primarily to rheological considerations, so this is likely to be secondary to a rapid 
increase in neutrophil stiffness as it traverses the inflamed lung, though changes in adhesion 
molecule expression (not only on the neutrophil, but also on vascular endothelium) could 
theoretically be involved. 
The decreased clearance of neutrophils seen in the inflamed lung was inhibited by 
ARIL.8.2, so that clearance in the two lungs of ARIL.8.2 treated animals was not only equal 
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to each other, but also equal to that in the left, uninflamed lung of PBS treated control 
rabbits. 
This shows the ARIL.8.2 was producing an effect, and this would be consistent with 
inhibiting IL -8 induced increases in neutrophil stiffness in the pneumonic lung. From this it 
can be inferred that the ARIL.8.2 utilised does indeed possess in vivo anti -IL -8 activity, as 
also demonstrated by its ability to inhibit neutrophil influx to the skin. 
4.5.5 Im m un oh isto ch emistry 
The anti -IL -8 antibody used in this study was a whole antibody. Thus, when it binds 
to IL -8 it is possible this would result in complement activation. This may be particularly 
relevant if IL -8 binds to the vascular endothelium in the lung, as in situ complement 
activation could then occur. leading to further inflammatory damage localised to the site of 
previous inflammation. Whilst IL -8 binding to endothelium has been found in other vascular 
beds but not in the lung (Rot et al, 1996), this possibility was investigated by 
immunohistochemistry. Goat anti -mouse immunoglobulin was used to detect tissue bound 
ARIL.8.2. None was discovered. 
Activation of neutrophils by complement leads to their sequestration in the lung 
(Webster et al, 1982). Further, it has been shown that low levels of complement may act 
synergistically with other factors such as LPS to produce a more damaging response 
(Worthen et al, 1987). It is possible that more diffuse complement activation after 
ARIL.8.2 /IL -8 binding acts in this way to cause neutrophil accumulation in the lung, 
increasing the neutrophils available for recruitment to the inflamed site. 
Nevertheless, neutrophil influx in response to local generation of immune complexes 
in the skin, during the reverse passive Arthus response, was shown to be capable of 
inhibition by systemic anti -IL -8 antibody (Zhang et al, 1995) as has immune -complex 
mediated glomerulonephritis (Harada et al, 1994). 
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4.5.6 Plasma and broncho- alveolar lavage IL -8 levels 
In a random selection of animals from each experimental group, plasma IL -8 levels 
were measure before antibody was administered. IL -8 was always undetectable at this time. 
Further measurements were also made on blood obtained immediately post mortem. In PBS 
treated control animals, levels were usually still undetectable. However, in ARIL.8.2 treated 
animals, there was an increase in plasma IL -8 seen in each of the four groups. 
IL -8 levels were also measured in broncho- alveolar lavage fluid. Although IL -8 could 
be detected in some PBS controls, median levels were undetectable in PBS controls from 
each of the four groups. Levels were clearly higher in ARIL.8.2 treated animals than in the 
PBS treated controls. 
This surprising finding is not directly explicable on the basis of available data. 
Supplied antibody had low endotoxin levels. It could result from intra- vascular complement 
activation resulting from antibody -antigen complexes, as discussed above. Immune complex 
formation could lead to further inflammation that in itself results in IL -8 formation. 
If ARIL.8.2 /IL -8 activates complement and leads to further IL -8 generation, this 
would be expected to be apparent whenever IL -8 and ARIL.8.2 are present simultaneously, 
but this has not been found to be true. Pigs injected with Pseudomonas aeruginosa 
developed high plasma IL -8 levels (up to 6 ng/ml). Free IL -8 levels were decreased after 
ARIL.8.2 to a maximum of 2 ng/ml or less (C. Hébert, personal communication). 
If activation of complement is not responsible for the elevated IL -8 seen after 
ARIL.8.2, it might be hypothesised that IL -8 blockade interferes with negative feedback 
control of its production. This would lead to an increased production that would tend to 
overcome the effect of such a blockade, minimising its functional efficacy. Teleologically 
speaking, the body senses that 'not enough' IL -8 is being produced, and produces more to 
overcome this. 
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This sort of feedback control is not without precedence. For instance, a study of C5 
sufficient and deficient mice challenged with Pseudomonas aeruginosa found that mortality 
was higher in deficient mice. Although neutrophil accumulation in the lungs was initially 
lower in the deficient mice, later neutrophil numbers were actually higher in the deficient 
mice (Larsen et al, 1982), indicating an adaptive response. A second example is seen in the 
action of anti -CD18 antibody on the neutrophil influx to the peritoneum after E. coli or 
thioglycollate broth (Winn and Harlan, 1993). As has been discussed in chapter three, this 
results in inhibition of neutrophil accumulation at 4 hours, but by 24 hours, neutrophil 
numbers had actually 'caught up', so that they were equal in antibody- treated animals and 
controls. 
Negative feedback control of IL -8 production has not been demonstrated in vitro. 
Nevertheless, a wide variety of cells are capable of IL -8 production in response to a range of 
different stimuli, and it seems quite possible such control loops are established as part of 
local cytokine networks in vivo. It is notable that despite the fact that IL -8 in vitro causes 
selective neutrophil recruitment, injection of IL -8 into the joint space of rabbits produce full 
expression of the inflammatory response. There is initial neutrophil recruitment followed by 
mononuclear cell recruitment, before resolution occurs (Endo et al, 1991). 
The potential for complex in vivo interaction of IL -8 is further emphasised by the 
realisation that its actions are not exclusively confined to the neutrophil. In the skin, for 
instance, it is also associated with angiogenesis, modulation of keratinocyte HLA -DR 
expression, proliferation, chemotaxis and Candida albicans killing, whilst IL -8 receptors are 
present on T- lymphocytes, macrophages, and mast cells (see Kemény et al, 1994). IL -8 
production may well be part of much broader and more interactive processes than just being 
an 'on -off signal for neutrophil influx, and this would suggest it is likely to be subject to 
subtle controls to ensure reliability and robustness of the system. 
198 
4.5.7 Comparison of antibody effects on neutrophil influx to pneumonia with 
other studies 
IL -8 levels have been demonstrated to be elevated in the lung during bacterial 
pneumonia (Boutten et al, 1996, Chollet -Martin et al, 1993, and Villard et al, 1995), 
although there was no correlation between IL -8 levels and neutrophil numbers in broncho- 
alveolar lavage. Indeed, Villard et al note that IL -8 levels in broncho- alveolar lavage were 
similar in patients with pneumonia or ARDS, but the neutrophil influx was much greater in 
the former. Further, the finding of a correlation between neutrophil numbers and IL -8 levels 
ill ARDS but not pneumonia raises the possibility that other chemotactic factors are 
important in pneumonia. The need for extreme caution in interpreting such correlations of 
neutrophil number and IL -8 levels has been discussed in the general introduction. However, 
the contention that factors additional to IL -8 are important in neutrophil influx during 
pneumonia is also supported by functional data. Broncho -alveolar lavage fluid from patients 
with pneumonia possesses chemotactic activity that can be split into three fractions. These 
were identified as C5a, LT B4 and a protein (presumably IL -8) with an approximate 
molecular weight of 10 000 (Hopkins et al, 1989). 
The demonstration of elevated levels of IL -8 in broncho- alveolar lavage in this study 
is entirely compatible with the clinical studies quoted above. 
Contradictory findings have been made on plasma IL -8 levels in pneumonia. They 
have been found to be unchanged (Boutten et al, 1996) or elevated (Chollet -Martin et al, 
1993). The latter group was composed of patients requiring mechanical ventilation and 
hence may represent a subgroup with more severe disease. The finding in this study that 
plasma IL -8 was rarely raised in control animals with pneuS or pneuE is therefore in 
agreement with clinical findings. 
The in vitro ability of IL -8 to cause neutrophil chemotaxis together with its presence 
in pneumonia, a condition characterised by the presence of abundant numbers of 
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neutrophils, suggests functional studies of its rôle in this disease would be appropriate. To 
date, none have been performed. The contribution of IL -8 to neutrophil influx to other sites 
and in other diseases has been assessed in a few studies using anti -IL -8 antibodies. 
A number of studies have documented the ability of anti -IL -8 antibodies to inhibit 
neutrophil accumulation in the skin, in response to a variety of stimuli; intradermal IL -8, IL- 
1, local immune complex deposition in the reverse passive Arthus reaction (Zhang et al, 
1995), intradermal LPS (Harada et al, 1993), and the tuberculin reaction (Larsen et al, 
1995). Anti -IL -8 antibody has also been demonstrated to inhibit neutrophil accumulation in 
response to immune -complex mediated glomerulonephritis, LPS and IL -1 induced arthritis, 
and lung reperfusion injury (Harada et al, 1994) and endotoxin induced pleurisy (Broaddus 
et al, 1994). Neutrophil accumulation was also inhibited by anti -IL -8 antibody in response to 
hydrochloric acid instillation in the lung (Folkesson et al, 1995), whether the antibody was 
given prior to or 1 hour after the insult. 
No studies documenting the failure of anti -IL -8 antibodies to inhibit recruitment of 
neutrophils to inflammatory sites have yet been published. Preliminary findings from one 
study of gut ischaemia- reperfusion show that although neutrophil influx locally to the 
damaged gut is inhibited by anti -IL -8 antibody, the antibody is without effect on the 
neutrophil accumulation to the lung that usually occurs following this insult (C. Hébert, 
personal communication). Although a publication bias against negative studies may partially 
account for this, other reasons must be sought. 
As discussed above, the antibody ARIL.8.2 used in the current experiments has been 
shown in other studies to cause inhibition of neutrophil recruitment in other models. It was 
active as supplied when tested in vitro. Storage conditions of the antibody were not a factor 
as the antibody used for in vitro tests was taken from a randomly selected aliquot of a pool 
used for in vivo experiments, and was stored for a similar duration. Calculations suggest the 
dose should have been of sufficient magnitude, and higher doses had an effect that was no 
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different. The fact that it inhibited neutrophil influx to the skin, and prevented increased 
early neutrophil retention at the inflammatory site, demonstrate it was active in vivo during 
this study. 
Taking the results at face value, several possible conclusions could be drawn. It is 
possible that neutrophil influx in pneumonia simply proceeds by mechanisms in which IL -8 
is not essential, either because it usually has a minor rôle, or because other chemotactic 
factors such as C5a, LTB4 or bacterially- derived products easily compensate. Their presence 
has been demonstrated in broncho- alveolar lavage fluid. Anti -IL -8 antibodies have been 
shown to inhibit neutrophil chemotactic activity of biological fluids from inflammatory sites 
by a maximum of 75 %, but often only 30 %, suggesting a contributory rather than dominant 
rôle for IL -8 in neutrophil chemotaxis in vivo. 
Secondly, IL -8 may be under negative feedback control. Anti -IL -8 antibody could 
inhibit feedback, giving rise to generation of extra IL -8 (reflected in increased plasma and 
broncho -alveolar lavage IL -8 levels), sufficient to overcome the blockade. Why either of 
these first two mechanisms should occur is not apparent, 
one would have to hypothesise mechanisms unique to pneumonia. 
Thirdly, binding of IL -8 to anti -IL -8 antibody may cause complement activation 
either throughout the vasculature, locally on the vessel wall, or in the interstitium, at the site 
of inflammation, any of which could cause neutrophil recruitment. Although no direct 
evidence for such complement activation was obtained, the fact that complement activation 
causes neutrophil sequestration specifically in the lung may account for the difference 
between both this study and the preliminary findings of selective lack of efficacy of anti -IL- 
8 antibody on neutrophil influx to the lung after gut ischaemia- reperfusion, compared to 
other studies in other sites. It also provides an explanation for the raised plasma and 
broncho- alveolar lavage IL -8 levels seen after antibody administration. The fact that anti -IL- 
8 antibody was able to block immune complex- mediated neutrophil influx to the skin and 
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the kidney is not necessarily relevant given the particular ability of complement activation to 
cause neutrophil accumulation in the lung. 
Fourthly, there may be a general difference in the requirement for IL -8 in areas 
supplied by pulmonary and vascular circulations, in a manner analogous to the differing 
requirement for CDl 8 in the two territories (Doerschuk et al, 1990, and Hellewell et al, 
1994). The fact that ARIL.8.2 has been used to successfully inhibit neutrophil accumulation 
to the lung makes this argument less likely (Folkesson et al, 1995). 
Fifthly, the timing of administration of the antibody differed in this study from all 
others. It was administered after either 6 or 30 hours in this study, whereas in all other 
studies (except one in which it was administered one hour after the insult) the antibody has 
been administered prior to the challenge. If IL -8's importance in neutrophil influx is 
confined to the early part of the evolution of inflammation, and other factors then supersede, 
then the lack of effect on neutrophil influx in the current study combined with the inhibitory 
effect seen in other studies would be expected. The change in functional importance of IL -8 
with time has only been addressed once. It was found to have increased importance after 2 
hours, as assessed by the ability of anti -IL -8 antibody to inhibit the chemotactic activity of 
peritoneal fluid, (as assessed in the back skin of assay rabbits), obtained at intervals after 
intraperitoneal injection of zymosan (Collins et al, 1991). Nevertheless, this may be 
different in other situations. Unpublished work also shows that the functional rôle of IL -8 
may change with time. Replication deficient adenoviruses induce prolonged expression of 
IL -8 in primates as assessed by sequential broncho- alveolar lavage over several weeks, 
whereas neutrophil accumulation is transitory, lasting several days at most (R. Wilmott, 
personal communication). 
Sixthly, the current study measures specific neutrophil influx whereas the other 
studies measure neutrophil numbers. The possibility that neutrophil numbers decrease after 
anti -IL -8 because of an increase in clearance rather than a decrease in influx is unlikely, 
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given the known in vitro neutrophil activating and chemotactic actions of IL -R. In vitro IL -8 
has no effect on neutrophil apoptosis (Colotta et al, 1992). Indeed, chapter four presents 
results showing broncho -alveolar lavage interleukin -8 levels correlate weakly with total 
neutrophil apoptosis rather than demonstrating the inverse relationship this explanation 
would suggest. 
Finally, the current study is the only one performed with live bacteria. Although 
studies with nebulised bacteria suggest after 4 hours only 7.3 % of Strep. pneumoniae are 
viable, whilst 88.5 % of E. coli are viable (Jay et al, 1976), after bolus challenge, viability 
may be greater (Ansfield et al, 1977). At least in the 6 hour group, there may well be viable 
bacteria in the lung when anti -IL -8 antibody is introduced. Any reduction in neutrophil 
influx and activation could give rise to increased survival, providing a further stimulus to 
inflammation, mitigating the inhibitory effects of the antibody. 
The apparent lack of effect of the anti -IL -8 antibody on neutrophil influx in 
pneumonia may therefore be because IL -8 is not of over -riding importance in the lung 
during pneumonia, or that its importance is confined to the first 6 hours of disease. 
Alternatively, it could be secondary to complement generation, or interference with positive 
feedback controls. The most likely explanations in view of the raised IL -8 levels in plasma 
and broncho- alveolar lavage fluid after the administration of antibody, coupled with the 
trend to an increased influx after antibody rather than merely absence of inhibition, are that 
anti -IL -8 antibody results in activation of complement giving secondary neutrophil influx, or 
that there is release of a negative feedback mechanism. 
4.6 Summary 
1) ARIL.8.2 was able to inhibit IL -8 induced neutrophil shape change in vitro. 
2) ARIL.8.2 was able to inhibit neutrophil influx in response to intradermal IL -8 in 
vivo. 
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3) Administration of 2 mg /kg ARIL.8.2 prior to administration of i l l indium- label led 
neutrophils failed to produce any reduction of influx at either 6 or 30 hours in pneuS and 
pneuE. Indeed there was a trend to increased influx. It was however able to inhibit the 
increased early retention of In -wbc in the inflamed lung, as assessed by external gamma 
scintigraphy. 
4) Administration of 6mg /kg of ARIL.8.2 produced identical results. 
5) Immunohistochemistry failed to demonstrate localisation of ARIL.8.2 to the 
pulmonary vascular epithelium, failing to support the contention that endothelially bound 
IL -8 could be involved in immune complex generation. 
6) Administration of the ARIL.8.2 in animals with pneumonia was associated with 
increased plasma and broncho -alveolar lavage IL -8. This may reflect immune complex 
formation between ARIL.8.2 and IL -8, giving complement activation and further IL -8 
generation, or the release of normal feedback inhibition of IL -8 formation. 
7) In view of the increased plasma and broncho -alveolar lavage IL -8 levels after IL -8 
administration, it is considered that the lack of ability of ARIL.8.2 to inhibit neutrophil 
influx in pneumonia is most likely to be secondary to interference with a normal in vivo 
feedback control of IL -8 production. Other possible mechanisms are discussed, and although 
there is some evidence against it, it is possible that ARIL.8.2 /IL -8 immune -complex 
formation is important. 
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5s THE ROLE AND CONTROL OF APOPTOSIS IN 
NEUTROPHIL CLEARANCE IN PNEUMONIA 
5.1 Introduction 
Neutrophils are recruited to the lungs in vast numbers during pneumonia. This places 
the lung in a potentially precarious position, given the array of potentially histotoxic 
products associated with neutrophils (Haslett et al, 1989, Henson and Johnson, 1987, Root 
and Cohen, 1981). It is remarkable that in pneumococcal pneumonia (Johnston, 1991), 
restoration of lung architecture is usually prompt and complete. This implies a safe and 
efficient clearance mechanism for neutrophils. In gram negative pneumonia there is often 
some disruption of pulmonary structure (Coalson, 1995). As discussed in chapter two, there 
is a more prolonged influx of neutrophils to the right lung in pneuE than pneuS, and this 
may give an increased lung neutrophil burden, contributing to lung damage. Manipulations 
of neutrophil number with G -CSF or cyclophosphamide have supported this view that some 
of the lung damage produced in gram negative pneumonia is secondary to neutrophils rather 
than being a directly due to bacteria (Terashima et al, 1995). 
Neutrophils have never been observed to return to the circulation once they have left 
it, so they must meet their fate in the tissues. As discussed in the general introduction, it was 
long presumed there was passive degeneration of the neutrophils. An alternative, much less 
hazardous explanation is provided by the finding that neutrophils are able to undergo 
apoptosis (programmed cell death) (Savill et al, 1989). In vitro experiments have shown that 
after this process, macrophages can the engulf the neutrophil without generation of further 
inflammatory mediators (Meagher et al, 1989). Studies have suggested that this 
accomplished by a mechanism using the vitronectin receptor and the thrombospondin 
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receptor on the macrophage, with thrombospondin forming a 'bridge' to the neutrophil 
(Savill, 1992), or by a process inhibitable by phosphatidylserine (Fadok et al, 1992). 
The presence of apoptotic neutrophils and macrophages that have ingested apoptotic 
neutrophils in broncho -alveolar lavage fluid after pulmonary LPS challenge suggests 
strongly that this mechanism could be important in pneumonia (Cox et al, 1995). A large 
number of inflammatory mediators affect the rate of neutrophil apoptosis in vitro, 
suggesting that this process could be actively controlled in vivo. Inflammatory mediators 
(such as GM -CSF, G -CSF, C5a, FMLP, IL -6 and IFN -y) have usually been shown to delay 
apoptosis, as have bacterial components such as inactivated Streptococci and LPS 
(referenced in general introduction). Generally, it has been considered likely that these act at 
the inflammatory site in order to prolong neutrophil lifespan there, thus prolonging its 
ability to perform defensive actions (Haslett, 1992). Without specific modulatory instruction 
via inflammatory mediators, the neutrophil will be programmed to have an early and safe 
end to its life via apoptosis. 
It was therefore decided to seek evidence for apoptosis during pneuS and pneuE by 
quantifying neutrophil numbers in broncho- alveolar lavage fluid. The presence of alveolar 
macrophages with apoptotic bodies was also sought. The ability of broncho -alveolar lavage 
fluid to modulate the rate of apoptosis of neutrophils in vitro was then examined as an 
indirect way to measure the modulatory effect of the inflammatory environment of the 
pneumonic lung. 
5.2 Methods 
Pneumonia was induced as in previous experiments. 6 animals were initially 
examined at 0 (unbronchoscoped control), 12, 24, 48, 72 and 96 hours. Following these 
preliminary experiments, 6 further animals were studied at 0, 12, 24 and 48 hours. Formal 
statistical analysis was performed on the complete data sets where n = 12, but data from the 
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remaining two data points where n = 6 are presented graphically for comparison. It should 
be noted that timings referred to in this chapter refer to actual time after the induction of 
pneumonia, not the time between induction of pneumonia and injection of In -wbc, as 
referred to in other chapters. 
Animals were killed with an intravenous overdose of pentobarbital. The great vessels 
were sectioned intra- abdominally and the heart and lungs removed en bloc. The pulmonary 
vasculature was flushed twice with 30 ml of normal saline introduced via a 19 G 
hypodermic needle within the right ventricle. The number of apoptotic cells recovered was 
expected to be low for reasons examined in the discussion. For this reason, selective 
broncho- alveolar lavage of the right cranial and medial lobes was performed, rather than 
lavage of the entire right lung. Cells from the area of active inflammation would be far less 
'diluted' by cells from the remaining lung, a consideration far less important when using 
radiolabelled cells, when the technique is 'blind' to the presence of unlabelled cells. The left 
main bronchus was tied off with 2/0 Mersilk as before. Connective tissue was dissected 
away from the right main bronchus to expose the right caudal lobe bronchus which was 
ligated. A portion of tubing from a wide bore extension set was tied in place in the trachea. 
As much as possible of a 10 ml aliquot of PBS (without cations) with 50 U of heparin per ml 
was introduced, then aspirated, and this was repeated twice. The whole procedure was 
repeated with a further 10 ml aliquot. Broncho -alveolar lavage was kept on ice until further 
processing. 
The lungs were inflated to 25 cm. of water pressure with 10 % (w /v) 
paraformaldehyde in PBS, and fixed overnight. They were then sectioned for light 
microscopy. 
Cytocentrifuge preparations were prepared in quadruplicate using 100 µl of broncho- 
alveolar lavage for each. These were stained with Diff- Quik ®. Differential counts were 
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performed on at least 500 cells per slide. In particular, the number of alveolar macrophages 
containing large, chromatin inclusions representing apoptotic bodies was counted and 
expressed as a percentage of the total alveolar macrophage numbers. 
Apoptotic rabbit neutrophils were found to retain their morphology unreliably on 
cytocentrifuge preparation. Cells were therefore assessed for apoptosis in suspension using 
acridine orange staining. 6 µl of 40 % formaldehyde was added to a 100 pl of broncho- 
alveolar lavage sample, and saved at 4 °C for later acridine orange staining from which 
differential counts of all macrophages (with and without inclusions) and all neutrophils 
(apoptotic or non -apoptotic) were obtained. 
Erythrocytes were lysed by the addition of 4 drops of Zap -Oglobin (Coulter 
Electronics, Luton) to a further 100 pl of broncho- alveolar lavage and Isoton was added to 
10 ml. A Coulter counter (Coulter Counter® ZM with Sampling Stand IIa) was used to count 
cells, and total cell recovery calculated. 
A 25 µl aliquot of 25% glutaraldehyde (electron microscopy grade, BDH Laboratory 
Supplies, Poole) was added to a further 200 pl sample of broncho- alveolar lavage, and 
stored at 4 °c for later preparation for electron microscopy. 
In view of the fact that at some time points the percentage of neutrophils in broncho- 
alveolar lavage was quite low, and that apoptotic cells were expected to be a small fraction 
of this, neutrophils were concentrated for further assessment. The remaining broncho- 
alveolar lavage was centrifuged at 250g for 6 minutes. The cell pellet was resuspended in 10 
ml of a 6:4 mixture of hetastarch (Hespan ®, Geistich Pharma, Chester) and 90 % Percoll in 
10 x Hanks Buffered Salt Solution without cations. This was transferred to a 15 ml 
polyethylene centrifuge tube, and centrifuged at 2500g for 10 minutes. 
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Following this, macrophages were found on the surface of the hetastarch:Pecoll 
mixture. They were aspirated together with much of the supernatant. On the bottom of the 
tube were the erythrocytes, and the neutrophils were mixed with and just above this layer. 
(A test of this gradient with a mixture of 50 % alveolar macrophages and 50 % neutrophils 
showed the upper layer to contain 97.8 % macrophages and the lower layer to contain 96.8 
neutrophils). 
The neutrophil layer was aspirated and washed once with phosphate buffered saline 
without cations, before being resuspended in 2001_1.l of PBS. Half of this was added to 25 pi 
of 25% glutaraldehyde, and half added to 6 µl of 40 % formaldehdye. These were stored at 
4 °C. The former was later processed for electron microscopy. The latter was stored for later 
acridine orange staining, and the per centage of cells that were apoptotic were counted. 
Meanwhile, the broncho- alveolar lavage fluid supernatant was centrifuged at 2500g 
for 10 minutes at 4 °C. The supernatant was then saved in 1.5 ml Eppendorf tubes at -70 °C 
until further use. 
Acridine orange staining was performed by adding 1 of acridine orange (1 mg /ml in 
PBS) to 10 µl of cell suspension. Examination of cells was performed using fluorescence 
microscopy. At least 500 cells were counted per specimen, with the exception that so few 
neutrophils were obtained from unbronchoscoped animals that only 100 - 200 cells (and 
occasionally even fewer) could be counted. Apoptotic cells were recognised by their 
uniformly staining, compacted chromatin, often with separation of the lobes of the nucleus, 
in shrunken cells. 
5.2.1 Electron microscopy 
Material for electron microscopy was kindly prepared by Mr. S. McKenzie, Dept. of 
Pathology, Edinburgh University Medical School using reagents obtained from TAAB 
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Laboratories Equipment Ltd., Aldermaston. Fixed cells were washed in sodium cacodylate 
buffer. They were post fixed in 1 % osmium tetroxide in sodium cacodylate buffer for 2 
hours. then dehydrated through grades of ethanol to 100 %. They were impregnated in 
Araldite epoxy resin overnight, before embedding in fresh Araldite epoxy resin. This was 
polymerised at 56 °C for 3 days. 
Ultrathin, 60 nm sections were cut on a LKB Nova ultrotome. Sections were stained 
with uranyl acetate and lead citrate. 
Sections were viewed on a Philips CM14 Electron Microscope. 
5.2.2 In vitro experiments using rabbit neutrophils 
The ability of broncho -alveolar lavage fluid supernatant to modulate apoptosis of 
rabbit neutrophils cultured in vitro was assessed. Neutrophils were prepared as described 
and resuspended at 4 x 106/m1 in Iscove's Modified Dulbecco's Medium, supplemented with 
20 % normal rabbit serum, and 100 U /ml penicillin and 200 mg/ml streptomycin. A 100.tí 
aliquot of cell suspension was placed in the wells of a 96 well tissue culture plate, 9 wells 
being set up per assay condition. 100 p.1 of PBS without cations, with 50U per ml heparin 
(negative control), or 100 µl of broncho -alveolar lavage fluid supernatant was added to each 
set of 9 wells. Experiments were arranged so that lavages from a series of animals receiving 
bacteria from the same pool were assayed together using neutrophils from a single pool. 
The neutrophils were incubated at 37 °C in 5 % CO2. After 5, 10 and 20 hours, cells 
from two wells for each condition were removed and fixed by the addition of 6 µl40 % 
formaldehyde. The cells were stained with acridine orange, and the percentage of 
neutrophils that were apoptotic assessed by counting at least 500 cells on a fluorescent 
microscope (Olympus Optical Co., London). The mean of the duplicates was used for data 
presentation. A 50 µl aliquot of cell suspension was taken from a further well and used to 
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measure cell recovery with a Coulter counter. Recovery of cells was around 70 % and did 
not vary between groups. A 20 tl aliquot of cell suspension was added to 20 µl of Trypan 
Blue, and the percentage of cells able to exclude the dye was counted as a measure of 
viability. Cells obtained at 20 hours showed high rates of Trypan Blue positivity and were 
excluded from further assessment. At earlier time points > 95 % (and usually > 98 %) were 
able to exclude Trypan Blue dye. 
Data is presented as the ratio of apoptosis produced in a given condition to apoptosis 
produced by PBS /heparin control. 
5.2.3 Chemokine assays 
Measurement of IL -8 in broncho -alveolar lavage fluid was kindly performed by 
Genentech Inc., San Francisco, USA, as described in chapter 4. 
Gro and MCP -1 were kindly measured by O. Kajikawa in the laboratory of T. Martin, 
Seattle, using ELISAs. 
5.2.4 In vitro experiments using human neutrophils 
Similar experiments to those performed with rabbit neutrophils were performed with 
human neutrophils, with the exception that assessment was performed at 6 and 20 hours, and 
used Diff- Quik ®- stained cytocentrifuge preparations instead of acridine orange stained cell 
suspensions, as they produced clear morphology with this technique. Slides were kindly 
counted by Dr. S. Hannah, Rayne Laboratory, Edinburgh, blinded to treatment, with at least 
500 cells being classified for the presence or absence of apoptosis per slide. Data is 
presented as for data with rabbit neutrophils. 
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5.2.5 Inhbition of in vitro apoptosis using blocking antibodies 
Preliminary experiments were performed to establish whether blockade of the 
neutrophil Fas or soluble TNFa dimished the pro -apoptotic effect of broncho -alveolar 
lavage fluid. 
Broncho -alveolar fluid samples were selected on the basis of their demonstrated 
ability to induce high levels of apoptosis. Anti -TNF (demonstrated to inhibit rabbit TNFa in 
L929 cytotoxicity assays using supernatant from endotoxin -stimulated rabbit alveolar 
macrophages as a source of TNFa) was obtained via R &D and was preincubated with 
bronchoalveolar lavage fluid to a concentration of 10.tg/ml for 30 minutes. The anti -human 
Fas antibody CHI 1 (Upstate Biotechnology) was preincubated at 0.5 µg/ml with human 
neutrophils for 30 minutes prior to the addition of broncho -alveolar lavage fluid. Apoptosis 
after 6 or 20 hours as assessed on Diffquik staining was then compared to apoptosis in the 
abscence of antibody, or after preincubation with 7F4, a control antibody (an anti -CD44 
antibody, courtesy of I. Dransfield) with broncho- alveolar lavage fluid or neutrophils (as 
appropriate), or incubation with 12.5 ng/ml TNFa as a positive control. The anti -TNF 
antibody used was able to completely inhibit the effect of this dose of TNF. 
5.3 Discussion of methods 
Pneumonia was induced as in experiments described in chapter 2, and as discussed 
there, this reliably produces a localised, intense inflammation, showing the expected 
progression from neutrophil to mononuclear predominance, with progression to resolution. 
Standard, established methods were used to assess apoptotic morphology on light 
microscopy and electron microscopy (Wyllie et al, 1980, Kerr et al, 1987, Payne et al, 
1994). On light microscopy, neutrophils were shrunken, with dense chromatin condensation, 
frequently accompanied by a degree of nuclear fragmentation. On electron microscopy, 
apoptotic neutrophils displayed characteristic smoothness of the cell membrane with a lack 
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of pinocytic vesicles, dilatation of the endoplasmic reticulum, and dense condensation of the 
chromatin. Acridine orange staining has been successfully used to study apoptosis in a 
variety of leukocytes (Arends et al, 1990, Stern et al, 1992 and Bellingan et al, 1994). 
Apoptotic cells appear small, and the nucleus is seen to be contracted, with uniform, intense 
staining of the chromatin, rather than the normal diffuse pattern. 
Many publications relating to apoptosis have included biochemical confirmation of 
apoptosis by DNA gel electrophoresis and demonstration of a'ladder' pattern of DNA 
fragments produced by internucleosomal cleavage. This is applicable to cell culture studies, 
where large numbers of cells may proceed to apoptosis without the presence of macrophages 
to clear them. However, in tissue, apoptotic cells are generally cleared rapidly, so that even 
with a significant clearance of cells by apoptosis, free apoptotic cells are only rarely found 
because of prompt clearance. DNA electrophoresis will not produce clear results in these 
circumstances, so was not attempted in these studies. 
Although only morphological assessment is used here, this should be fully adequate. 
Neutrophils showing morphological apoptosis, but not showing associated biochemical 
features of apoptosis, have never been described. It should also be remembered that the 
original definition of apoptosis was based on a morphological classification of modes of cell 
death (Kerr et al, 1972). Thus, morphological appearances are sufficient to confidently 
classify a cell as apoptotic. 
5.4 Results 
5.9.1 Light microscopy of tissue 
Light microscopy of lung tissue from animals with pneumonia clearly demonstrated 
that some neutrophils showed the classical morphological appearances of apoptosis (see 
Figure 5 -1). In addition, alveolar macrophages were seen that contained apoptotic 
neutrophils in varying degrees of degradation (see Figure 5 -2). 
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Figure 5-1 Apoptotic neutrophils seen on tissue sections 
The photomicrographs show clear examples of apoptotic neutrophils (an-owed) in the alveolar 
spaces during pneumonia (H&E, om x1000) 
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Figure 5 -2 Alveolar macrophages containing apoptotic neutrophils, seen on 
tissue sections 
The photomicropgraphs show alveolar macrophages with vacuoles showing apoptotic neutrophils 
(arrowed) in varying stages of degradation (H &E, om x1000). 
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5.4.2 Cellular constituents of bronc /zoalveolar lavage 
5.4.2.1 Presentation of results 
Initially, 6 animals were studied at the following time points; 0, 12, 24, 48, 72 and 96 
hours. Examination of these preliminary time points suggested that changes in apoptotic cell 
recovery and number of macrophages containing apoptotic bodies was greatest between the 
first four of these points. A further 6 rabbits were therefore examined at these time points. 
Statistical analysis is performed for 0, 12, 24, and 48 hours, with n = 12 per group. Graphs 
include data for 72 and 96 hour groups for comparison and examination of trends, but these 
are not included in formal statistical analysis. 
5.4.2.2 Morphological appearances 
Light microscopy using Diff-Quik® -staining of BAL cytocentrifuge preparations, and 
acridine orange -staining of concentrated neutrophils from BAL, showed morphological 
evidence of apoptosis (see figure Figure 5 -3 and Figure 5 -4) in both types of pneumonia. In 
addition, light microscopy of Diff -Quik® stained cytocentrifuge preparations showed 
evidence of alveolar macrophages that had ingested apoptotic neutrophils, and these were 
present within vacuoles in varying degrees of degradation (see Figure 5 -5) 
Electron microscopy confirmed both of these findings (see Figure 5 -6 and Figure 5 -7). 
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Figure 5 -3 Neutrophils showing apoptosis from BAL (Diff -Quik ®) 
The photomicrographs show examples of neutrophils from BAL showing morphological features 
of apoptosis (arrowed). (Diff-Quik®, om x1000). 
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Figure 5 -4 Neutrophils showing apoptosis from BAL (Acridine orange) 
The photomicrographs show neutrophils with the morphological appearances of apoptosis 
(avowed). Although the photomicrographs show the condensed, smooth, featureless chromatin of 
apoptotic cells, this is much clearer during microscopy. As they are examined in suspension, it is 
necessary to continually alter the plane of focus to appreciate their morphology fully. (Acridine 
orange, om x400). 
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Figure 5-5 Alveolar macrophages containing apoptotic bodies from BAL 
The photomicrographs show examples of alveolar macrophages from BAL, containing apoptotic 
neutrophils with varying amounts of degradation (arrowed). (Diff-Quike, om x1000). 
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Figure 5 -6 Electron microscopy of neutrophils showing apoptosis from BAL 
The electron- micrographs show the appearances of neutrophil recovered from BAL. The upper 
panel shows a neutrophil showing early apoptosis. It has a smooth outline. One of the nuclear 
lobes has condensed chromatin, but the others retain normal structure, including pale 
euchromatin. The bottom pair of electron micrographs show shrunken apoptotic cells with 
smooth, featureless membranes and condensed, uniform chromatin. (om x 9 600). 
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Figure 5 -7 Electron microscopy of alveolar macrophages from BAL showing 
vacuoles containing apoptotic neutrophils 
The electron micrographs show alveolar macrophages with vacuoles containing partially 
degraded apoptotic neutrophils (arrowed). (om x5600). 
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5.4.2.3 Total recovery of neutrophils from broncho- alveolar lavage 
Figure 5 -8 Recovery of neutrophils from broncho -alveolar lavage 
The graph shows the total number of neutrophils recovered from broncho- alveolar lavage. 
Data is presented as means, error bars show SEM. Complete data sets (n = 12 ) were 
obtained for 0 to 48 hour time groups, and these were included in statistical analysis. P 
values show the significance of the effect of time for pneus and pneuE ( ANOVA). * shows 

















Time after pneumonia induction (hrs) 
In control animals the recovery of neutrophils by selective bronchoalveolar lavage of 
the right cranial and middle lobes was very low (5.5 x 104 + 0.4 x 104 and 3.4 x 104+ 0.5 x 
104 in the two groups). ANOVA of groups with complete data sets (i.e. control, 12 hour, 24 
hour and 48 hour for which n = 12) showed a significant effect of time in both pneuS and 
pneuE (p = 0.0063 and p = 0.002 respectively). Post hoc analysis showed that only the 12 
hour group had a significant elevation of neutrophil numbers above control levels, rising 
about 80 to 100 fold in the two types of pneumonia. The trend was for a high early peak at 
12 hours followed by a decline, which implies neutrophil clearance has begun between 12 
and 24 hours. 
222 
5,4.2.4 Total recovery of apoptotic neutrophils from bronchoalveolar lavage 
Figure 5 -9 Recovery of apoptotic neutrophils from broncho -alveolar lavage 
The graph shows the total number of apoptotic neutrophils recovered from broncho- alveolar 
lavage. Data is presented as means, error bars show SEM. Complete data sets (n = 12 ) were 
obtained for 0 to 48 hour time groups, and these were included in statistical analysis. P 
values show the significance of the effect of time for pneuS and pneuE (ANOVA). * shows 
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Right cranial and middle lobe bronchoalveolar lavage recovered very few apoptotic 
neutrophils from control animals (1.5 x 104+ 1.3 x 104 and 0.5 x 104 + 2 0.2 x 104, mean ± 
SEM in the two control groups). In pneuS there was a significant effect of time on recovery 
of apoptotic neutrophils (p = 0.0017) but this just failed to reach significance in the pneuE 
group (p = 0.055). Post hoc analysis showed that the 24 hour pneuS group was the only one 
in which apoptotic neutrophil recovery was significantly greater than control, with 17.4 x 
104+ 3.4 x 104 (mean + SEM) being recovered. It is notable that this peak of apoptotic 
neutrophil recovery follows the peak in total neutrophil recovery, and indeed the overall 
trend is for a later, more sustained rise in numbers of apoptotic neutrophils compared to total 
neutrophils, as expected if neutrophils are ageing in situ and becoming apoptotic. 
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Overall, a similar pattern is seen in pneuE, even though the changes just fall short of 
reaching significance. 
5.4.2.5 Total alveolar macrophages containing apoptotic bodies recovered from 
broncho- alveolar lavage 
Figure 5 -10 Total number of macrophages containing apoptotic bodies 
recovered from broncho -alveolar lavage 
The graph shows the total number of macrophages containing apoptotic bodies recovered 
from broncho -alveolar lavage. Data is presented as means, error bars show SEM. Complete 
data sets (n = 12 ) were obtained for 0 to 48 hour time groups, and these were included in 
statistical analysis. P values show the significance of the effect of time for pneuS and pneuE 
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Broncho- alveolar lavage of control, unbronchoscoped rabbits contained very few 
alveolar macrophages containing apoptotic bodies (2.2 x 104 + 1.2 x 104 and 2.9 x 104 ± 0.9 
104, mean + SEM for the two control groups). In both pneuS and pneuE there was a 
significant effect of time on the number of these cells (p = 0.0013 and p = 0.003 
respectively). Post hoc analysis revealed numbers were significantly raised above control in 
24 and 48 hour groups. The trend for the later groups not included in formal analysis was to 
show even higher levels before returning towards normal, with an eventual maximum of 
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67.7 x 104 + 18.0 x 104 and 69.6 x 104+ 22.5 x 104 (mean ± SEM) for pneus and pneuE 
respectively, each occurring at 72 hours. 
Overall, the results show that there is a decline in total neutrophil numbers form 12 
hours onwards, and that the trend is for a later increase in total apoptotic cells. Thus, as 
neutrophil numbers fall, apoptotic cell numbers rise, and the number of alveolar 
macrophages containing apoptotic bodies increases. This is consistent with the hypothesis 
that ageing neutrophils in the lung undergo apoptosis and as they do so they are cleared by 
alveolar macrophages. 
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5,43 In vitro apoptosis; rabbit neutrophils 
Figure 5 -11 a) and b) Effect of broncho -alveolar lavage fluid on rabbit 
neutrophil apoptosis in vitro 
The graphs show the effect of culturing rabbit neutrophils with 50 % broncho- alveolar 
lavage fluid taken at intervals after induction of pneuS or pneuE on the amount of apoptosis 
in the neutrophils. Data is expressed as the ratio of apoptosis in the presence of test broncho- 
alveolar lavage fluid and PBS control, showing median apoptotic ratio and interquartile 
ranges. n = 6 per group. Graph a) shows apoptotic ratio after 5 hours, graph b) shows 
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Broncho- alveolar lavage supernatants collected from control animals and from 
animals12, 24, 48, 72 and 96 hours after induction of pneumonia were assessed for their 
ability to induce apoptosis in rabbit neutrophils in vitro, 100 µl being added to 100111 of 
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neutrophil suspension. The results are expressed as the ratio of apoptosis induced by the test 
bronchoalveolar lavage fluid to that produced by a control of PBS. n = 6 for each time point. 
In absolute terms, the ranges of percent of neutrophils that were apoptotic when culured 
with PBS for 5, 10 or 20 hours were 0.7 -3.3 %, 0.41 -15.4 %, and 5.7 -21.3 %. For culture 
with control bronchoalveolar lavage, the ranges were 3.9 -11.3 %, 3.06 -23.1 % and 4.28 -58.9 
%. For culture with bronchoalveolar lavage from animals with PneuS the ranges were 2.6- 
36.5 %, 2.8 -53.1% and 5.7 % to 60.7 %. For culture with broncho- alveolar lavage from 
animals with PneuE the ranges were 0.6 -16.1 %, 1.2 -33.7 % and 4.9 -44.7 %. 
Broncho -alveolar lavage fluid was found to induce very variable amounts of apoptosis 
after 5 and 10 hours. At these time points > 95 % and usually > 98 % of neutrophil were 
viable as assessed by Trypan Blue exclusion, and there was no difference in neutrophil 
recovery between groups. Neutrophils were also examined at 20 hours, but by this time 
many were unable to exclude Trypan Blue and could not be assessed. This is in keeping 
with previous unpublished studies that found rabbit neutrophils to be less robust in vitro 
than human neutrophils (C. Haslett, personal communication). 
Overall, the results at 5 and 10 hours were very variable. However, it was notable that 
at all time points and in both sorts of pneumonia, as well as unbronchoscoped controls, 
broncho -alveolar lavage fluid produced neutrophil apoptosis greater than that produced by 
PBS alone. This means all broncho- alveolar lavage induces neutrophil apoptosis. 
The large interquartile ranges show that within this overall picture there is 
considerable variability. In particular, some broncho- alveolar lavage samples induced quite 
dramatic levels of apoptosis. This is revealed by an examination of maximal apoptosis 
induced for each group in absolute percentages. 
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Table 5.1 Maximum amount of apoptosis produced per group 
The table shows the maximum amount of apoptosis produced in rabbit neutrophils by 5 
hours culture in the presence of broncho -alveolar lavage fluid from each Brou 
Group (n = 6) PBS Control 12 hr 24 hr 48 hr 72 hr 96 hr 
Max. apoptosis 
( %) pneuS 
3.3 11.3 36.5 26.72 18.9 25.0 32.0 
Max. apoptosis 
( %) pneuE 
3.7 7.6 5.1 15.66 16.14 7.35 9.96 
It is clear that the maximal rates of apoptosis induced by BAL are way in excess of 
any seen in PBS controls. In every experimental group there are cases in which the apoptosis 
produced is completely outside the control range. Some animals appear to be producing a 
factor that induces apoptosis in neutrophils, but this effect is highly variable and is not so 
clearly apparent in pooled data. 
In pneuS, there is a highly significant (though weak) relationship between the levels 
of the three chemokines IL -8, MCP -1 and gro in broncho- alveolar lavage fluid, and 
neutrophil apoptosis produced by that broncho- alveolar lavage fluid in vitro at 5 and (to a 
slightly lesser extent) at 10 hours. In addition, in pneuS the amount of apoptosis seen in 
vitro at 10 hours correlated significantly (though weakly) with the total apoptotic 
neutrophils in BAL (r = 0.49, p < 0.01). The correlation did not quite reach significance at 5 
hours (r = 0.4207). None of these correlations held true in pneuE. 
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Table 5.2 Correlation between neutrophil apoptosis induced in culture by 
broncho -alveolar lavage fluid and broncho -alveolar lavage fluid chemokine 
levels 
The table shows correlation coefficients relating the amount of apoptosis seen in neutrophils 
cultured in the presence of broncho- alveolar lavage fluid, and the amounts of the 
chemokines IL -8, MCP -1 and gro measured in the fluid. Data is given as correlation 
coefficients. * Significant at p < 0.01 ** significant at p < 0.001 
NS = no significant correlation 
IL-8 MCP-1 gro 
Neutrophil apoptosis at 5 hr 
pneuS 
0.5873** 0.5594** 0.6215** 
Neutrophil apoptosis at 10 hr 
pneuS 
0.4776* 0.5635** 0.5302* 
Neutrophil apoptosis at 5 hr 
pneuE 
NS NS NS 
Neutrophil apoptosis at 10 hr 
pneuE 
NS NS NS 
Table 5.3 Ranges of chemokine levels in broncho -alveolar lavage fluid 
(Minimum, Maximum) 
IL -8 (ng/ml) MCP -1 (µg/ml) gro (p.g/ml) 
Control 0, 0 0, 125.6 0, 0.04 
PneuS 0, 2770 0, 400 0, 0.47 
PneuE 0, 8207 0, 400 0, 0.81 
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In vitro apoptosis; human neutrophils 
Figure 5 -12a) and b) Effect of broncho -alveolar lavage fluid on human 
neutrophil apoptosis in vitro 
The graphs show the effect of culturing human neutrophils with 50 % broncho- alveolar 
lavage fluid taken at intervals after induction of pneuS or pneuE on the amount of apoptosis 
in the neutrophils. Data is expressed as the ratio of apoptosis in the presence of test broncho- 
alveolar lavage fluid and PBS control, showing median apoptotic ratio and interquartile 
ranges. n = 6 per group. Graph a) shows apoptotic ratio after 6 hours, graph b) shows 
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Broncho -alveolar lavage fluid from a second group of animals was used to assess the 
ability of rabbit BAL to affect human neutrophil apoptosis. BAL was from 
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unbronchoscoped controls and 12, 24 and 48 hours after the induction of pneumonia. 
Viability as assessed by ability to exclude Trypan Blue was >95 % in all cases at 20 hours as 
well as 6 hours, and in very nearly all cases was > 98 %. 
Overall, in contrast to when rabbit neutrophils were used there was a tendency 
towards inhibition of neutrophil apoptosis. However, in pneus and pneuE in the 6 hour 
group there were examples of broncho- alveolar lavage fluid that induced apoptosis, 
particularly BAL from animals 12 hours after the induction of pneumonia. Re -assay of 
selected samples showed this to be reproducible. 
Table 5.4 Maximum amount of apoptosis produced per group 
The graph shows the maximum amount of apoptosis produced in human neutrophils by 6 
hours culture in the presence of broncho- alveolar avage fluid from each Brou 
Group (n = 6) PBS Control 12 hr 24 hr 48 hr 
Max. apoptosis 
( %) pneuS 
3.5 2.93 4.7 35.12 7.36 
Max. apoptosis 
( %) pneuE 
3.5 3.01 16.4 8.57 3.83 
The absolute rate of human neutrophil apoptosis produced in control broncho -alveolar 
lavage was not outside that seen in PBS controls. However, at all other time points in both 
types of pneumonia there were examples of broncho- alveolar lavage fluid that produced 
apoptosis above the range seen in the PBS control. This showed that some broncho -alveolar 
lavage samples contained a factor that induced neutrophil apoptosis, but the presence of this 
factor was highly variable even within groups. 
At 20 hours, there was very little tendency for broncho- alveolar lavage to either 
promote or inhibit human neutrophil apoptosis. The only exception to this was in the 12 
hour pneuS group where there was a tendency to inhibition, though this did not reach 
statistical significance. 
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It is notable that TNF a produces early neutrophil apoptosis and diminished late 
apoptosis. Pre -incubation of selected BAL samples that produced high 6 hour apoptosis 
were tested for the ability of anti -TNF antibody to inhibit the pro -apoptotic effect of the 
samples. No inhibition was demonstrated. In addition, the correlation between apoptosis at 6 
hours and 20 hours though relatively weak was positive (r = 0.418, p = 0.040), unlike the 
negative relationship seen with TNF a. Further preliminary studies showed incubation of 
neutrophils with anti -Fas antibody also failed to inhibit the pro -apoptotic activity of the 
broncho- alveolar lavage fluid. Each of these studies used a control lavage that was not able 
to induce apoptosis, a lavage from pneuS at 24 hours that showed intermediate ability to 
induce apoptosis, and a lavage from pneuE at 24 hours that showed great ability to induce 
apoptosis. Each lavage sample produced consistent effects on apoptosis on each occasion 
they were studied. 
Human neutrophil apoptosis in vitro at 6 hours in pneuS produced by broncho- 
alveolar lavage fluid correlated significantly with total neutrophils recovered from the 
lavage (r = 0.597, p < 0.01). No such correlation was seen at 20 hours, or with pneuE. This 
paralleled the relationship seen with rabbit neutrophils. 
5.5 DISCUSSION 
5.5.1 Cellular recovery from broncho- alveolar lavage 
Neutrophil recovery from selective broncho- alveolar lavage of the right cranial lobe 
was greatest at 12 hours and declined progressively thereafter in both pneus and pneuE. In 
chapter two, broncho- alveolar lavage neutrophil recovery was prolonged in pneuE compared 
to pneuS. Two differences in technique explain this apparent discrepancy. Firstly, timings of 
groups in chapter two refer to time of injection of In -wbc. The actual lavages were taken 
21 hours later. Thus, '6 hour' and '30 hour' groups were actually lavaged at 27 and 51 hours, 
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and are more comparable to 24 and 48 hour lavages in this chapter. Examination of 
neutrophil numbers at these time points reveals a pattern not so dissimilar to that seen in 
chapter two. 
Nevertheless, neutrophil influx to the right lung at 30 hours, assessed using In -wbc, 
was as high as at 6 hours in pneuE, but not pneuS. The fact that neutrophil recovery fell 
between these times even in pneuE in studies reported in this chapter is likely to be due to 
the selective sampling of the cranial and middle lobes in these studies, whereas the entire 
right lung was sampled in studies for chapter two. From the data presented in chapter two, 
the ratio of indium influx, (as determined by tissue gamma well counting), between the 
cranial and middle lobes, and the caudal lobe, in the 6 hour group is 8.24 and 4.24 in pneuS 
and pneuE respectively, and in the 30 hour group is 3.78 and 1.51. This suggests the 
inflammation in pneuS is proportionately more confined to the cranial lobe, whereas there is 
greater spread of influx to the caudal lobe in pneuE. This spread would not be sampled in 
the current experiment, but would be consistent with the finding that pneuS in clinical 
disease is more likely to show a lobar pattern whereas gram negative pneumonias more 
commonly manifest as a more diffuse bronchopneumonia (Coalson, 1995). If the spread of 
inflammation in pneuE proceeds outwards from the initial focus, late neutrophil influx 
would be concentrated at the peripheral parts of the lesion, i.e. in the caudal lobe. This 
would be sampled in the experiments in chapter two, but not in the current experiments, and 
it accounts for the apparent differences. 
As expected, low numbers of morphologically apoptotic neutrophils were recovered. 
It has been shown that after injection of anti -CD4 antibody sufficient to cause 50 % cell 
lymphocyte loss after 24 hours, only 2 - 3 % of cells appeared apoptotic on morphological 
examination (Howie et al, 1993). This is because apoptotic cells are rapidly cleared form 
tissues (Kerr et al, 1987, Wyllie et al, 1980). 
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Because of the low numbers present, neutrophils were concentrated from broncho- 
alveolar lavage by centrifugation on a hetastarch -Percoll gradient. Erythrocytes and 
neutrophils were deposited at the base of this gradient as a loose pellet. The macrophage 
rich cell layer on top of the gradient rarely contained any neutrophils, apoptotic or 
otherwise, so it seems unlikely this gave relative concentration or dilution of apoptotic 
compared to normal neutrophils. In view of the fact that neutrophil adhesive functions 
diminish during apoptosis, it is possible that apoptotic cells were selectively lavaged 
compared to normal neutrophils (Dransfield et al, 1995). However, even though this could 
give slight overestimation of their numbers, it should still allow demonstration of 
differences between groups. 
Apoptotic neutrophils were recognised by their morphological appearances (Wyllie et 
al, 1980). The shrunken nature of apoptotic cells, together with nuclear condensation was 
readily apparent on acridine orange staining. The delicate fine granularity of the chromatin 
in normal cells was quite different from the uniform, bright staining of chromatin in 
apoptotic cells. Usually the multilobed nature of the nucleus was retained, but often the 
lobes appeared to be completely separated. Acridine orange staining was routinely used for 
quantitation of rabbit neutrophils, as they appeared delicate when apoptotic, often making 
cytocentrifuge preparations unclear. Nevertheless, examples of clear apoptotic morphology 
were apparent in the latter. Electron microscopy also confirmed the presence of cells with 
ultra -structural characteristics of apoptosis. 
At least 500 cells were counted per sample with the exception that, in control animals, 
neutrophil recovery was so low as to preclude this. Usually 100 - 200 cells (but sometimes 
even fewer) could be counted in the control group. As only a few per cent of neutrophils 
were apoptotic, this meant a significant degree of variability was inevitable. Despite this, 
there was a significant effect of time on total apoptotic neutrophil recovery in pneus, with 
post hoc testing revealing the 24 hour time point to have significantly greater apoptotic 
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neutrophil recovery than controls. Whilst in pneuE the effect of time fell just short of 
reaching significance (p = 0.055), the overall pattern appeared similar in both types of 
pneumonia, with a prolonged increase in apoptotic neutrophils. Numbers after 72 hours were 
similar to those after 12 hours. Thus, the peak of apoptotic cell recovery was broader and 
delayed compared with that of total neutrophil recovery. Freshly recovered neutrophils 
hardly ever lost the ability to exclude Trypan Blue dye, meaning they were not undergoing 
necrosis. 
Data relating to alveolar macrophages was more robust due to the larger cell 
recoveries. They were examined on routine cytocentrifuge preparations stained with Diff- 
Quik° for the presence of apoptotic bodies. These were recognised as vacuoles containing 
large basophillically stained inclusions. These were sometimes clearly recognisable as 
apoptotic neutrophils, although on other occasions, degradation had proceeded to a degree 
where direct recognition was not possible. It is unlikely that they represented the ingestion 
of any other cell type more than infrequently. The very large number of neutrophils present 
initially declined as these cells appeared, and as noted some inclusions could be directly 
identified as neutrophils. Although epithelial cell damage occurs in pneumococcal 
pneumonia, it is unlikely they are lost in sufficient numbers to contribute significantly to the 
number of inclusions seen, or there would be gross destruction of the lung's architecture in a 
way that is not usually witnessed (Johnston, 1991). In addition, electron microscopy showed 
examples of alveolar macrophages with vesicles containing partially degraded remnants that 
were clearly compatible with apoptotic neutrophils. The total number of macrophages 
conatining such inclusions increased throughout both types of pneumonia. 
Only occasional neutrophils recovered from broncho- alveolar lavage were found to be 
unable to exclude Trypan Blue. Thus, most appeared to be normal or apoptotic, rather than 
necrotic. Nevertheless, in areas of very intense inflammation, degenerate neutrophils were 
apparent histologically. Indeed, it would be remarkable if some neutrophils did not suffer a 
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necrotic death in view of the toxic factors that accumulate at the inflammatroy site. It is 
virtually impossible to directly compare the number of neutrophils becoming necrotic with 
those becoming apoptotic because the latter are only transiently present, and the former 
may be difficult to recognise as more than cellular fragments. The clear demonstration of 
apoptotic neutrophils at the inflammatory site suggests apoptosis does play a rôle in 
neutrophil clearance. Furthermore, even the presence of low numbers of apoptotic cells 
implies the removal of large numbers of cells by this mechanism, as discussed (Howie et al, 
1994). 
In addition, the temporal sequence of cell recovery follows the pattern expected if 
neutrophil apoptosis plays a significant rôle in neutrophil clearance, with an initial peak in 
total neutrophils, followed by a later peak in apoptotic neutrophils, followed by a later peak 
of alveolar macrophages containing apoptotic bodies,. 
It is concluded that apoptosis contributes significantly to neutrophil clearance from 
the lung during pneumonia. 
5.5.2 Comparison of cell recovery data with other studies 
As described in the general introduction, a number of historical studies have 
described neutrophil apoptosis by macrophages during inflammation, without realising the 
full implications of the process. This includes the description of neutrophils with pyknotic 
nuclei being taken up by macrophages after 24 to 48 hours of experimental pneumonia 
(Loosli, 1942b). 
1 to 11 % of neutrophils from inflamed synovial fluid were morphologically apoptotic 
(Savill et al, 1989), and apoptotic neutrophils have also been observed in broncho- alveolar 
lavage from babies with respiratory distress syndrome (Grigg et al, 1991). 
Two abstracts presented to the American Thoracic Society relate to studies of 
apoptosis of neutrophils in vivo. One of these used the TUNEL method to demonstrate 
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extremely high numbers of apoptotic cells in pneumonia histologically (Kutkoski et al, 
1996). As discussed in the general introduction, this method is quite likely to overestimate 
apoptosis compared to morphological methods, and there must be some doubt to its 
applicability at inflammatory sites. The study did indeed demonstrate fewer apoptotic 
neutrophils from broncho- alveolar lavage, these being assessed by morphology. The exact 
numbers are not given in the abstract. 
The other study examined the number of apoptotic cells in broncho- alveolar lavage 
from patients with ARDS (Matute -Bello et al, 1996). The most surprising fact about this 
study was that the majority of apoptotic neutrophils were said to be free, with less than 1 % 
being found within macrophages. The reason for this unique finding is not clear from the 
abstract. However, between 1 and 3.3 % of neutrophils were found to be apoptotic, of the 
same order as in the current study. 
After instillation of thioglycollate broth into guinea pig peritoneum, there is a 
neutrophil accumulation that peaks at 24 hours before declining (Yasamato et al, 1995). 
Macrophages were found to ingest neutrophils, and the maximal proportion of macrophages 
containing neutrophils was at 48 hours, when 20 % of macrophages showed this 
phenomenon. Although the experimental model is very different, this is broadly similar to 
the current study. 
A much more similar study was performed to examine apoptotic neutrophil 
appearance and macrophage uptake after intrapulmonary instillation of LPS in rats. 
Broncho- alveolar lavage was performed at 6, 18, 24, 48 and 72 hours. Neutrophil recovery 
was greatest at 18 hours, declining a little by 24 hours. This was commensurate with the 
current study. The peak in apoptotic cell number occurred at 24 hours. Macrophages 
showing apoptotic bodies also increased to a maximum at 48 hours, but were still clearly 
elevated 48 hours later. These timings are in excellent agreement with the current study. The 
data of Cox et al show very tight peaks of total and apoptotic cell number, with a standard 
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deviation of roughly 20 % of the mean despite a maximum rate of apoptosis of 3 % of total 
neutrophil numbers. This is likely to relate to the use of LPS rather than live stimuli. Live 
stimuli are intrinsically more variable, and early intrapulmonary growth may 'blur' the onset 
of inflammation so that it varies in different areas, though the use of LPS suffers from the 
criticism that this is an artificial stimulus. Cox et al found 1 to 3 % of neutrophils were 
apoptotic overall, whereas this study found 5 to 10 % were apoptotic. Cox et al also found a 
maximum of 10 % of alveolar macrophages showing evidence of having ingested 
neutrophils. Interestingly, they found roughly 1.5 free apoptotic neutrophils per alveolar 
macrophage containing a recognisable apoptotic body, compared to 1 at 24 hours and 2 at 48 
hours in the current study, implying a similar removal rate. Overall, the results are in 
excellent agreement. 
5.5.3 The effect of broncho- alveolar lavage fluid on rabbit neutrophil apoptosis in 
vitro 
When neutrophils were cultured in a 50:50 mix of broncho- alveolar lavage fluid and 
culture medium supplemented with serum, a greatly variable rate of apoptosis was observed 
observed at 5 and 10 hours of culture. At 20 hours of culture there was a significant degree 
of Trypan Blue positivity, precluding further analysis of this point. 
Although the rate of apoptosis was variable, every broncho -alveolar lavage sample 
produced greater apoptosis than PBS controls, showing that in general, broncho- alveolar 
lavage was able to induce apoptosis. In addition, at every time point, there were examples of 
lavages that produced amounts of apoptosis in excess of that produced by any control 
lavage. Either the expression of the factor in control broncho -alveolar lavage that was able 
to induce apoptosis was increased, or a further factor was elaborated. 
In pneuS, the amount of apoptosis produced by broncho- alveolar lavage fluid 
correlated with the levels of the chemokines IL -8, gro and MCP -1, the strongest correlation 
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being with gro. IL -8 has been reported not to have any effect on neutrophil apoptosis in 
vitro, (Colotta et al, 1992), whilst the effect of MCP -1 and gro have not been reported. 
MCP -1 has generally been found to have no effect on neutrophils. Gro shares receptors with 
IL -8, and has many overlapping functions, so it would be surprising if it proved to have 
radically different effects on apoptosis. In addition, as discussed, most pro -inflammatory 
mediators inhibit rather than enhance apoptosis. It is more likely therefore that this 
correlation reflects co- expression of an apoptosis promoting substance with the chemokines 
rather than a direct action. 
It is interesting that the relationship between in vitro apoptosis and chemokine levels 
doses not hold true in E. coli pneumonia. This was despite the fact that there was an 
induction of apoptosis by some examples of broncho -alveolar lavage from pneuE. Broncho- 
alveolar lavage from an inflammatory site will undoubtedly have a variety of substances 
capable of modulating apoptosis to some degree, and the final effect will be a balance of 
these. It seems that the factor that induces apoptosis is not as dominant in pneuE as in 
pneuS. One possible explanation is the LPS that is likely to be present in lavage from pneuE. 
This is known to inhibit neutrophil apoptosis in vitro (Colotta et al, 1992), and similar 
effects have been observed in vivo (Yamamoto et al, 1993). 
The relevance of these findings is suggested by the fact that the amount of apoptosis 
induced by broncho- alveolar lavage after 10 hours in vitro correlates significantly (though 
weakly) with apoptotic neutrophil recovery in vivo. On the other hand, this relationship was 
not found in pneuE. This finding was confirmed using human neutrophils and a different set 
of lavages from pneuS and pneuE, when 6 hour neutrophil apoptosis was again found to 
correlate with in vivo neutrophil recovery from pneuS and pneuE. It suggests that the 
modulation of apoptosis in pneuS is dominated by a factor that induces apoptosis, whereas 
in pneuE this factor is not able to exert such clear dominance. Differences in conditions, 
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such as dilutional factors, in vivo and in vitro, may allow other factors (such as LPS) to 
dominate. 
5.5.4 The effect of broncho -alveolar lavage fluid on neutrophil apoptosis in vitro, 
and possible mechanisms of broncho -alveolar lavage induction of neutrophil 
apoptosis 
The effect of rabbit broncho- alveolar lavage fluid was also tested on human 
neutrophil apoptosis in vitro. This was performed as human neutrophils retain the ability to 
exclude Trypan Blue dye in culture beyond 20 hours. This difference from rabbit cells, 
which seem much less robust than human cells, has been noted before (C. Haslett, personal 
communication). In addition, this performs a cross check of the results obtained with rabbit 
cells in a more fully characterised system (there are no published studies of apoptosis of 
rabbit neutrophils in culture). Further, it prepares for future studies using blocking 
antibodies to neutrophil receptors; these reagents are often not available for use with rabbit 
cells. 
Unlike the case with rabbit neutrophils, 6 hour apoptosis of human neutrophils was 
not enhanced by control broncho- alveolar lavage. However, as in the case of rabbit 
neutrophils, although there was no consistent pattern throughout pneumonia, there were 
clear examples of induction of apoptosis by rabbit neutrophils, and this was clearly 
repeatable for individual lavages. Once again, virtually every time point in both types of 
pneumonia produced examples of broncho -alveolar lavage fluid capable of induction of 
apoptosis. The lack of induction with control lavage is most likely to be due to species 
difference in response. This may be because a single apoptosis -inducing substance is present 
but stimulates human neutrophils less than rabbit cells so there is little effect at resting 
concentrations. Alternatively, there may be more than one apoptosis producing substance 
present, with the predominant substance present in control samples cross -reacting poorly, 
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whilst that induced during inflammation cross -reacts well. Clearly this at present remains 
highly speculative. 
After 20 hours of neutrophil culture in the presence of broncho -alveolar lavage, there 
was very little change in the amount of apoptosis. In fact, broncho- alveolar lavage samples 
collected 12 hours after induction of pneuS tended to inhibit this late neutrophil apoptosis. It 
is notable that early induction of neutrophil apoptosis with late inhibition is an unusual 
property possessed by TNFa (Murray et al, In press). However, correlation of apoptosis 
produced after 6 and at 20 hours culture showed a positive correlation for individual 
samples, as opposed to the negative one expected if the effect is solely due to TNFa. 
The action of Fas- ligand on Fas has also been found to induce apoptosis in 
neutrophils (Liles et al, 1996). Fas- ligand can be produced by neutrophils. Therefore, at sites 
of inflammation with elevated neutrophil density, increased Fas- ligand might be expected. 
This could induce neutrophil apoptosis, providing negative feedback control of tissue 
neutrophil burden. This merits further investigation, although preliminary experiments have 
shown the induction of human neutrophil apoptosis by broncho -alveolar lavage fluid is not 
inhibited by anti -Fas antibody. 
A similar negative feedback mechanism is provided by the finding that a variety of 
proteases that can be produced by the neutrophil cause neutrophil apoptosis (Trevani et al, 
1996). This could be useful in sensing an excess liberation of neutrophil enzymes, so that if 
their concentration is elevated in the internal milieu, apoptosis of surrounding neutrophils 
would be induced. It is possible that tissue proteases in broncho -alveolar lavage fluid 
mediate the induction of apoptosis in neutrophils. This could also explain the correlation 
with IL -8 and gro levels, which are known to cause neutrophil degranulation. However, 
proteases still produce increased apoptosis at 18 hours, rather than the biphasic response 
seen with human neutrophils. 
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Although TNFa, Fas- ligand and proteases may contribute to the pro -apoptotic effect 
of broncho -alveolar lavage, none seem to offer a complete explanation for the phenomenon. 
These are the only non- pharmacological substances demonstrated to enhance neutrophil 
apoptosis to date. This raises the possibility that a novel pro -apoptotic factor may be 
responsible. This could have exciting implications therapeutically, acting to down- regulate 
inappropriately recruited neutrophils in such diseases as the Adult Respiratory Distress 
Syndrome, or pulmonary fibrosis, thereby diminishing their capacity to cause damage. 
Analogous experiments were performed using synovial fluid from inflamed joints 
(Bell et al, 1995). Apoptosis of neutrophils was enhanced when cultured with the synovial 
fluid. This differed from the current study in that apoptosis was enhanced at 24 hours; in 
fact, earlier effects were not assessed. Interestingly, they also found the effect to be highly 
variable. Several samples produced no effect, whilst some showed dramatic enhancement 
(10 to nearly 100 % in one case). They found that GM -CSF was unable to reverse this 
effect, whereas others have found the stimulatory effects of TNFa can be overcome thus (E. 
Chilvers, personal communication), suggesting TNFa is not responsible. 
Formerly, it has been thought that high concentrations of inflammatory mediators at 
the inflammatory site lead to prolongation of neutrophil survival there (Haslett, C., 1992). 
Consideration of the results of the this study and those of Bell et al suggests the situation is 
more complex. At the inflammatory site the neutrophil is exposed to both pro- and anti - 
apoptotic signals. It would be very surprising if this ability to modulate apoptosis has 
evolved accidentally, and this is strong evidence that the apoptosis does indeed have an 
important part to play in limitation and resolution of the acute inflammatory process. 
5.6 Summary 
1) Cells recovered from BAL of pneuS and pneuE contained apoptotic neutrophils 
and alveolar macrophages containing apoptotic, as determined by light and electron 
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microscopy. Such cells were also seen on light microscopy of tissue sections of pneumonic 
lung. 
2) In both pneuS and pneuE, selective broncho- alveolar lavage of the right cranial 
lobe recovers cells in the order expected if apoptosis plays a role in neutrophil clearance 
during pneumonia. Initially, neutrophil levels peak at 12 hours, followed by a broader peak 
of apoptotic neutrophils extending from 12 to 72 hours. Alveolar macrophages containing 
apoptotic neutrophils become common from 48 hours. 
3) The magnitude and timing of these responses are in good agreement with other 
studies, and are sufficient to suggest apoptosis plays an important rôle in neutrophil 
clearance in pneumonia. 
4) In vitro, rabbit neutrophils cultured in the presence of broncho- alveolar lavage 
fluid demonstrated induction of apoptosis. This was variable, but in some cases could be 
quite marked. In pneuS, there was a correlation between induction of apoptosis and 
chemokine levels, but this was not true in pneuE. In addition, in vitro induction of apoptosis 
correlated with in vivo apoptotic neutrophil recovery in pneuS but not pneuE. 
5) Using human neutrophils, it was confirmed that some examples of broncho- 
alveolar lavage from pneuS and pneuE were able to induce early (6 hour) apoptosis. Use of 
human cells also allowed the effect at 20 hours to be studied. By this time, little effect was 
apparent, with the exception of an inhibitory action at 6 hours in pneuS. Once again, a 
correlation between early in vitro neutrophil apoptosis induction and in vivo apoptotic 
neutrophil recovery was observed in pneuS but not pneuE, despite the use of different 
lavage samples. 
6) TNFa can produce early stimulation and late inhibition of apoptosis, but there was 
a positive rather than a negative correlation of 6 and 20 hour apoptosis induced in human 
cells. Preliminary experiments suggest anti -TNFa antibody is unable to block the effect. 
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7) Protease and Fas- ligand may also contribute to the pro -apoptotic action of broncho- 
alveolar lavage fluid and both are likely to be present. However, preliminary data suggests 
anti -Fas anti- bodies are unable to block the pro -apoptotic effect of broncho- alveolar lavage 
fluid. Proteases do not produce the biphasic response witnessed with human neutrophils. 
8) As the known physiological factors that are pro -apoptotic for neutrophils do not 
seem to provide adequate explanation for the pro -apoptotic effects seen, this raises the 
possibility a novel factor or factors may be important. Such a factor could play a crucial part 
in resolution of acute inflammation. 
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6. OVERALL SUMMARY 
Despite medical advances, pneumonia remains of great importance, both within 
hospitals and the community at large. Indeed, the emergence of resistant organisms and the 
increasing incidence of pathological and iatrogenic immunosuppression are likely to 
increase its importance. 
As reviewed, there is abundant evidence that the inflammatory response is carefully 
regulated during pneumonia. The response depends on the type of initiating stimulus, and its 
mode of delivery and dose. Variations of any of these parameters may give rise to 
qualitative and quantitative differences in cellular response. In addition, it is clear the acute 
inflammatory response is dynamic and evolving rather than static. 
Other studies have been noted, showing there are clear differences in neutrophil 
recruitment in areas supplied by the pulmonary and systemic circulations. A large part of 
this difference is likely to be due to low pressure, pulsatile blood flow in lungs, coupled with 
narrow capillary segments that physically inhibit neutrophil passage. 
In vitro, many mechanisms have been defined that may contribute to inflammatory 
control in vivo. It is often difficult to predict how these different processes interact to 
produce the specificity of response noted. This highlights the importance of in vivo models 
that attempt to reintegrate important data gained from important reductionist studies. It 
emphasises the need for selection of specific models that parallel disease processes as 
accurately as possible. 
245 
Although the neutrophil is essential to host defence, it may cause secondary damage 
to host tissues. This thesis hypothesised that in CAP, typified by infection with 
Streptococcus pneumoniae, the remarkably successful restoration of tissue structure and 
function is due to successful control of tissue neutrophil burden. It hypothesised that the 
increased lung damage during NP caused by gram negative organisms, such as E. coli, is due 
to a greater tissue neutrophil burden. 
Neutrophil burden is determined by the balance between neutrophil influx and 
clearance. Relatively few studies have addressed these two separate parameters specifically, 
and there is little data on how they vary during evolution of disease. A rabbit model of 
pneumonia allowed these parameters to be examined. 
Data presented in chapter two confirmed that there was a prolonged neutrophil influx 
in pneuS than pneuE, contributing to a greater tissue neutrophil burden. The mechanism 
underlying this is uncertain, but could relate to greater persistence of viable E. coli than 
Strep. pneumoniae within the lung. 
The contribution of CD18 and IL -8, two molecules thought to be of widespread 
importance in mediation of inflammation, were then studied. Anti -CD18 antibodies 
inhibited neutrophil influx in pneuE, and there was no change in this with time. Anti -IL -8 
antibodies were rather surprisingly found not to inhibit neutrophil influx in any group 
studied. The finding of elevated BAL and plasma IL -8 levels after anti -IL -8 antibody raises 
the possibility that negative feedback loops had been interfered with, although other 
mechanisms could not be excluded. This emphasises the fact that the in vivo consequences 
of a molecule may not be easily predicted from its in vitro effects. 
Data in chapter four shows that apoptosis of neutrophils occurs during pneumonia. It 
also shows that factors are produced during pneumonia that are capable of modulating this. 
This is potentially important because necrosis of neutrophils could produce significant tissue 
damage, whereas apoptosis should promote neutrophil removal without concomitant 
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damage. Quantitation of the exact contribution of apoptosis to neutrophil clearance is 
difficult, because of the low numbers of apoptotic cells seen at any given time, and no 
difference in recovery of apoptotic cells between pneuS and pneuE was detected. 
Nevertheless, the finding that the ability of BAL from pneuS to induce early in vitro 
neutrophil apoptosis correlates with recovery of apoptotic cells in vitro, whereas that from 
pneuE does not, raises the possibility that apoptosis of neutrophils is more tightly controlled 
in pneuS than in pneuE. This could lead to the decreased lung damage seen in pneuS than 
pneuE. 
Overall. the experiments presented support the hypothesis that there is an increased 
tissue neutrophil burden in pneuS than in pneuE. Different patterns of neutrophil influx are 
shown to contribute to this. No changes in CD18 or IL -8 usage were seen to explain 
modulation of influx. Indeed, blockade of IL -8 unexpectedly produced no inhibition of 
neutrophil influx. Neutrophil apoptosis occurs in pneumonia, and there is evidence of its 
active regulation. It may be more tightly regulated in pneuS than pneuE, helping to prevent 
lung damage in the former. 
Further experiments are merited in the future to investigate the reason for differences 
in influx patterns, and the mechanisms controlling these, and to investigate the factors 
controlling apoptosis during pneumonia. 
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